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SUMMARY 
At present, the global obesity epidemic is showing no signs of abating, which is fuelling an explosion 
in numbers of type 2 diabetes (T2D) worldwide. In order to control these two associated diseases, 
lifestyle modification, which encompasses diet, physical activity, and healthy habits, might be useful. 
Several studies have focused the attention on modifying the main nutrients of the diet to reduce body 
weight and to enhance blood glycaemia among other metabolic biomarkers. The use of 
phytochemicals and bioactive compounds obtained from vegetable sources might be a favourable 
approach to reduce the risk of metabolic chronic diseases; however, it is still a challenge to face. 
Coffee silverskin (CS) and spent coffee grounds (SCG) are very abundant coffee wastes worldwide 
generating global environmental problems. They are natural sources of several bioactive compounds 
with potential to reduce the risk of chronic non-communicable diseases, such as chlorogenic acid 
(CGA), caffeine and dietary fibre. The widespread interest in select foods that might promote health 
has resulted in the use of functional foods to provide specific health benefits beyond basic nutrition. 
Therefore, these coffee wastes may become sustainable high value-added ingredients of interest for 
the management of obesity and T2D. 
The present PhD thesis aimed to produce sustainable high sensorial quality beverage and foods, for 
reducing the risk of chronic metabolic diseases, by means of employing as novel ingredients coffee 
by-products (CS and SCG) and their derivatives, in combination with other healthy ingredients. In 
addition, the present investigation search for studying the impact of the digestive process of these 
functional foods containing coffee by-products, on the release of satiety hormones; as well as,  the 
implication of this physiological event on the formation of potential harmful compounds such as 
Maillard reaction products (MRPs).  
For the first time, the application of CS for the elaboration of a high sensorial quality and sustainable 
antioxidant beverage was proposed. CS extract (CSE)-containing beverages possessed suitable 
nutritional quality regarding the content of soluble dietary fibre, proteins and glycaemic sugars. 
Physiologically active concentrations of bioactive compounds such as CGA and caffeine were 
detected in the beverages, which have shown to contribute in the reduction of fat deposits in the 
worm model of Caenorhabditis elegans. The beverage prepared with Robusta CSE (RCSE), at 10 
mg/ml, was the most effective dose, achieving a body fat reduction of 24%. Moreover, this beverage 
presented similar effect on body fat accumulation to that found in a commercial decaffeinated green 
coffee supplement. Furthermore, the feasibility of the combined use of non-nutritive sweetener and 
CS, in order to achieve healthier, nutritious and good quality biscuits, was also investigated. CS was 
used as a natural colouring and as a source of dietary fibre, leading to full recovery of this coffee 
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waste. The texture and nutritional properties of the biscuits were also improved, and the typical 
golden colour expected of the baked products was provided. The neo-contaminant 
hydroxymethylfurfural (HMF) was greatly reduced and no bioaccessible acrylamide was detected in 
the digests of the new biscuits.  
On the other hand, this is the first time that SCG from the instant coffee process have been 
proposed as sustainable natural source of antioxidant insoluble dietary fibre. Its application as food 
ingredient in bakery products was patented (WO2014128320 A1) during the development of the PhD 
thesis. The coffee fibre was exhausted of sugars and processing contaminants, and presented small 
levels of free bioactive compounds (CGA and caffeine), as a consequence of the extraction process 
in the preparation of soluble coffee beverage. The coffee fibre was stable to the baking and to the 
abiotic gastrointestinal digestion in vitro. All these findings make the coffee fibre valid for its use as 
food ingredient. Non-nutritive sweeteners and fructooligosaccharides (FOS) were included in 
biscuits, which contain antioxidant coffee fibre, to obtain bakery products that meet consumers’ 
preferences. No significant differences were found with those commercial biscuits presenting high 
consumer adhesion and similar characteristics in terms of non-nutritive sweeteners and dietary fibre 
content. The novel coffee fibre-containing biscuit (CFB) presented reduced levels of neo-
contaminants, in particular 67% less of acrylamide (166 µg acrylamide/kg) than the indicative values 
in biscuits established by the European Commission. A 4-fold decrease in the compounds 
associated to diabetes, such as advanced glycation end products (AGEs), was also detected 
compared to a sucrose-containing biscuit (SCB). The digest obtained from simulated human 
digestion of the CFB presented significantly lower glycaemic sugar content (60.6 mg/g) and a higher 
antioxidant capacity (15.1 mg CGA/g) than SCB. Antidiabetic and satiety effects were described for 
the CFB. The bioaccessible fraction of the CFB digest presented significantly higher inhibitory effect 
on α-glucosidase activity (IC50 = 3.3 mg/ml) than the SCB (IC50 = 6.2 mg/ml), and promoted the 
release of satiety hormones, serotonin and glucagon-like peptide-1 (GLP-1) by Caco-2 and HuTu-80 
cells, respectively (355% and 278%), in the same order of magnitude as the SCB. 
The formation of MRPs during digestive process of simplified meal systems was for the first time 
examined. Our results support the formation of non-fluorescent AGEs associated to the 
pathogenesis of diabetes during the digestion of model systems mimicking sugar-containing and 
average meals, respectively. Decrease of lysine (11.7-34%), arginine (24-35%) and other amino 
acids occurred during the digestion process affecting their bioavailability and involving health 
implications. Fructosamine (42.6 and 332.9 µg/ml) and fluorescent adducts (22270 and 9283 RFU) 
were detected in digests of those meals containing high-fructose corn syrup (HFCS) and starch, 
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respectively. Carboxymethyl-lysine (CML) (5 µg/ml) and methylglyoxal (MGO)-derivative AGEs (12.2 
µg/ml) were found in the meal systems composed of fructose.  
In conclusion, the findings derived from the present PhD thesis demonstrate the feasibility of using 
coffee by-products, CS and SCG, in the development of novel sustainable beverages and foods with 
enhanced technological, nutritional and sensorial quality. For the first time, technological strategies 
were achieved for valorisation of coffee by-products into novel health promoting food ingredients, 
avoiding the production of new industrial wastes. Scientific evidences regarding the potential of the 
sustainable beverages and foods for reducing the risk of obesity and T2D were obtained. The novel 
beverages and foods decreased body fat deposits in vivo, induced the release of satiety gut 
hormones related to the feeling of fullness ex vivo and exhibited inhibitory effect on α-glucosidase 
enzyme in vitro. Finally, preliminary evidence on the impact of the digestive process of an average 
and sugary meal systems suggested the formation of compounds of interest in health and diseases 
in the intestinal lumen. 
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RESUMEN 
Actualmente, la epidemia mundial de obesidad no muestra signos de disminución, lo cual está 
conduciendo a una explosión de diabetes tipo 2 en todo el mundo. Con el fin de controlar estas dos 
enfermedades asociadas, la modificación del estilo de vida, la cual incluye cambios en la dieta, 
actividad física y hábitos saludables, parece ser de utilidad. Varios estudios han centrado la 
atención en la modificación de los principales nutrientes de la dieta con el fin de reducir el peso 
corporal y mejorar la glucemia sanguínea entre otros biomarcadores metabólicos. El uso de 
fitoquímicos y compuestos bioactivos obtenidos a partir de fuentes vegetales podría ser una 
estrategia adecuada para reducir el riesgo de enfermedades crónicas metabólicas; sin embargo, 
sigue siendo un reto a abordar. La cascarilla y los posos de café, son abundantes subproductos del 
café que generan problemas medioambientales a nivel mundial. Son fuentes naturales de algunos 
compuestos bioactivos con potencial para reducir el riesgo de enfermedades crónicas no 
transmisibles, como el ácido clorogénico, la cafeína y la fibra dietética. El interés creciente por 
alimentos que puedan promover la salud, ha resultado en la aparición de los alimentos funcionales, 
con el fin de proporcionar así beneficios específicos para la salud, más allá de la propia nutrición 
básica. Por tanto, estos residuos de café podrían convertirse en ingredientes sostenibles de interés 
con alto valor añadido para el control de la obesidad y la diabetes tipo 2. 
La presente tesis doctoral tiene como objetivo elaborar bebidas y alimentos sostenibles de alta 
calidad sensorial, con el fin de reducir el riesgo de las enfermedades crónicas metabólicas, 
mediante el empleo de subproductos del café (cascarilla y posos de café) y sus derivados, en 
combinación con otros ingredientes saludables. Además, la presente investigación busca estudiar el 
impacto del proceso digestivo de los alimentos funcionales elaborados, que contienen estos 
subproductos del café, sobre la liberación de hormonas de saciedad, así como la implicación de 
este evento fisiológico en la formación de posibles compuestos nocivos, tales como los productos 
de la reacción de Maillard (MRPs, de sus siglas en inglés). 
Por primera vez se ha propuesto la aplicación de cascarilla de café, para la elaboración de una 
bebida antioxidante, sostenible, y de alta calidad sensorial. Las bebidas preparadas con extracto de 
cascarilla presentaron una adecuada calidad nutricional en relación al contenido de fibra dietética 
soluble, proteínas y azúcares glucémicos. Se encontraron concentraciones fisiológicamente activas 
de compuestos bioactivos en estas bebidas, tales como ácido clorogénico y cafeína, los cuales 
mostraron contribución sobre la reducción de depósitos de grasa en el modelo de gusano 
Caenorhabditis elegans. La dosis más eficaz la mostró la bebida preparada con extracto de 
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cascarilla Robusta, en concentraciones de 10 mg/ml, logrando una reducción del 24% de la grasa 
corporal. Además, esta bebida presentó un efecto similar sobre los depósitos de grasa corporal al 
mostrado por un suplemento comercial de café verde descafeinado. Además, se ha investigado 
también la viabilidad del empleo combinado de edulcorantes no nutritivos y cascarilla de café con el 
fin de lograr galletas más sanas, nutritivas y de buena calidad. La cascarilla se utilizó como 
colorante natural y como fuente de fibra dietética, lo que condujo a una recuperación completa de 
este subproducto de café. Se consiguió una mejora de la textura y propiedades nutricionales de las 
galletas y además se proporcionó el color dorado típico de los productos horneados. El contenido en 
hidroximetilfurfural se redujo considerablemente y no se detectó acrilamida bioaccesible en los 
digeridos de las nuevas galletas. 
Por otra parte, se ha propuesto por primera vez, el uso de los posos de café procedentes del 
proceso de café instantáneo como fuente natural sostenible de fibra dietética antioxidante insoluble. 
Su aplicación, como ingrediente alimentario en productos de panadería, ha sido patentada 
(WO2014128320 A1) durante el desarrollo de la tesis doctoral. La fibra de café mostró estar 
exhausta en azúcares y contaminantes del procesado, y además presentó bajos niveles de 
compuestos bioactivos libres (ácido clorogénico y cafeína), como consecuencia del proceso de 
extracción en la preparación de la bebida de café soluble. La fibra de café presentó estabilidad al 
horneado y a la digestión gastrointestinal abiótica in vitro. Todos estos hallazgos hacen que la fibra 
de café sea válida para su uso como ingrediente alimentario. Edulcorantes no nutritivos y 
fructooligosacáridos (FOS) se incorporaron en la formulación de galletas, las cuales contenían fibra 
de café antioxidante, con el fin de obtener productos de panadería que satisfagan las preferencias 
de los consumidores. No se encontraron diferencias significativas con galletas comerciales con alta 
aceptación en el mercado y características similares en cuanto a edulcorantes no nutritivos y 
contenido en fibra dietética. La nueva galleta de fibra de café presentó niveles reducidos de neo-
contaminantes, en particular un 67% menos de acrilamida (166 μg acrilamida/kg) que los valores 
indicativos para galletas establecidos por la Comisión Europea. También se detectó una 
disminución 4 veces menor en compuestos asociados a la diabetes, como son los productos 
avanzados de la glicación (AGEs, de sus siglas en inglés), en comparación con una galleta de 
sacarosa. El digerido obtenido a partir de la digestión humana simulada de la galleta de fibra de 
café, presentó un contenido de azúcar glicémico significativamente menor (60,6 mg/g) y una 
capacidad antioxidante mayor (15,1 mg CGA/g), que la galleta de sacarosa. La galleta de fibra de 
café mostró efectos antidiabéticos y de saciedad.  La fracción bioaccesible del digerido exhibió un 
efecto inhibidor sobre la actividad α-glucosidasa (IC50 = 3,3 mg/ml), el cual fue significativamente 
mayor que la galleta de sacarosa (IC50 = 6,2 mg/ml) y además, promovió la liberación de hormonas 
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de saciedad tales como, serotonina y péptido similar al glucagón tipo 1, en las células Caco-2 y 
HuTu-80, respectivamente (355% y 278%), en el mismo orden de magnitud que la galleta de 
sacarosa. 
Por primera vez se ha evaluado la formación de MRPs, durante el proceso digestivo a partir de 
sistemas de comida simplificada. Nuestros resultados apoyan la formación de AGEs no 
fluorescentes asociados a la patogénesis de la diabetes durante la digestión de sistemas modelo 
que simulan comidas con azúcar y una comida promedio, respectivamente. Se observó una 
disminución de lisina (11,7-34%), arginina (24-35%) y otros aminoácidos durante el proceso de 
digestión, afectando así su biodisponibilidad y por tanto, con implicaciones para la salud. En los 
digeridos de sistemas de comida con jarabe de alto contenido en fructosa o almidón, se detectaron 
fructosamina (42,6 y 332,9 μg/ml) y aductos fluorescentes (22270 y 9283 RFU), respectivamente. 
En los modelos de comida preparados con fructosa se encontraron carboximetil-lisina (CML) (5 
μg/ml) y AGEs derivados de metilglioxal (12,2 μg/ml).   
En conclusión, los resultados derivados de la presente tesis doctoral demuestran la viabilidad del 
empleo de subproductos del café, cascarilla y posos, en el desarrollo de nuevas bebidas y alimentos 
sostenibles, de mayor calidad tecnológica, nutricional y sensorial. Por primera vez se han logrado 
estrategias tecnológicas, para la revalorización de los subproductos del café, como nuevos 
ingredientes alimentarios que promueven la salud, y evitando así la producción de nuevos 
subproductos industriales. Se han obtenido además, evidencias científicas sobre el potencial de las 
bebidas y alimentos sostenibles, para reducir el riesgo de obesidad y diabetes tipo 2. Las nuevas 
bebidas y alimentos disminuyen los depósitos de grasa corporal in vivo, promueven la liberación de 
hormonas de saciedad intestinales ex vivo y muestran un efecto inhibidor in vitro sobre la enzima α-
glucosidasa. Por último, la evidencia preliminar sobre el impacto del proceso digestivo de sistemas 
de comida azucarada y de una comida promedio, sugiere la formación en el lumen intestinal de 
compuestos de interés en la salud y enfermedades. 
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INTRODUCTION 
1. Metabolic chronic diseases: Obesity and Diabetes 
Currently, chronic diseases are the leading global causes of death. It is projected to increase up to 
52 million of deaths by 2030 [1]. Obesity and type 2 diabetes (T2D) have reached epidemic 
proportions and are worldwide health problems. These metabolic chronic diseases are caused, to a 
large extent, by behavioural risk factors such as changes in dietary macronutrient intake [2]. 
Therefore, it is possible to reduce the risk of these metabolic diseases through different strategies 
being the most sustainable the promotion of a healthy diet.   
1.1. Obesity 
Obesity is a chronic disease characterized by the expansion of adipose tissue and an inflammatory 
component [3]. Adipose tissue it is now recognized as an active tissue in the regulation of 
physiological and pathological processes, including immunity and inflammation. Adipose tissue 
releases a variety of adipokines, anti- or pro-inflammatory cytokines such leptin, TNF-α and 
interleukin [IL]-4 [4]. These pro-inflammatory molecules play an important role on the development of 
metabolic disease such as T2D and cardiovascular disease [5].  
Obesity can be classified according to different criteria: 
 By body mass index (BMI) and its related risk of mortality: class I for a BMI between 30 and 
34.9 kg/m2, class II for a BMI between 35 and 39.9 kg/m2, and class III for a BMI ≥ 40 kg/m2 [6]. 
In turn, class I obesity is associated with a “moderate risk”, class II with a “high risk”, and class 
III with a “very high risk” of mortality [7].  
 By anatomic phenotypes, it is referred as visceral or a subcutaneous obesity depending on the 
degree of central (i.e. visceral) and peripheral (i.e. subcutaneous) fat. The first term indicates a 
major risk factor for metabolic complications while subcutaneous fat seems to be much more 
benign [8].  
 From an etiologic standpoint obesity can be fundamentally classified as primary or secondary. 
Obesity presents as primary etiology, multifactorial causes involving genetics, hormones, diets, 
and environment [9]. Diet is an important regulatory factor on immune response and there is 
evidence to suggest that over-nutrition leads to immune-activation which is related to obesity 
[4]. A secondary obesity is that developed as a consequence of for example pharmacologic 
treatments. 
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Moreover, there is another important phenotype called “metabolically obese normal weight 
individuals”. They are characterized by increased levels of adiposity and insulin resistance and a 
higher susceptibility to T2D and cardiovascular diseases [10]. Ongoing investigations reveal this 
phenotype is not uncommon [11], however, a consensus on the definition is lacking, and measuring 
the degree of insulin resistance or adiposity is not widely applicable.  
Overweight and obesity have been increasing in all countries. In 2014, 39% of adults aged 18 years 
and older (38% of men and 40% of women) were overweight. The prevalence of obesity nearly 
doubled between 1980 and 2014. In fact, in 2014, 11 % of men and 15% of women were obese. 
Thus, more than half a billion adults worldwide are classed as obese (figure 1) [1].  
Figure 1. Age-standardized prevalence of obesity (BMI ≥ 30 kg/m2) in adults aged 18 years and over by region 
and income group, comparable country estimates, 2014. [AFR=Africa, AMR=America, SEAR =South-East 
Asia, EUR=Europe, EMR=Eastern Mediterranean, WPR=Western Pacific] (World Health Organization (WHO), 
2014) [1]. 
1.2. Diabetes 
Diabetes mellitus is a chronic disorder characterised by major derangements in glucose metabolism 
and abnormalities in fat and protein metabolism [12]. Diabetes is broadly classified under two 
categories, type 1 (T1D) and type 2 diabetes (T2D). 
 T1D is the chronic condition caused by the absence of insulin secretion due to either the 
marked inability of the β-Langerhans islet cells of the pancreas to produce insulin, then glucose 
accumulates in the blood serum unless insulin is supplied [13]. The insulin-dependent diabetes 
is inherited and usually occurs early in life. The major factor in the pathophysiology of T1D is 
considered to be autoimmunity, with immune response against altered β-cells [13].  
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 T2D is a progressive condition in which the body becomes resistant to the normal effects of 
insulin and/or gradually loses the capacity to produce enough insulin in the pancreas [13]. T2D 
has a different pathophysiology and etiology than T1D. T2D is a combination of low amounts of 
insulin production from pancreatic β-cells and peripheral insulin resistance. These two events 
must occur simultaneously for T2D to develop (figure 2) [14]. T2D is the most common type of 
diabetes representing 90–95% of all cases. Most patients with T2D, but not all, are overweight 
or obese, in fact, this excess weight itself causes some degree of insulin resistance. Nutritional 
intervention is a good strategy for reducing the risk of TD2 and one of the main research lines 
of the present PhD thesis. 
Figure 2. Type 2 diabetes (T2D) state. Figure adapted from Peirce & Vidal-Puig (2013) [14]. 
International Diabetes Federation calculates that the diabetic population worldwide will reach 645 
million by 2040, which is equivalent to 1 in 10 adults [15]. World Health Organization (WHO) 
estimates that, globally, 422 million adults aged over 18 years were living with diabetes in 2014 
(table 1) [16]. 
Table 1. Estimated prevalence of people with diabetes (18+ years). Table adapted from WHO (2016) [16]. 
 
WHO region 1980 2014 
Millions % Millions % 
Africa 4 3.7 25 5.9 
America 18 16.7 62 14.7 
Eastern Mediterranean 6 5.6 43 10.2 
Europe 33 30.6 64 15.2 
South-East Asia 17 15.7 96 22.7 
Western Pacific 29 26.8 131 31.0 
Total  108 100 422 100 
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1.3. Relationship between obesity and type 2 diabetes  
Several epidemiologic studies reveal a parallel increase of the twin epidemics of obesity and 
diabetes. Diabesity is a new term, which refers to diabetes occurring in the context of obesity. The 
increase in the prevalence of T2D is associated to the upsurge in obesity. It is estimated that about 
90% of T2D is attributable to excess weight [17]. The connection between obesity and diabetes is 
associated to both, insulin resistance and insulin deficiency (figure 3).  
Figure 3. Links  between obesity and diabetes. Figure adapted from Verma & Hussain (2017) [17]. 
Obesity causes sustained elevation of free fatty acids (FFAs) levels in plasma, both in the basal 
state and following glucose load, which present a major factor for insulin resistance. Increased 
plasma FFAs augment their cellular uptake and induce their mitochondrial β-oxidation, blocking at 
the level of substrate competition, intermediates accumulation, enzyme regulation, intracellular 
signalling and/or gene transcription of the glucose metabolism. The increase in lipid oxidation 
induces a diminution of glucose uptake by muscle and decreased rates of glycogen synthesis in 
skeletal muscle. This state of chronic hyperglycaemia further impairs insulin sensitivity. 
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Hyperglycaemia and compensatory hyperinsulinemia associated with insulin resistance and glucose 
intolerance lead to pathological glycation of circulating proteins. This progression ultimately leads to 
a pancreatic β-cell secretory failure and apoptosis (figure 3) [17]. 
Heritability for obesity and T2D is ~70 and ~35%, respectively [18,19]. Recent advancement in 
human genetics has led to the identification of a relatively big number of obesity- and T2D-
associated genes, however, their contribution to the disease risk has been shown to be smaller than 
expected, greatly contributing other lifestyle factors  [20].  
2. Food components in obesity and type 2 diabetes 
Foods and diet play a key role on both metabolic diseases. An unhealthy diet and some eating 
behaviours such as snacking/eating frequency, binge-eating patterns and eating out have been 
linked to obesity and finally to T2D [21]. In recent years, the Spanish Society of Community Nutrition 
(SENC) has been working on updating the 'Food Guidelines for the Spanish population' based on 
scientific evidence (figure 4)[22]. 
Figure 4. Healthy Eating Pyramid designed by the Spanish Society of Community Nutrition (SENC, 2015)[22]. 
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Beyond the food recommendations themselves, the SENC has been paid special attention to healthy 
lifestyles advises which may affect greater than 40% on illnesses, i.e. physical activity and emotional 
balance. The intake of carbohydrates appears in its newer version as whole grains emphasizing the 
importance of fibre and the reduction of the frequent intake of sugary foods. On the top of the 
pyramid, a new tip appears regarding nutritional supplements, nutraceuticals and functional foods. 
Moreover, the SENC recommends healthy culinary techniques such as steaming, grilling and oven 
cooking, and a sustainable diet committed to the environment. 
Furthermore, the Harvard School of Public Health pinpoints the importance of a quality diet. They 
propose to divide a plate in 4 parts: the half of the plate for vegetables and fruits, a quarter for whole 
grains and the other quarter for healthy proteins (figure 5).  
Figure 5. Healthy Eating Plate created by Harvard School of Public Health. 
Previous studies support the protective role of diet, exercise and its combination in individuals 
genetically susceptible to both pathologies [20,23]. For example, insulin sensitivity and glucose 
uptake can be improved through regular physical activity and healthy diets that include sufficient 
fibre [16]. Table 2 provides information on the role of lifestyle facts on the risk of obesity and T2D.  
Copyright © 2011, Harvard University. For more information about The Healthy Eating Plate, please see The Nutrition Source, Department of 
Nutrition, Harvard School of Public Health, www.thenutritionsource.org, and Harvard Health Publications, www.health.harvard.edu. 
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Table 2. Impact of lifestyle factors in obesity and type 2 diabetes (T2D). Table adapted from WHO (2003) [21]. 
Evidence 
Increased Risk Decreased Risk 
Overweight/Obesity T2D Overweight/Obesity T2D 
Convincing Sedentary lifestyles Overweight and obesity Regular physical activity Voluntary weight loss in 
overweight and obese people 
High intake of energy-dense 
micronutrient-poor foods a 
Abdominal obesity High dietary intake of non-starch 
polysaccharides (dietary fibre) 
Physical activity 
 Physical inactivity   
 Maternal diabetes   
    
Probable Heavy marketing of energy-dense foods Saturated fats Home and school environments that 
support healthy food choices for children 
Non-starch polysaccharides 
High intake of sugars-sweetened soft 
drinks and fruit juices 
Intrauterine growth retardation Breastfeeding  
Adverse socioeconomic conditions (in 
developed countries, especially for 
women) 
   
    
Possible Large portion sizes 
 
Total fat intake Low glycaemic index foods n-3 fatty acids 
 
High proportion of food prepared 
outside the home (developed countries) 
Trans fatty acids  Low glycaemic index foods 
 
‘‘Rigid restraint/periodic disinhibition’’ 
eating patterns 
   
    
Insufficient Alcohol Excess alcohol Increased eating frequency Vitamin E 
   Chromium Magnesium 
   Moderate alcohol 
a Energy-dense and micronutrient-poor foods tend to be processed foods that are high in fat and/or sugars. Low energy-dense (or energy-dilute) foods, such as fruit, 
legumes, vegetables and whole grain cereals, are high in dietary fibre and water. 
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2.1. Nutrients 
2.1.1. Digestible carbohydrates 
Carbohydrates are an important part of the diet and their quality even yet. The structure will 
determine its digestibility, absorption and metabolism and therefore, the impact on the postprandial 
glucose and insulin concentration [24].  
Jenkins et al. (1981) [25] pioneered the glycaemic index (GI) concept. It is a measure of the average 
concentration of glucose in the blood of subjects following a test food containing 50 g of available 
carbohydrate over 2 hours, and is expressed relative to glucose or white bread (GI = 100) [26]. 
Foods are categorized as low (≤55), moderate (56-69) and high (≥70) GI foods. Foods low on the GI 
scale tend to release glucose slowly and steadily, while foods high on the GI release glucose rapidly.  
Food-related factors that influence the GI include: 1) the nature and amount of available 
carbohydrate (particle size, degree of hydration, nature of starch, etc.), 2) other food components 
(fat, protein, dietary fibres, phytochemicals); and 3) the food form, processing and preparation [26]. 
Research shows that similar amounts of carbohydrate from different foods can elicit different 
glycaemic responses (figure 6).  
Figure 6. Blood glucose response curves for different foods (vegetarian food, meal replacer shake and muesli 
bar). Figure adapted from Sadler (2011) [26]. 
Moreover, the glycaemic load (GL) provides additional information about the glycaemic quantity in 
relation to a portion size (high (GL ≥ 20), medium (GL = 11-19) and low (GL = 0-10) GL foods). This 
concept incorporates the total available carbohydrate in the food portion. GL is the product obtained 
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by multiplication of GI and the amount of dietary carbohydrate. For an individual food, the GL is 
therefore more relevant than the GI. Some fruits and vegetables present high GI values, however 
their amount of carbohydrate is low (GL) and has little effect on blood glucose [24]. International 
tables of GI and GL values of foods have been updated [27]. Table 3 presents a selection of the 
data correspond to common cereal-based foods and beverages. 
Table 3. Glycaemic index (GI) and glycaemic load (GL) per serving, for selected common cereal-based foods 
and beverages, in subjects with normal glucose tolerance. Table adapted from Atkinson et al. (2008) [27]. 
The term of “free sugars”, stablished by the WHO, includes monosaccharides and disaccharides 
added to foods and beverages, and sugars naturally present in honey, syrups, fruit juices and fruit 
juice concentrates [28]. There is increasing concern that intake of free sugars – particularly in the 
FOOD GI 
Serving size 
(g) 
GL per serving 
BAKERY PRODUCTS AND BREADS    
Apple muffin, made with rolled oats and sugar 44±6 60 13 
Apple muffin, made with rolled oats and 
without sugar 
48±10 60 9 
White wheat flour bread, average 75 30 11 
Whole wheat bread, average 69 30 9 
BREAKFAST CEREALS    
All-Bran®, average 44 30 9 
Cornflakes®, average 81 30 20 
BISCUITS    
Wheat based cereal biscuit 72±10 30 14 
Wheat biscuits with extra wheat bran 61±4 30 10 
SNACKS FOODS    
Corn chips, plain, salted 42 50 11 
Potato chips, average 56 50 12 
Pretzels, oven-baked 83±9 30 16 
PASTA AND NOODLES    
Macaroni and Cheese (Kraft®) 64 180 33 
Spaghetti, white, boiled, average 46 180 22 
BEVERAGES 
   
Coca Cola® (US formula) 63 250 mL 16 
Fanta®, orange soft drink 68±6 250 mL 23 
JUICES    
Apple juice, unsweetened,  average 41 250 mL 12 
Pineapple juice, unsweetened 46 250 mL 16 
SPORT DRINKS  250 mL  
Gatorade 78 ± 13 250 mL 12 
Isostar 70 ± 15 250 mL 13 
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form of sugar-sweetened beverages – increases overall energy intake and reduces foods more 
nutritionally adequate, leading to higher risk of these metabolic chronic diseases [29]. These 
beverages include soft drinks, fruit drinks, energy and vitamin water drinks. They are composed of 
naturally derived caloric sweeteners such as sucrose, high fructose corn syrup (HFCS), which is 
mostly composed of 45% glucose and 55% fructose, or even fruit juice concentrates [30]. A 20-year 
study on 120,000 men and women found that people who increased their sugary drink consumption 
by one 12-ounce serving per day gained more weight over time -on average, an extra pound every 
four years- than people who did not change their intake [31]. People who consume sugary drinks 
regularly, one to two cans a day or more, have a 26 % greater risk of developing T2D than people 
who rarely have such drinks [32]. The hydration pyramid proposed by the SENC recommends 
replacing the intake of sodas by water (mineral or tap water), tea and coffee in their natural forms 
(unsweetened) [22]. Likewise, these recommendations fit with those given by the Harvard School of 
Public Health in its Healthy Eating Plate.  
Regarding the digestible complex carbohydrates, starch is classified into rapidly digestible starch 
(RDS) and slowly digestible starch (SDS)[33]. RDS is that digested within 20 minutes of enzymatic 
action and is common in fresh white bread, white rice, and freshly cooked potatoes. SDS is the 
starch fraction digested between 20 and 120 minutes and is mainly present in pasta, wholegrain 
bread, waxy maize starch, sorghum and legumes (figure 7A). RDS induces a fast increase in blood 
glucose and insulin levels and SDS causes slow and prolonged release of glucose into the blood 
stream, coupled to a low glycaemic response (figure 7B) [34]. Thereby, RDS can induce health 
complications (T2D) and SDS starch may be helpful in controlling and preventing hyperglycaemia-
related diseases. 
Figure 7. Nutritional starch fractions according to (A) their digestibility in vitro and (b) their in vivo glycaemic 
response. Rapidly digestible starch (RDS) and slowly digestible starch (SDS). Figure adapted from Miao et al. 
(2013) [34].  
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Energy-dense foods tend to be high in digestible sugars and starches. The fructose component in 
sugar causes directly dysregulation of lipid and carbohydrate metabolism, and, sugar indirectly 
promotes positive energy balance, thus body weight and fat gain, which also cause dysregulation of 
lipid and carbohydrate metabolism [35,36]. In fact, WHO strongly recommends reducing the intake of 
free sugars to less than 10% of total energy intake and suggests a further reduction below 5% of 
total energy intake to get additional benefits for health [28].  
In this sense, the use of low-energy and low-GI sweeteners has gained increasing interest in the last 
years, due to the growing need as alternatives to sugar and to control the glycaemic responses [37]. 
The effects of low-energy sweeteners (LES) on energy intake and body weight have been the 
subject of many studies over the past 30 years. A very recent systematic review of relevant studies 
in animals and humans consuming LES with ad libitum access to food energy has been conducted 
[38]. A meta-analysis of short-term randomized controlled trials (129 comparisons) showed reduced 
total energy intake for LES versus sugar-sweetened food or beverage consumption with no 
difference with water. Meta-analysis of sustained intervention randomized controlled trials (4 weeks 
to 40 months) also presented that consumption of LES versus sugar led to relatively reduced body 
weight and a similar relative reduction in body weight versus water. Overall, the balance of evidence 
indicates that use of LES in place of sugar, in children and adults, leads to reduced energy intake 
and body weight.  
Stevia is a natural source of non-nutritive sweeteners providing zero-calories that can be used as a 
substitute of sugar or artificial sweeteners. The main sweet components in leaves, approximately 
250–300 times sweeter than sucrose, are stevioside and rebaudioside A (figure 8) [39].  
Figure 8. Chemical structure of the main sweet components in stevia leaves, (a) stevioside and (b) 
rebaudioside A. 
(a) (b) 
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The use of steviol glycosides (E-960) as food additive is accepted by the European Comssion 
(Regulation (EC) No 1333/2002 on food additives). A selection of foods, which can include in their 
formulation this non-nutritive sweetener, is defined in the Regulation (EU) No 1131/2011. Moreover, 
the European Food Safety Authority (EFSA) established an Acceptable Daily Intake (ADI) for steviol 
glycosides of 4 mg/kg body weight/day. Human digestive enzymes are not capable of hydrolysing 
the β-glycosidic bonds and the intestinal microflora converts steviol glycosides to steviol. Steviol 
glucuronide was found to be the main metabolite in plasma, which is eliminated via urine [40].  
Stevia has been found to increase insulin sensitivity in rodent models [41] and to have beneficial 
effects on blood glucose and insulin levels in human studies [42,43]. Recent research has evaluated 
a possible effect of stevia on glucose transport and its molecular mechanism of action [39]. Results 
reveal that stevia extracts and insulin behave similarly, being stevia as efficient as insulin in 
increasing glucose uptake. The co-treatment with insulin and stevia extracts causes a rise of glucose 
transport significantly higher than the increase due to insulin alone. These findings suggest that the 
use of stevia extracts beyond their sweetening power and it may offer therapeutic benefits. 
2.1.2. Non-digestible carbohydrates 
Dietary fibre was traditionally classified as soluble and insoluble fibre and this division is still used in 
nutrition labelling, however, scientific evidence supporting that soluble fibres lower cholesterol and 
glucose, and insoluble fibres increase stool weight is inconsistent [44]. Resistant starch and inulin, 
both soluble fibres, do not appear to lower blood cholesterol and the insoluble fibre effect on stool 
weight is highly variable. Many fibre sources are soluble but still enlarge stool weight. Nowadays, 
EFSA defines dietary fibre as non-digestible carbohydrates plus lignin that comprises [45]: 
 Non-starch polysaccharides (NSP): cellulose, hemicelluloses, pectins, hydrocolloids (gums, 
mucilage, beta-glucans); 
 Resistant oligosaccharides: fructo-oligosaccharides (FOS), galacto-oligosaccharides (GOS), 
other oligosaccharides that resist digestion (with three or more monomeric units);  
 Resistant starch: physically enclosed starch, some types of raw starch granules, retrograded 
amylose, chemically and/or physically modified starches;  
 Lignin naturally associated with dietary fibre polysaccharides. 
Dietary fibre is a non-digestible nutrient that can be partially fermented in the colon by the 
microbiota. Short-chain fatty acids are released during its fermentation which are absorbed and 
available as metabolizable energy (2 kcal/g) [46]. The fibre is considered as a “nutrient of public 
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health concern” since low intakes are associated with potential health risks 
((http://www.fda.gov/nutritioneducation). A daily intake of 25 g of total dietary fibre is set as a dietary 
reference value for a normal bowel function in adults, while consumption above 25 g of total dietary 
fibre per day may reduce risk of T2D and improve weight maintenance [45]. In this sense, a health 
claim regarding non-digestible carbohydrates such as FOS from inulin and their ability to reduce 
post-prandial glycaemic responses has been approved [47]. The fibre slows the breakdown of starch 
into glucose –thus maintaining a steady blood sugar rather than causing sharp spikes. 
Dietary fibre is positively associated with enhanced weight control and obesity [48]. A higher intake 
of foods high in NSP contributes to a reduction in total energy intake and eventually in lower weight 
[21]. Resistant starch and inulin, which are sources of fermentable substrate for the large bowel 
microbiota may prevent body-weight and waist circumference gain [49]. Multitude of cross-sectional 
studies [50,51] and large observational studies [52,53] relate inversely dietary fibre intake and body 
weight gain. Regarding the possible mechanisms associated to effect of dietary fibre on weight 
reduction body and fat-mass regulation a complex of multiple factors is involved: central nervous 
circuits, peripheral sensation stimuli, mechanical and chemical satiation signals arising in the 
gastrointestinal tract, afferent vagal input, and adiposity signals from fat tissue and liver [54]. The 
potential biological mechanisms of the fibre associated with enhanced body weight regulation and 
weight loss are summarized in Table 4.  
Table 4. Potential mechanisms for fibre and fibre-rich diets on body weight regulation and weight loss. Table 
adapted from Dreher (2015) [55]. 
Target Level Increase Decrease 
Food Intake 
Food volume 
Chewing time 
Diet energy density (fibre=2 kcal/g) 
Dietary fat intake 
Hunger 
Stomach Satiety signals (e.g., ghrelin) 
Gastric emptying 
Lipid emulsification 
Hunger 
Small intestine 
Satiety signals (cholecystokinin (CCK), glucagon-like 
peptide-1 (GLP-1) and peptide YY) 
Hunger 
Circulation 
Insulin sensitivity 
Short chain fatty acids 
Satiety signals 
Postprandial glucose and insulin 
Large intestine 
Fibre fermentation 
Short chain fatty acids 
Prebiotic microbiota 
Unabsorbed macronutrients (fibre fat) and bile acids 
Metabolizable energy 
Body weight Negative energy balance 
Weight gain 
Total body fat gain 
Abdominal and visceral fat gain 
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On the other hand, dietary fibre has been associated with reduced risk of T2D. A 6-month 
randomized parallel study demonstrated an improvement in the daily blood glucose profile and 
glycated haemoglobin (HbA1C) levels with 50 g soluble fibre/day compared to 15 g/day [56]. In a 
study of more than 160,000 women whose health and dietary habits were followed for up to 18 years 
presented 30% less likely to develop T2D when consumed  2-3 servings of whole grains a day than 
those who rarely ate them [57]. Moreover, setting out a low GI diet results in an increased intake of 
unavailable carbohydrate (fibre) and in a concomitant decrease in GL. Moreover, lowering GL and 
raising unavailable carbohydrate both independently act to control fasting blood glucose similarly 
(figure 9) [58].  
Figure 9. Implications of the effect of unavailable carbohydrate intake, glycaemic load (glucose equivalents/d) 
and glycaemic index on fasting blood glucose concentrations. Figure adapted from Livesey et al. (2008) [58]. 
Dietary fibre is mainly obtained from fruits, vegetables, cereals and legumes. Food processing of 
those products generates large amounts of by-products which contain significant fibre content [59]. 
The use of these natural sources of fibre is a sustainable approach in the management of chronic 
diseases such as obesity and T2D. Apple pomace is a by-product biomass that possesses high 
content of total dietary fibre (74%) and other functional properties such as density, water and oil 
holding capacity and swelling capacity including glucose dialysis retardation index (37%). Moreover, 
linked to this dietary fibre the phenolic compound, phlorizin, acts as an oral antidiabetic drug for the 
T2D by inhibiting sodium-glucose co-transporter-2 (SGLT 2) [60]. By-products from the coffee 
process such coffee pulp and husks are also sustainable source of dietary fibre, which involves 
phytochemicals adhered to its structure and might play and important role on reducing the risk of 
these chronic diseases [61].  
Unavailable 
carbohydrate intake 
(g/d) 
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2.2. Non-nutritive food components 
2.2.1. Antioxidants 
A variety of antioxidant compounds have been studied for their ability to exert anti-obesity and anti-
diabetic effects [62,63] Their bioavailability is essential to achieve these health properties. The 
gastrointestinal tract may act as an extractor where both the mechanical and chemical action 
contribute to the extraction of these phytochemicals from the food matrix [64,65]. 
Coffee is a major source of antioxidants such as chlorogenic acid (CGA) (figure 10) [66]. Different 
mechanisms of actions have been proposed for the CGA to improve glucose and lipid metabolism: 
1) activation of AMP activated protein kinase (AMPK), a master sensor and regulator of cellular 
energy balance which leads to increased glucose transport; 2) improvement of cellular mechanisms; 
3) inhibition of the intestinal α-glucosidase activity; 4) alteration of glucose-dependent insulinotropic 
peptide (GIP) hormone and therefore insulin secretion [63].  
 
Figure 10. Chemical structure of chlorogenic acid. 
Several studies have been reported anti-obesity effect of CGA [67,68]. CGA significantly lowers body 
weight, visceral fat, mass triglyceride and cholesterol concentrations in high-fat diet-induced-obese 
mice  [67]. CGA presents anti-lipidemic effects in mice by inhibiting fatty acid synthesis in a dose- 
and time-dependent manner, enhancing dyslipidaemias and lipid profile [69]. Furthermore, CGA acts 
as a principle active in glucose metabolism regulation. A daily intake of 3 to 4 cups of decaffeinated 
coffee containing high CGA amounts significantly reduces the risk for T2D by 30% [70]. CGA is a 
novel insulin sensitizer that stimulates insulin secretion from rat islets of Langerhans [71] and 
improves glucose tolerance and insulin resistance in obese Zucker rats [72]. Very recently, our group 
has reported that coffee silverskin extract (CSE), which possess CGA, improves glucose-stimulated 
insulin secretion and protects against streptozotocin-induced damage in pancreatic INS-1E beta 
cells [73] and demonstrated a chemo-protective effect in pancreatic tissue in rats [74], thereby 
reducing the risk of diabetes.  
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On the other hand, other dietary antioxidants may reduce reactive oxygen species (ROS) generated 
in T2D patients. These reactive species impair insulin signalling pathways and induce cytotoxicity in 
pancreatic β-cells. Neutralisation of oxidants by increased antioxidant availability may mitigate these 
effects. In a meta-analysis, significantly reduced HbA1C levels were observed by antioxidant 
supplementation, suggesting that antioxidants may have some benefit in protecting against the 
complications of T2D [75].  
2.2.2. Alpha-glucosidase inhibitors 
Alpha-glucosidase is a membrane bound enzyme located in the brush border of the enterocytes of 
the jejunum in the small intestine, which works to facilitate the absorption of digestible carbohydrates 
by catalysing the hydrolytic cleavage of oligosaccharides into absorbable monosaccharides [76]. By 
the inhibition of α-glucosidase in the intestine, the process of carbohydrate digestion spreads to the 
lower part of small intestine [77], therefore slowing the elevation of blood sugar following a 
carbohydrate meal. The mechanism of action of α-glucosidase in the absence and presence of α-
glucosidase inhibitors is shown in figure 11. 
 
Figure 11. Mechanism of action of α-glucosidase on carbohydrates in the (a) absence and in the (b) presence 
of α-glucosidase inhibitors. [AG: α-glucosidase; AGI: α-glucosidase inhibitor]. Figure adapted from Patil et al. 
(2015) [78].  
The main drawback of the current α-glucosidase inhibitor -acarbose- is its side effects such as 
abdominal distention, flatulence and diarrhoea [79]. Consequently, search of alternative natural 
compounds has rapidly increased. A wide range of phytochemicals present in plants and foods 
behave as α-glucosidases inhibitors so they are used as bioactive compounds for the glycaemic 
AGI 
AG AG 
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control in T2D [80–83]. Normally, the bioaccessibility of the α-glucosidase inhibitors requires 
disruption of the cell walls and cellular compartments and cleavage from carbohydrates [84]. The 
majority of polyphenols appear to be released during the gastric phase by the pepsin action in 
conjunction with peristaltic movements and low pH, favouring the diffusion from the matrix  [85,86]. 
CGA appears again as a potent α-glucosidase inhibitor, which has been described to act in a 
synergistic manner [63] or non-competitive manner in rats [87]. In a recent patent published by our 
group, it has been reported that CGA and CSE present inhibitor effect on the α-glucosidase enzyme 
in vitro [88]. Moreover, CGA inhibits α-glucosidase activity and reduces postprandial blood glucose 
in rats [89]. Other numerous coffee bioactive substances different to CGA present inhibitor effects on 
glucosidase enzyme, such as anthocyanin extracts from coffee pulp [90] or β-carboline alkaloid 
norharman [83]. Therefore, due to all these active principles present in coffee it may be possible a 
synergistic action against α-glucosidase activity.  
On the other hand, different types of fibre present inhibition of these digestive enzymes. It might be 
attributed to several possible factors such as the presence of inhibitors incorporated on the fibre 
structure (i.e polyphenols) or even by direct adsorption of the enzyme on fibres, leading to 
decreased glucosidase activity [91]. However, further investigation would be required to gain insight 
into what types of sustainable fibres from food wastes, such as coffee fibres, may have inhibitor 
effect and their specific mechanisms of action.  
Furthermore, aqueous extracts obtained from stevia leaves revealed to have effect on α-glucosidase 
by decreasing its activity that  is retained after its incorporation on a food matrix [92]. 
2.2.3. Lipase inhibitors 
Pancreatic lipase plays a key role in the efficient digestion of triglycerides. It removes fatty acids from 
the α and α’ position of dietary triglycerides, yielding β-monoglycerides and long chain saturated and 
polyunsaturated fatty acids as the lipolytic products. Pancreatic lipase is responsible for the 
hydrolysis of 50–70% of total dietary fats [93]. In this context the inhibition of fat digestion is an 
interesting approach for reducing fat absorption and therefore body weight gain [94]. 
Orlistat, one of the two clinically approved drugs for obesity treatment, has been shown to act 
through inhibition of pancreatic lipase. However, this anti-lipidemic drug has certain unpleasant 
gastrointestinal side effects like oily stools, oily spotting, and flatulence among others. Therefore, 
research is required to identify newer pancreatic lipase inhibitors that lack some of these unpleasant 
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side effects [95]. Extracts from hundreds of species of medicinal plants, vegetables, and fruits as 
well as products from microorganisms, fungi and marine algae are being screened for potential 
lipase inhibitory activity [96].  
It is well known that polyphenols from plants have an affinity for proteins, mainly through 
hydrophobic bonding. Many polyphenolic compounds such as flavones, flavonols, tannins and 
chalcones are active against pancreatic lipase [95]. Coffee that contains large amounts of phenolics 
acts as an anti-lipidemic agent by inhibiting pancreatic lipase. The major polyphenols, 5-
caffeoylquinic acid (CQA), 4-CQA, and 3-CQA are stable and preserved in coffee after simulated 
digestion to inhibit the lipase [97]. Moreover, polyphenols other than CQAs, such as feruloyl quinic 
acid isomers or ferulic acid, exhibit a lipase inhibitory effect [98]. Taken together, the results suggest 
that the lipase inhibition activity of both CQA and dicaffeoylquinic acid (DCQA) drive the lowering 
effect of free fatty acid release during the simulated digestion in the instant coffee [97]. In addition, 
the CSE patented by our group has shown to exert inhibitory effect on the pancreatic lipase [99] as 
well as the CGA [88].  
Dietary fibre can affect lipid metabolism through inhibition of pancreatic lipase. Wheat bran and 
wheat germ may inhibit pancreatic lipase and decrease intestinal absorption of dietary fats and 
cholesterol [100,101]. Citrus pectin strongly inhibits the activity of digestive lipases as well [102]. 
Moreover, it has been reported that dietary fibre becomes an important inhibitor of lipase when a 
basic group is introduced in its structure. Basic dietary fibres are strong inhibitors of gastrointestinal 
lipase reactions and are reversible reaction inhibitors [103].  
Furthermore, stevia leaves is able to inhibit the activity of the pancreatic lipase, thereby acting as an 
inhibitor agent, useful for the management of obesity [104]. 
2.3. Food-processing compounds 
The Maillard reaction (MR) is a series of reactions between proteins and carbohydrates that occur in 
foods during their storage and cooking, with the rate of reaction accelerating as temperature 
increases. The dietary MR products (MRPs) provide predominantly the characteristic colour and 
aroma of cooked foods. The main factors determining their rate of formation in food include nutrient 
composition (protein, carbohydrates and fat), temperature, duration of heat application, humidity, pH, 
and the presence of trace metals [105,106].  
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Briefly, MR starts by condensation of the carbonyl group of a reducing sugar with the amino groups 
of a protein generating Schiff bases, which rearrange to Amadori or Heyns products. These early 
MRPs undergo dehydration and rearrangements followed by other reactions, such as cyclisation, 
oxidation and dehydration, to form more stable advanced glycation end products (AGEs). Reactive 
dicarbonyl products such as methylglyoxal (MGO) are formed as intermediate products during all 
stages of the MR, but also as intermediates of glucose autoxidation and lipid peroxidation. The 
accumulation of these reactive products produces the formation of oxidative AGEs such as 
carboxymethyl-lysine (CML), and pentosidine [107]. Table 5 presents the content of selected early 
MRPs and AGEs in different foods. 
Table 5. Content of selected early MRPs and AGEs in different foods. Table adapted from Hellwig and Henle 
(2014) [108] and references therein, Uribarri et al. (2010) [105] and He et al. (2014) [109]. 
 
Food 
AP 
(g/kg) 
CML 
(mg/kg) 
Pyrraline 
(mg/kg) 
Pentosidine 
(mg/kg) 
AGE 
(MU/kg) 
Milk, pasteurized 0.1 0.2-0.5 n.d. n.d. 0.01-0.1 
Evaporated milk 7-18 46 0.4-3.2 0.02-0.04 - 
Pasta 1-19 2.4-3.0 n.d-12 - - 
Bread 6-7 3-40 6-69 - 1.1-1.5 
Bread crusts - 37-94.3 60-240 0.03-0.18 0.4-0.7 
Meat, roasted - 2-20 - - 47-100 
Butter - 0.3-0.4 - - 233-265 
Coffee, roasted - - - 1.0-4.0 - 
Biscuit, baked - 50.7-117.5 - - 13.4-14.7 
Cookies, baked - - - - 0.9-32.2 
AP: Amadori product expressed as fructoselysine; CML: Carboxymethyl-lysine; n.d.: not detectable; -: non-available data 
Melanoidins are high molecular weight and brown-coloured compounds generated in the late stages 
of the MR. These products are mainly responsible of the specific colour and typical appearance of 
processed foods [110]. Due to their complex structure melanoidins can be defined as a type of 
“maillardized fibre”. It is very complex to structurally separate fibre from melanoidins and vice versa 
because carbohydrates are integral components of coffee melanoidins [111]. The current importance 
of melanoidins is linked with their health-promoting properties. Many beneficial effects have been 
associated to these compounds, such as antioxidant, antimicrobial, anti-inflammatory, 
antihypertensive or prebiotic activity [112]. On the other hand, acrylamide and 5-
hydroxymethylfurfural (HMF) are mainly formed through MR and can be regarded as the most 
important heat-induced neo-contaminants occurring in bakery products. Many studies indicate that 
acrylamide is neurotoxic in animals and humans and that it is a reproductive toxicant, germ-cell 
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mutagen and carcinogen in rodents [113–115]. HMF has been shown to be converted in vivo to a 5-
sulfoxymethyfurfural which is a genotoxic compound [116].  
Dietary AGEs are partially absorbed (10–30%) [117,118] and a rapid rising peak of AGEs in serum is 
observed after consumption of a meal [119]. These dietary AGEs together with those endogenously 
produced have important implications in health. AGEs have been largely associated to oxidative 
stress and inflammation, eventually causing most chronic diseases such as T2D and obesity 
[120,121]. A diet low in AGEs seems to improve hyperinsulinemia (~40%) in fully treated T2D 
patients, confirming that exogenous AGEs actively participate in the metabolic dysfunctional milieu of 
T2D [122].  Moreover, dietary AGEs have been related to the development of insulin resistance and 
diabetes in animals, and more recently also in humans [123]. New studies have introduced an 
instructive view proposing that the abundance of pro-oxidant AGEs could potentially account for the 
initiation and progression of pre-diabetes to diabetes in the highly industrialized modern food 
environment [118]. On the other hand, certain dietary MRPs are largely undigested by human gut 
enzymes and are degraded by the colonic microbiota, mainly those in the early staged of the MR 
[124]. Some of these MRPs can play a role in colon toxicology, through increased colonic protein 
fermentation, and may also act as systemic toxicants and inducers of inflammation [125]. They may 
adversely alter the colonic microbial composition, potentially enhancing their risk for the development 
of metabolic diseases such as obesity and T2D [126]. More research needs to be carried out in this 
sense.  
3. Satiety and chronic diseases 
Satiety, the feeling of fullness that persists after eating, is an important factor in suppressing 
overconsumption, which can lead to overweight and obesity [127]. The literature demonstrates that 
foods that target within-meal satiation and post-meal satiety provide a plausible approach to weight 
management [128]. Foods that generate strong satiety sensations have obvious benefits for these 
chronic diseases.  
3.1. “Foods for Specific Groups (FSGs)” and “Functional Foods”   
A new regulation commonly referred to as the Food for Specific Groups Regulation or FSGs 
(Regulation (EU) No 609/2013) has replaced the Directive 2009/39/EC on foodstuffs intended for 
particular nutritional uses (PARNUTS) from 20th July 2016. The FSGs regulation abolishes the 
concept of dietetic foods and provides limited number of well-established and defined categories of 
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food that are considered as essential for certain vulnerable groups of the population: “processed 
cereal based food”; “food for special medical purposes”; “infant formula and follow-on formula”; and 
“total diet replacement for weight control” are the four categories for FSG. Diabetic food group is, 
however, under the Regulation (EC) No 1924/2006 on nutrition and health claims. 
Regarding the commonly known functional foods, the Functional Food Center (FFC) has recently 
proposed a new definition: “natural or processed foods that contains known or unknown biologically-
active compounds; the foods, in defined, effective, and non-toxic amounts, provide a clinically proven 
and documented health benefit for the prevention, management, or treatment of chronic disease”. 
This definition pay attention to the bioactive compounds, such as phenolic acids, fibres, and 
polysaccharides [129]. 
Nutritional and health claims, which are under the European Regulation (EC) No 1924/2006, are 
used to legally highlight particular beneficial effects of functional foods with scientific evidence 
enough to declare on the product label or in advertising: 
 Nutrition claim states, suggests or implies that a food has particular beneficial nutritional 
properties due to: 1) the energy it provides at a reduced or increased rate or does not provide; 
and 2) the nutrients or compounds it contains, contains in reduced or increased proportions or 
does not contain. “Low sugar”, “with no added sugars” or “high fibre” are some of the permitted 
nutrition claims which may be closely related to low-energy dense and low-GI foods.  
 Health claim states a relationship between food and health: 1) “Function Health Claims” relating 
to the growth, development and functions of the body, or psychological and behavioural 
functions, or slimming/ weight-control; 2) “Risk Reduction Claims”; and 3) “Claims referring 
to children's development”. Some of the multitude proposed “Function Health Claims” that 
would be associated to those functional foods exerting enhanced satiety are “helps you to feel 
full for longer”, “helps to manage body weight” or “promotes satiety”. 
The development and design of functional foods or foods for special medical purposes have a key 
role to play in combating certain chronic diseases such as obesity and T2D [130]. Enhanced satiety 
foods directly promote reduced food intake by lessening the effect of sensations of hunger [131]. 
3.2. Physiological mechanisms of satiety 
The sensation of satiety is dependent on more than just the metabolic effects of nutrients in the gut 
and intestine [132]. The satiety cascade model proposes that even before food arrives in the gut, 
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cognitive and sensory signals generated will influence not only how much is eaten at that eating 
episode (satiation) but also in the period after consumption (satiety). These early satiety signals will 
integrate with post-ingestive and post-absorptive signals to determine satiety.  
A schematic figure of the pathways involved in communication of satiation and satiety between the 
body and the brain is presented in figure 12. When the food is ingested, the gastric distension is 
communicated to the brain via the vagus nerve, initiating satiation. Gut hormones released from the 
stomach and intestine as a consequence of the food components reaction send signals to the brain, 
acting on that areas of the brain involved in appetite. Moreover, leptin from adipose tissue and 
insulin from the pancreas act on the brain to modulate satiation and satiety in the longer term. All 
these signals are integrated in the brain to affect energy intake. 
Figure 12. Schematic pathways for the physiological satiation and satiety signalling mechanism. Adapted from 
Benelam (2009) [127].  
Broadly, satiety is influenced by both, short term (“episodic” signals in response to the consumption 
of food) and longer term (“tonic” signals indicating the levels of energy stores in the body). Focusing 
the attention on the short term, a number of hormones are secreted from the gut to indicate that food 
has been consumed. Ghrelin, cholecystokinin (CCK), oxyntomodulin (OXM), glucagon-like peptide-1 
(GLP-1), peptide YY (3-36) (PYY 3-36) and pancreatic polypeptide (PP) are some of the gut-derived 
hormones involved in satiety.  
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GLP-1 and serotonin can be secreted in response to chemical and mechanical stimuli during meals,  
[133,134]. Both are mainly synthesized by the enteroendocrine cells of the gastrointestinal tract 
[135,136], causing an enhance of the feeling of fullness and therefore regulating the appetite. In 
addition, GLP-1 decreases blood glucose levels during hyperglycaemia by stimulating insulin 
secretion and reducing glucose-dependent glucagon secretion [137]. Very recently, a mechanism for 
intestinal secretion of these gut-derived hormones has been proposed (figure 13) [138]. Dietary 
compounds may stimulate GLP-1 release from enteroendocrin cells (EEC) via interaction with a G-
coupled protein receptor (GPCR) (figure 13A), simultaneously the nutrient may stimulate extra-
intestinal serotonin concentrations from enterochromaffin cells (ECC) via interaction with a GPCR 
(figure 13B). Consequently this induced serotonin release may stimulate (additional) GLP-1 release 
via interaction with a 5-HT receptor (5-HTR) on EEC (figure 13C). 
 
Figure 13. Proposed mechanisms of secretion for serotonin (5-HT) and glucagon-like peptide-1 (GLP-1) by 
modulation of dietary compounds in the ileum. Figure adapted from Ripken et al. (2016) [138].  
3.3. Satiating food components 
3.3.1. Nutrients 
Proteins 
Protein generally increases satiety and in this way it may facilitate a reduction of food intake [139–
141]. Research suggests that the type of protein matters in inducing satiety and they should not be 
considered generically [139]. Dietary intake of proteins may be effective in satiety due to their ability 
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to increase GLP-1 secretion [137]. After ingestion, proteins are partially hydrolysed by pepsin in the 
stomach, and the digestion is completed in the small intestine by pancreatic proteases. The resulting 
peptides are able to stimulate GLP-1 release by the intestinal enterocytes [142]. Digested wheat 
proteins exert strong effects on the satiety and anti-diabetic effect through GLP-1 stimulation  
[143,144]. 
Carbohydrates 
The effect of carbohydrates on satiety depends on the form of the carbohydrate and other aspects of 
the food such the dietary fibre content from which it is delivered. Regarding the non-digestible 
carbohydrates, different mechanisms have been proposed for the satiating effect of the fibre: 1) 
Higher mastification, which increases satiety signals to the brain; 2) Gastric distension due to the 
ability of soluble fibres to form gels and thereby signal sending to the central nervous system; 3) 
Belated nutrient absorption, as for instance, lower glucose- and insulin responses, and thereby 
delayed hunger and reduced energy intake at the next meal; and 4) Gut hormones release (i.e. GLP-
1) as a consequence of the slower absorption of macronutrients in the first part of the small intestine 
prolonging their contact in the last part of the small intestine [145]. Moreover, several factors appear 
as main contributors of the satiating effect of the fibre: amount, extent to which the food was refined 
or processed, particle size in grain-based foods and energy density of fibre are important [146].  
The literature on dietary fibre and satiety has been reviewed by several authors [146,147]. The 
intake of 16 g of FOS per day leads to higher feeling of satiety and less energy intake [148]. The 
mechanisms could be related to changes in the levels of blood hormones that have an effect on 
satiety. It was found with rodent trials that blood levels of GLP-1 and ghrelin changed in such a way 
that appetite was suppressed [149,150]. In a longer study (120 days), 55 overweight women took a 
daily supplementation of 0.14 g/kg of FOS and satiety sensation was greater with a significant 
decrease in body weight [151]. More recently, a positive effect on satiety and hunger was found in 
normal volunteers with the intake of coffee enriched with inulin and dextrin [152]. Furthermore, 
galactomannan may enhance satiety by forming a viscous gel in the stomach, which slows gastric, 
thereby enhancing fullness. In a clinical trial, an 8-gram dose significantly increased mean ratings of 
satiety and fullness in comparison to 0 or 4 grams of galactomannan fibre [153].  
3.3.2. Non-nutritive food components 
Food can contain a variety of bioactive compounds that may increase satiety and decrease energy 
intake. The coffee beverage has shown to enhance intestinal serotonin [154] and GLP-1 tested on 
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cells, mice [155] and humans [156]. Bioactive compounds present in the coffee drink such as CGA 
and caffeine, and non-nutritive sweeteners such as stevia are some of the satiating compounds.  
Stevia 
Stevia sweetener, in particular rebaudioside A, is able to induce satiety hormone release such as 
GLP-1 and peptide YY, at various locations of the small intestine using porcine ex vivo model [137, 
153]. These findings may contribute to improve weight management and glucose control. However, 
clinical studies are necessary to confirm the potential satiety-inducing properties of rebaudioside A. 
CGA 
The main phenolic compound of the coffee beverage, CGA seems to enhance the satiety via 
stimulation GLP-1 hormone [71,157]. High increase of this hormone secretion is observed in 
intestinal secretin tumour cell line (STC-1) [157]. Additionally, the intake of 12 g decaffeinated coffee, 
1 g chlorogenic acids and 500 mg trigonellines increases GLP-1 appear 30 min after compared to 
the placebo group [158]. 
Caffeine 
This bioactive compound present in coffee has been greatly related to appetite control. The potential 
effects of different doses of caffeinated coffee (low, 3 mg/kg body weight and high, 6 mg/kg body 
weight) on appetite feelings and energy intake of male and female healthy volunteers were observed 
[159]. Coffee containing 3 mg caffeine/kg body weight induced a significant reduction in hunger 
feelings at 15, 30 and 60 min compared to water, and the consumption of high-caffeine coffee led to 
a lower energy intake at the ad libitum meal. A randomized placebo-controlled, double-blind study of 
overweight people showed that high-caffeine (524 mg/day) increases satiety compared with a low-
caffeine diet (151 mg/day) [160].   
In view of the widespread consumption and availability of coffee, and its content in bioactive 
compounds, the use of coffee-derived products may be very useful in the design of functional foods 
with potential properties for the preventative tool for obesity and T2D. These bioactive compounds, 
CGA and caffeine, and dietary fibre, are found at active physiological concentrations in coffee 
wastes. Therefore, this supports the use of coffee by-products as natural sustainable sources of 
bioactive compounds in the management of metabolic chronic diseases.  
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4. Coffee silverskin and spent grounds as natural 
sustainable sources of functional ingredients for 
chronic diseases 
Coffee is mainly commercialized as a beverage obtained from ground roasted beans. During this 
processing, over 90% of the coffee cherry is discarded as an agricultural waste, which contains 
health promoting phytochemicals and nutrients [161]. Due to the great demand for coffee, large 
amounts of wastes are generated in the coffee industry. The interest in valorisation of agronomical 
by-products into diverse and useful novel products to achieve a global sustainable world has been 
recently published [162]. Figure 14 represents coffee silverskin (CS) and spent coffee grounds 
(SCG) production employing the wet process of the bean and the instant coffee processing, which 
are studied in the present investigation. 
CS represents 4% (w/w) of the coffee cherry. It is a thin tegument of the outer layer of the two beans 
forming the green coffee seed obtained as a by-product of the roasting process. SCG are the most 
abundant coffee by-product (45%) generated during the treatment of coffee powder with hot water to 
prepare coffee infusion or steam for the instant coffee preparation [163]. About 2 kg of wet SCG are 
obtained from each kg of instant coffee produced, with an annual generation of around 6 million tons 
worldwide [164].  
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Figure 14. Diagram of coffee silverskin and spent coffee grounds production from the wet processing of the 
bean and the instant coffee process. Figure adapted from Fernandez-Gomez et al. (2016) [165]. 
CS has a high dietary fibre content (68-80%), which includes about 85% insoluble dietary fibre and 
15% soluble dietary fibre [166,167]. Polysaccharides are also abundant components (60-70%) in CS 
[166,168–170] and sugars are polymerized into cellulose and hemicellulose structures which contain 
glucose, xylose, galactose, mannose and arabinose. CS contains protein, fat, and ash, at 16–19%, 
2–3%, and 5-7%, respectively [61]. This coffee by-product presents phenolic compounds, mainly 
CGA, and other phytochemicals that contribute to its high antioxidant capacity. Moreover, it has been 
proposed as a natural source of prebiotic carbohydrates and dietary fibre [166,171].  
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Our research group patented an aqueous CSE from Arabica (Coffea arabica) and Robusta (Coffea 
canephora) (WO 2013004873 A1) enriched in caffeine and CGA and obtained using an 
environmentally friendly technology [99]. The chemical composition of the patented CSEs is 
summarized in table 6. CSEs present a total dietary fibre content ranging from 29 to 36%, including 
4-9% insoluble dietary fibre and 24-26% soluble dietary fibre. CSEs are a good source of 
polyphenols, in particular CGA (1-7 %), being the most relevant 5-O-, 3-O- and 4-O-caffeoylquinic 
acids [172]. CSE is also a good source of caffeine (3 %) and melanoidins (17-23 %). Melanoidins are 
formed during coffee roasting process [172]. As we previously mentioned melanoidns form part of 
the Maillardized fibre and contribute to the antioxidant capacity of the coffee and coffee wastes  
[173].  
Table 6. Chemical composition of coffee silverskin extracts (adapted from del Castillo et al. (2013), Mesías et 
al. (2014) [99,172]) and spent coffee grounds (adapted from del Castillo et al. (in press)[61]). 
Regarding the chemical composition of SCG, polysaccharides are the major macronutrients (75%) 
(table 6). Among them, dietary fibre is the most important fraction (43-54%), being the insoluble fibre 
predominant (47-50%). SCG also contain protein, fat and ashes (14-17%, 2.3% and 1.3-1.6%, 
respectively). The polysaccharides are mainly constituted by 37% mannose, 32% galactose, 24% 
glucose and 7% arabinose. Caffeine content ranges from 0.2 to 0.8% depending on the caffeine 
extraction process and SCG variety. Different health-related chemicals bound to dietary fibre and 
Compounds ACSE  RCSE  SCG  
Fat (%) - - 1.6-2.3 [169,170] 
Proteins (%) 5.36 [99] 0.99 [99] 13-17 [169,170,174] 
Carbohydrates (%) 5.44 [99] 13.43 [99] 71-75 [170,174] 
Total dietary fibre (%) 28.69 [172] 36.21 [172] 54-60 [169,170] 
Soluble dietary fibre (%) 24.01 [172] 26.80 [172] 6-16 [169,170] 
Insoluble dietary fibre (%) 4.67 [172] 9.41 [172] 47-50 [169,170] 
Caffeine (%) 3.02 [99] 3.39 [99] 0.2-0.8 [175–177] 
Melanoidins (%) 17.26 [172] 23.94 [172] 13-25 [170] 
CGAs (%) 1.12 [172] 6.85 [172] 0.3-1.4 [170,175,176] 
Total phenolic content (%) 3.10 [172] 3.54 [172] 1-17 [170,175,176] 
ORAC (µmol trolox/g) 1194 [172] 1513 [172] 1821-2594 [175] 
DPPH  (µmol trolox/g) 219.9 [172] 231.3 [172] 74-112.1 [176] 
ABTS  (µmol trolox/g) 85.20 [172] 225.8 [172] 167.24-493 [170,176] 
FRAP  (µmol trolox/g) 829.8 [172] 640.1 [172] 498 [170] 
Values are expressed on the dry matter basis. Superscript numbers correspond to the cited literature. ABTS, 2,2'-azinobis-(3-
ethylbenzothiazoline-6-sulfonic acid; ACSE, Arabica coffee silverskin extract; CGAs, chlorogenic acids; DPPH, 2,2-diphenyl-1-
picrylhydrazyl; FRAP, Ferric reducing antioxidant power; ORAC, Oxygen radical absorbance capacity; RCSE, Robusta coffee silverskin 
extract; SCG, spent coffee grounds. 
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proteins such as phenolic compounds, mainly CGAs, have been reported in SCG from different 
sources [170,176]. The amount of coffee melanoidins that remained in SCG was approximately 15%. 
Coffee melanoidins fractions are diverse and possess different potential health benefits [173].  
The feasible applications of these coffee by-products have been mainly focused in the production of 
biofuels, composts, animal feed and specific materials such as biosorbents, enzymes, chemicals and 
cosmetics among others [61]. However, due to the highlighted chemical composition of these coffee 
by-products and the amount of bioactive compounds present in them. Recently, great interest has 
been taken for the development of novel value-added applications related to food and health, 
derivatives from the biorefinery concept in the coffee sector [163,169,178]. Nowadays, some of 
these novel applications just begun, while others have started to be patented and only a few are 
being industrially used by the moment [61,161,179]. 
CS due to its bioactive compounds has been associated to food technology and health properties. 
This coffee by-product can be used as prebiotic carbohydrate [166]. CS is involved in the production 
of FOS due to its great potential to immobilize cells as well as to serve as nutrient for the 
microorganisms [180]. Short chains of FOS are produced, which have more prebiotic activity and 
stronger sweetness [181]. Moreover, CS is used to obtain innovative coffee blends rich in bioactive 
compounds [182] and it has been also employed in the formulation of bread to reduce caloric density 
and increase the dietary fibre content [168]. On the other hand, our research group has recently 
reported new evidence on CSE and its effects on reducing the risk of metabolic chronic diseases. 
This is the first time it has been described a chemo-protective effect of the patented CSE in 
pancreatic tissue in Wistar rats. The metabolism of CGA and caffeine, which are present in the CSE, 
starts in the gastrointestinal tract during digestion and thereby their metabolites are able to protect 
the pancreatic cells against the risk of diabetes [74]. Moreover, new data has been reported by our 
group about the capacity of this CSE to improve glucose-stimulated insulin secretion and to protect 
against streptozotocin-induced damage in pancreatic INS-1E beta cells [73]. New evidence shows 
that the patented CSE inhibits AGEs formation by different pathways including protein-phenol 
conjugation. CGA seems to be a principal contributor to the antiglycoxidative properties of the CSE 
[183]. Therefore, taking into account all these new findings provided by our group, CSE may be used 
as a nutritional supplement or food ingredient to reduce the risk of metabolic syndrome diseases 
such as T2D.  
Regarding the SCG, they have been used as additives and coadjuvants. Beta-glucosidase is 
covalently immobilized onto SCG for the conversion of isoflavone glycosides into their aglycones in 
black soymilk, which presents higher biological activities than their respective glycosides [184]. A 
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distilled beverage with a coffee aroma has been produced from SCG [185] [185]. In addition, dietary 
fibre can be extracted from SCG employing different processes such as ohmic technology [186,187], 
alkaline hydrogen peroxide treatment [188] and autohydrolysis [189]. This dietary fibre is fermented 
by colon microbiota producing metabolites that exhibit strong anti-inflammatory potential by 
suppressing nitric oxide production and inhibiting inflammatory mediators such as IL-10, CCL-17, 
CXCL9, IL-1β and IL-5 cytokines. As a consequence, SCG have been proposed as protective agent 
against the onset and/or progression of chronic inflammatory diseases such as inflammatory bowel 
disease and rheumatoid arthritis. SCG have been also proposed as antimicrobial agents, which 
might be related to the melanoidin content [170]. However, to the best of our knowledge, there are 
not previous studies reporting the use of SCG as food ingredient and their effects on the energetic 
metabolism and satiety. 
Therefore, the use of these coffee by-products with potential to be valorised into food ingredients 
with health promoting properties related to the metabolic chronic diseases, will contribute to a 
sustainable nutrition for the population. 
5. References 
1. World Health Organization (WHO). Global status report on noncommunicable diseases 2014; 
Geneva, 2014. 
2. Nakamura, Y. K.; Omaye, S. T. Metabolic diseases and pro- and prebiotics: Mechanistic 
insights. Nutr. Metab. (Lond). 2012, 9, 60. 
3. Pérez de Heredia, F.; Gómez-Martínez, S.; Marcos, A. Chronic and degenerative diseases. 
Obesity, inflammation and the immune system. Proc. Nutr. Soc. 2012, 71, 332–338. 
4. Lee, H.; Lee, I. S.; Choue, R. Obesity, inflammation and diet. Pediatr. Gastroenterol. Hepatol. 
Nutr. 2013, 16, 143–52. 
5. Hajer, G. R.; van Haeften, T. W.; Visseren, F. L. J. Adipose tissue dysfunction in obesity, 
diabetes, and vascular diseases. Eur. Heart J. 2008, 29, 2959–2971. 
6. World Health Organization (WHO). Obesity: Preventing and managing the global epidemic; 
Geneva, 2000. 
7. Bray, G. A. Contemporary diagnosis and management of obesity; Handbooks in Health Care: 
Newton (PA), 1998. 
8. Jensen, M. D. Role of body fat distribution and the metabolic complications of obesity. J. Clin. 
Endocrinol. Metab. 2008, 93, s57-63. 
9. Kaila, B.; Raman, M. Obesity: A review of pathogenesis and management strategies. Can. J. 
Gastroenterol. 2008, 22, 61–68. 
10. Lee, S.-H.; Han, K.; Yang, H. K.; Kim, H.-S.; Cho, J.-H.; Kwon, H.-S.; Park, Y.-M.; Cha, B.-Y.; 
Yoon, K.-H. A novel criterion for identifying metabolically obese but normal weight individuals 
using the product of triglycerides and glucose. Nutr. Diabetes 2015, 5, e149. 
11. Meigs, J. B.; Wilson, P. W. F.; Fox, C. S.; Vasan, R. S.; Nathan, D. M.; Sullivan, L. M.; 
D’Agostino, R. B. Body mass index, metabolic syndrome, and risk of type 2 diabetes or 
cardiovascular disease. J. Clin. Endocrinol. Metab. 2006, 91, 2906–2912. 
Introduction 
 
 47 
 
12. Mentreddy, S. R. Medicinal plant species with potential antidiabetic properties. J. Sci. Food 
Agric. 2007, 87, 743–750. 
13. Al-Goblan, A. S.; Al-Alfi, M. A.; Khan, M. Z. Mechanism linking diabetes mellitus and obesity. 
Diabetes, Metab. Syndr. Obes. Targets Ther. 2014, 7, 587–591. 
14. Peirce, V.; Vidal-Puig, A. Regulation of glucose homoeostasis by brown adipose tissue. Lancet 
Diabetes Endocrinol. 2013, 1, 353–60. 
15. International Diabetes Federation (IDF). IDF Diabetes Atlas-7th Edition; Brussels, 2015. 
16. World Health Organization (WHO). Global report on diabetes; Geneva, 2016. 
17. Verma, S.; Hussain, M. E. Obesity and diabetes: An update. Diabetes Metab. Syndr. Clin. Res. 
Rev. 2017, 11, 73–79. 
18. Hemani, G.; Yang, J.; Vinkhuyzen, A.; Powell, J. E.; Willemsen, G.; Hottenga, J. J.; Abdellaoui, 
A.; Mangino, M.; Valdes, A. M.; Medland, S. E.; Madden, P. A.; Heath, A. C.; Henders, A. K.; 
Nyholt, D. R.; De Geus, E. J. C.; Magnusson, P. K. E.; Ingelsson, E.; Montgomery, G. W.; 
Spector, T. D.; Boomsma, D. I.; Pedersen, N. L.; Martin, N. G.; Visscher, P. M. Inference of the 
genetic architecture underlying bmi and height with the use of 20,240 sibling pairs. Am. J. Hum. 
Genet. 2013, 93, 865–875. 
19. Willemsen, G.; Ward, K. J.; Bell, C. G.; Christensen, K.; Bowden, J.; Dalgård, C.; Harris, J. R.; 
Kaprio, J.; Lyle, R.; Magnusson, P. K. E.; Mather, K. A.; Ordoňana, J. R.; Perez-Riquelme, F.; 
Pedersen, N. L.; Pietiläinen, K. H.; Sachdev, P. S.; Boomsma, D. I.; Spector, T. The 
concordance and heritability of type 2 diabetes in 34,166 twin pairs from international twin 
registers: The discordant twin (DISCOTWIN) consortium. Twin Res. Hum. Genet. 2015, 18, 
762–71. 
20. Temelkova-Kurktschiev, T.; Stefanov, T. S. Lifestyle and genetics in obesity and type 2 
diabetes. Exp. Clin. Endocrinol. Diabetes 2012, 120, 1–6. 
21. World Health Organization (WHO). Diet, nutrition and the prevention of chronic diseases. 
Report of a Joint WHO/FAO Expert Consultation; Geneva, 2003. 
22. Grupo Colaborativo de la Sociedad Española de Nutrición Comunitaria (SENC). Guías 
alimentarias para la población española (SENC, diciembre 2016); la nueva pirámide de la 
alimentación saludable. Nutr. Hosp. 2016, 33, 1–48. 
23. Vimaleswaran, K. S.; Li, S.; Zhao, J. H.; Luan, J.; Bingham, S. A.; Khaw, K.; Ekelund, U.; 
Wareham, N. J.; Loos, R. J. F. Physical activity attenuates the body mass index – increasing 
influence of genetic variation in the FTO gene. J. Am. Diet. Assoc. 2009, 90, 425–428. 
24. Sahyoun, N. R.; Anderson, A. L.; Tylavsky, F. A.; Lee, J. S.; Sellmeyer, D. E.; Harris, T. B. 
Dietary glycemic index and load and risk of type 2 diabetes in older adults. Am. J. Clin. Nutr. 
2008, 87, 126–131. 
25. Jenkins, D. J.; Wolever, T. M.; Taylor, R. H.; Barker, H.; Fielden, H.; Baldwin, J. M.; Bowling, A. 
C.; Newman, H. C.; Jenkins, A. L.; Goff, D. V. Glycemic index of foods: a physiological basis for 
carbohydrate exchange. Am. J. Clin. Nutr. 1981, 34, 362–6. 
26. Sadler, M. Food, glycaemic response and health; Brussels, 2011. 
27. Atkinson, F. S.; Foster-Powell, K.; Brand-Miller, J. C. International tables of glycemic index and 
glycemic load values: 2008. Diabetes Care 2008, 31, 2281–2283. 
28. World Health Organization (WHO). Guideline: sugars intake for adults and children; Geneva, 
2015. 
29. Gibson, S. Sugar-sweetened soft drinks and obesity: a systematic review of the evidence from 
observational studies and interventions. Nutr. Res. Rev. 2008, 21, 134–47. 
30. Malik, V. S.; Hu, F. B. Sweeteners and risk of obesity and type 2 diabetes: the role of sugar-
sweetened beverages. Curr. Diab. Rep. 2012, 12, 195–203. 
31. Mozaffarian, D.; Hao, T.; Rimm, E. B.; Willett, W. C.; Hu, F. B. Changes in diet and lifestyle and 
long-term weight gain in women and men. N. Engl. J. Med. 2011, 364, 2392–2404. 
Introduction 
 
48  
 
32. Malik, V. S.; Popkin, B. M.; Bray, G. A.; Després, J.-P.; Willett, W. C.; Hu, F. B. Sugar-
sweetened beverages and risk of metabolic syndrome and type 2 diabetes: a meta-analysis. 
Diabetes Care 2010, 33, 2477–83. 
33. Englyst, H. N.; Kingman, S. M.; Cummings, J. H. Classification and measurement of 
nutritionally important starch fractions. Eur. J. Clin. Nutr. 1992, 46, S33-50. 
34. Miao, M.; Jiang, B.; Cui, S. W.; Zhang, T.; Jin, Z. Slowly digestible starch-A review. Crit. Rev. 
Food Sci. Nutr. 2015, 55, 1642–1657. 
35. Stanhope, K. L.; Schwarz, J.-M.; Havel, P. J. Adverse metabolic effects of dietary fructose: 
results from the recent epidemiological, clinical, and mechanistic studies. Curr. Opin. Lipidol. 
2013, 24, 198–206. 
36. Stanhope, K. L. Sugar consumption, metabolic disease and obesity: The state of the 
controversy. Crit. Rev. Clin. Lab. Sci. 2016, 53, 52–67. 
37. Wiebe, N.; Padwal, R.; Field, C.; Marks, S.; Jacobs, R.; Tonelli, M. A systematic review on the 
effect of sweeteners on glycemic response and clinically relevant outcomes. BMC Med. 2011, 
9, 123. 
38. Rogers, P. J.; Hogenkamp, P. S.; de Graaf, K.; Higgs, S.; Lluch, A.; Ness,  a R.; Penfold, C.; 
Perry, R.; Putz, P.; Yeomans, M. R.; Mela, D. J. Does low-energy sweetener consumption 
affect energy intake and body weight? A systematic review, including meta-analyses, of the 
evidence from human and animal studies. Int. J. Obes. 2015, 40, 1–58. 
39. Rizzo, B.; Zambonin, L.; Angeloni, C.; Leoncini, E.; Dalla Sega, F. V.; Prata, C.; Fiorentini, D.; 
Hrelia, S. Steviol glycosides modulate glucose transport in different cell types. Oxid. Med. Cell. 
Longev. 2013, 2013, 1–11. 
40. European Food Safety Authority (EFSA). Scientific opinion of the panel on food additives and 
nutrient sources added to food on a request from the commission on the safety in use of steviol 
glycosides as a food additive. EFSA J. 2010, 8, 1–87. 
41. Chang, J.-C.; Wu, M. C.; Liu, I.-M.; Cheng, J.-T. Increase of insulin sensitivity by stevioside in 
fructose-rich chow-fed rats. Horm. Metab. Res. 2005, 37, 610–616. 
42. Curi, R.; Alvarez, M.; Bazotte, R. B.; Botion, L. M.; Godoy, J. L.; Bracht, A. Effect of Stevia 
rebaudiana on glucose tolerance in normal adult humans. Brazilian J. Med. Biol. Res. 1986, 19, 
771–4. 
43. Gregersen, S.; Jeppesen, P. B.; Holst, J. J.; Hermansen, K. Antihyperglycemic effects of 
stevioside in type 2 diabetic subjects. Metabolism. 2004, 53, 73–6. 
44. Slavin, J. Fiber and prebiotics: Mechanisms and health benefits. Nutrients 2013, 5, 1417–1435. 
45. European Food Safety Authority (EFSA). Scientific opinion on dietary reference values for 
carbohydrates and dietary fibre. EFSA J. 2010, 8, 1–77. 
46. Food and Argiculture Organization of the United Nations (FAO). Food energy - methods of 
analysis and conversion factors; Rome, 2003. 
47. European Food Safety Authority (EFSA). Scientific opinion on the substantiation of a health 
claim related to non-digestible carbohydrates and a reduction of post-prandial glycaemic 
responses pursuant to Article 13 (5) of Regulation (EC) No 1924/2006. EFSA J. 2014, 12, 1–
13. 
48. Slavin, J. L. Position of the American Dietetic Association: health implications of dietary fiber. J. 
Am. Diet. Assoc. 2008, 108, 1716–1731. 
49. Du, H.; van der A, D. L.; Boshuizen, H. C.; Forouhi, N. G.; Wareham, N. J.; Halkjaer, J.; 
Tjonneland, A.; Overvad, K.; Jakobsen, M. U.; Boeing, H.; Buijsse, B.; Masala, G.; Palli, D.; 
Sorensen, T. I.; Saris, W. H.; Feskens, E. J. Dietary fiber and subsequent changes in body 
weight and waist circumference in European men and women. Am. J. Clin. Nutr. 2010, 91, 
329–336. 
Introduction 
 
 49 
 
50. Kromhout, D.; Bloemberg, B.; Seidell, J. C.; Nissinen, A.; Menotti, A. Physical activity and 
dietary fiber determine population body fat levels: the Seven Countries Study. Int. J. Obes. 
2001, 25, 301–306. 
51. van de Vijver, L. P. L.; van den Bosch, L. M. C.; van den Brandt, P. A.; Goldbohm, R. A. Whole-
grain consumption, dietary fibre intake and body mass index in the Netherlands cohort study. 
Eur. J. Clin. Nutr. 2009, 63, 31–38. 
52. Liu, S.; Willett, W. C.; Manson, J. E.; Hu, F. B.; Rosner, B.; Colditz, G. Relation between 
changes in intakes of dietary fiber and grain products and changes in weight and development 
of obesity among middle-aged women. Am. J. Clin. Nutr. 2003, 78, 920–7. 
53. Koh-Banerjee, P.; Franz, M.; Sampson, L.; Liu, S.; Jacobs, D. R.; Spiegelman, D.; Willett, W.; 
Rimm, E. Changes in whole-grain, bran, and cereal fiber consumption in relation to 8-y weight 
gain among men. Am. J. Clin. Nutr. 2004, 80, 1237–45. 
54. Woods, S. Signals that influence food intake and body weight. Physiol. Behav. 2005, 86, 709–
716. 
55. Dreher, M. L. Role of fiber and healthy dietary patterns in body weight regulation and weight 
loss. Adv. Obesity, Weight Manag. Control 2015, 3, 68. 
56. Giacco, R.; Parillo, M.; Rivellese, A. A.; Lasorella, G.; Giacco, A.; D’Episcopo, L.; Riccardi, G. 
Long-term dietary treatment with increased amounts of fiber-rich low-glycemic index natural 
foods improves blood glucose control and reduces the number of hypoglycemic events in type 
1 diabetic patients. Diabetes Care 2000, 23, 1461–6. 
57. de Munter, J. S. L.; Hu, F. B.; Spiegelman, D.; Franz, M.; van Dam, R. M. Whole grain, bran, 
and germ intake and risk of type 2 diabetes: A prospective cohort study and systematic review. 
PLoS Med. 2007, 4, e261. 
58. Livesey, G.; Taylor, R.; Hulshof, T.; Howlett, J. Glycemic response and health-a systematic 
review and meta-analysis: relations between dietary glycemic properties and health outcomes. 
Am. J. Clin. Nutr. 2008, 87, 258S–268S. 
59. Yang, S.-T.; El-Ensashy, H.; Thongchul, N. Bioprocessing Technologies in Biorefinery for 
Sustainable Production of Fuels, Chemicals, and Polymers; Yang, S.-T.; El-Ensashy, H.; 
Thongchul, N., Eds.; John Wiley & Sons, Ltd., 2013. 
60. Bharat Helkar, P.; Sahoo, A. Review: food industry by-products used as a functional food 
ingredients. Int. J. Waste Resour. 2016, 6, 248. 
61. del Castillo, M. D.; Fernandez-Gomez, B.; Martinez-Saez, N.; Iriondo, A.; Mesa, M. D. Coffee 
By-Products. In Coffee: Chemistry, Quality and Health Implications; Farah, A., Ed.; RSC 
Publishing Inc.; In press. 
62. Rupasinghe, H. P. V.; Sekhon-Loodu, S.; Mantso, T.; Panayiotidis, M. I. Phytochemicals in 
regulating fatty acid β-oxidation: Potential underlying mechanisms and their involvement in 
obesity and weight loss. Pharmacol. Ther. 2016, 165, 153–163. 
63. Meng, S.; Cao, J.; Feng, Q.; Peng, J.; Hu, Y. Roles of chlorogenic acid on regulating glucose 
and lipids metabolism: a review. Evidence-based Complement. Altern. Med. 2013, 2013, 1–11. 
64. Tagliazucchi, D.; Verzelloni, E.; Bertolini, D.; Conte, A. In vitro bio-accessibility and antioxidant 
activity of grape polyphenols. Food Chem. 2010, 120, 599–606. 
65. Swieca, M.; Gawlik-Dziki, U.; Dziki, D.; Baraniak, B. Wheat bread enriched with green coffee - 
In vitro bioaccessibility and bioavailability of phenolics and antioxidant activity. Food Chem. 
2017, 221, 1451–1457. 
66. del Castillo, M. D.; Ames, J. M.; Gordon, M. H. Effect of roasting on the antioxidant activity of 
coffee brews. J. Agric. Food Chem. 2002, 50, 3698–3703. 
67. Cho, A.-S.; Jeon, S.-M.; Kim, M.-J.; Yeo, J.; Seo, K.-I.; Choi, M.-S.; Lee, M.-K. Chlorogenic acid 
exhibits anti-obesity property and improves lipid metabolism in high-fat diet-induced-obese 
mice. Food Chem. Toxicol. 2010, 48, 937–43. 
Introduction 
 
50  
 
68. Sun, N. N.; Wu, T. Y.; Chau, C. F. Natural dietary and herbal products in anti-obesity treatment. 
Molecules 2016, 21, E1351. 
69. Ong, K. W.; Hsu, A.; Tan, B. K. H. Anti-diabetic and anti-lipidemic effects of chlorogenic acid 
are mediated by ampk activation. Biochem. Pharmacol. 2013, 85, 1341–1351. 
70. Huxley, R.; Lee, C. M. Y.; Barzi, F.; Timmermeister, L.; Czernichow, S.; Perkovic, V.; Grobbee, 
D. E.; Batty, D.; Woodward, M. Coffee, decaffeinated coffee, and tea consumption in relation to 
incident type 2 diabetes mellitus. Arch. Intern. Med. 2009, 169, 2053–63. 
71. McCarty, M. F. A chlorogenic acid-induced increase in GLP-1 production may mediate the 
impact of heavy coffee consumption on diabetes risk. Med. Hypotheses 2005, 64, 848–853. 
72. Hsu, F.-L.; Chen, Y.-C.; Cheng, J.-T. Caffeic acid as active principle from the fruit of 
xanthiumstrumarium to lower plasma glucose in diabetic rats. Planta Med. 2000, 66, 228–230. 
73. Fernandez-Gomez, B.; Ramos, S.; Goya, L.; Mesa, M. D.; del Castillo, M. D.; Martín, M. Á. 
Coffee silverskin extract improves glucose-stimulated insulin secretion and protects against 
streptozotocin-induced damage in pancreatic INS-1E beta cells. Food Res. Int. 2016, 89, 1015–
1022. 
74. Fernandez-Gomez, B.; Lezama, A.; Amigo-Benavent, M.; Ullate, M.; Herrero, M.; Martín, M. Á.; 
Mesa, M. D.; del Castillo, M. D. Insights on the health benefits of the bioactive compounds of 
coffee silverskin extract. J. Funct. Foods 2016, 25, 197–207. 
75. Akbar, S.; Bellary, S.; Griffiths, H. R. Dietary antioxidant interventions in type 2 diabetes 
patients: a meta-analysis. Br. J. Diabetes Vasc. Dis. 2011, 11, 62–68. 
76. Baig, I. Phytochemical studies on ferula mongolica and other mongolian medicinal plants, 
University of Karachi, 2003. 
77. Lebovitz, H. E. Alpha-glucosidase inhibitors. Endocrinol. Metab. Clin. North Am. 1997, 26, 539–
51. 
78. Patil, P.; Mandal, S.; Tomar, S. K.; Anand, S. Food protein-derived bioactive peptides in 
management of type 2 diabetes. Eur. J. Nutr. 2015, 54, 863–880. 
79. Dong, H.-Q.; Li, M.; Zhu, F.; Liu, F.-L.; Huang, J.-B. Inhibitory potential of trilobatin from 
Lithocarpus polystachyus Rehd against α-glucosidase and α-amylase linked to type 2 diabetes. 
Food Chem. 2012, 130, 261–266. 
80. Gironés-Vilaplana, A.; Moreno, D. A.; García-Viguera, C. Phytochemistry and biological activity 
of Spanish Citrus fruits. Food Funct. 2014, 5, 764–72. 
81. Ruiz-Ruiz, J. C.; Moguel-Ordñez, Y. B.; Matus-Basto, A. J.; Segura-Campos, M. R. Antidiabetic 
and antioxidant activity of Stevia rebaudiana extracts (Var. Morita) and their incorporation into a 
potential functional bread. J. Food Sci. Technol. 2015, 52, 7894–7903. 
82. Winter, K. M. Identification of bioactive compounds in wheat, Southern Cross University, 2009. 
83. Kim, S.-D. α-Glucosidase inhibitor isolated from coffee. J. Microbiol. Biotechnol. 2015, 25, 174–
177. 
84. Bravo, L. Polyphenols: chemistry, dietary sources, metabolism, and nutritional significance. 
Nutr. Rev. 1998, 56, 317–33. 
85. Mandalari, G.; Bisignano, C.; Filocamo, A.; Chessa, S.; Sarò, M.; Torre, G.; Faulks, R. M.; 
Dugo, P. Bioaccessibility of pistachio polyphenols, xanthophylls, and tocopherols during 
simulated human digestion. Nutrition 2013, 29, 338–344. 
86. Bohn, T. Dietary factors affecting polyphenol bioavailability. Nutr. Rev. 2014, 72, 429–452. 
87. Matsui, T.; Ogunwande, I. A.; Abesundara, K. J. M.; Matsumoto, K. Anti-hyperglycemic 
potential of natural products. Mini Rev. Med. Chem. 2006, 6, 349–56. 
88. del Castillo, M. D.; Fernandez-Gomez, B.; Ullate, M.; Mesa, M. D. Uso de productos de la 
cascarilla de café para la prevención y tratamiento de las patologías que conforman el 
síndrome metabólico y de sus factores de riesgo. PCT/ES2015/070915. 2016. 
Introduction 
 
 51 
 
89. Zheng, Y.; Liu, K.; Jia, G.; Li, H.; Han, L.; Kimura, Y. Effect of hot-water extract of coffee seeds 
on postprandial blood glucose concentration in rats. J. Chinese Pharm. Sci. 2007, 42, 32–35. 
90. Murthy, P. S.; Manjunatha, M. R.; Sulochannama, G.; Naidu, M. M. Extraction, characterization 
and bioactivity of coffee anthocyanins. Eur. J. Biol. Sci. 2012, 4, 13–19. 
91. Ou, S.; Kwok, K.; Li, Y.; Fu, L. In vitro study of possible role of dietary fiber in lowering 
postprandial serum glucose. J. Agric. Food Chem. 2001, 49, 1026–1029. 
92. Ruiz-Ruiz, J. C.; Moguel-Ordoñez, Y. B.; Matus-Basto, A. J.; Segura-Campos, M. R. 
Antidiabetic and antioxidant activity of Stevia rebaudiana extracts (Var. Morita) and their 
incorporation into a potential functional bread. J. Food Sci. Technol. 2015, 52, 7894–7903. 
93. Shi, Y.; Burn, P. Lipid metabolic enzymes: Emerging drug targets for the treatment of obesity. 
Nat. Rev. Drug Discov. 2004, 3, 695–710. 
94. Bray, G. A.; Ryan, D. H. Drug treatment of the overweight patient. Gastroenterology 2007, 132, 
2239–2252. 
95. Birari, R. B.; Bhutani, K. K. Pancreatic lipase inhibitors from natural sources: unexplored 
potential. Drug Discov. Today 2007, 12, 879–889. 
96. de la Garza, A. L.; I Milagro, F.; Boque, N.; Campión, J.; Martínez, J. A. Natural inhibitors of 
pancreatic lipase as new players in obesity treatment. Planta med 2011, 773–785. 
97. Cha, K. H.; Song, D.-G.; Kim, S. M.; Pan, C.-H. Inhibition of gastrointestinal lipolysis by green 
tea, coffee, and gomchui (Ligularia fischeri) tea polyphenols during simulated digestion. J. 
Agric. Food Chem. 2012, 60, 7152–7. 
98. Murase, T.; Yokoi, Y.; Misawa, K.; Ominami, H.; Suzuki, Y.; Shibuya, Y.; Hase, T. Coffee 
polyphenols modulate whole-body substrate oxidation and suppress postprandial 
hyperglycaemia, hyperinsulinaemia and hyperlipidaemia. Br. J. Nutr. 2012, 107, 1757–1765. 
99. del Castillo, M. D.; Ibañez, M. E.; Amigo, M.; Herrero, M.; Plaza del Moral, M.; Ullate, M. 
Aplicación de productos de la cascarilla del café en cosmética antienvejecimiento y 
alimentación funcional. WO 2013004873 A1. 2013. 
100. Borel, P.; Lairon, D.; Senft, M.; Chautan, M.; Lafont, H. Wheat bran and wheat germ: effect on 
digestion and intestinal absorption of dietary lipids in the rat. Am. J. Clin. Nutr. 1989, 49, 1192–
202. 
101. Lairon, D.; Lafont, H.; Vigne, J.; Nalbone, G.; Léonardi, J.; Hauton, J. Effects of dietary fibers 
and cholestyramine on the activity of pancreatic lipase in vitro. Am. J. Clin. Nutr. 1985, 42, 629–
38. 
102. Tsujita, T.; Sumiyoshi, M.; Han, L.; Fujiwara, T.; Tsujita, J.; Okuda, H. Inhibition of lipase 
activities by citrus pectin. J Nutr Sci Vitaminol (Tokyo). 2003, 49, 340–345. 
103. Tsujita, T.; Takaichi, H.; Takaku, T.; Sawai, T.; Yoshida, N.; Hiraki, J. Inhibition of lipase 
activities by basic polysaccharide. J. Lipid Res. 2007, 48, 358–65. 
104. Adisakwattana, S.; Intrawangso, J.; Hemrid, A.; Chanathong, B.; Mäkynen, K. Extracts of edible 
plants inhibit pancreatic lipase, cholesterol esterase and cholesterol micellization, and bind bile 
acids. Food Technol. Biotechnol. 2012, 50, 11–16. 
105. Uribarri, J.; Woodruff, S.; Goodman, S.; Cai, W.; Chen, X.; Pyzik, R.; Yong, A.; Striker, G. E.; 
Vlassara, H. Advanced glycation end products in foods and a practical guide to their reduction 
in the diet. J. Am. Diet. Assoc. 2010, 110, 911–916. 
106. Goldberg, T.; Cai, W.; Peppa, M.; Dardaine, V.; Baliga, B. S.; Uribarri, J.; Vlassara, H. 
Advanced glycoxidation end products in commonly consumed foods. J. Am. Diet. Assoc. 2004, 
104, 1287–1291. 
107. Singh, R.; Barden,  a.; Mori, T.; Beilin, L. Advanced glycation end-products: A review. 
Diabetologia 2001, 44, 129–146. 
108. Hellwig, M.; Henle, T. Baking, ageing, diabetes: a short history of the Maillard reaction. Angew. 
Chemie Int. Ed. 2014, 53, 10316–10329. 
Introduction 
 
52  
 
109. He, J.; Zeng, M.; Zheng, Z.; He, Z.; Chen, J. Simultaneous determination of N ε-
(carboxymethyl) lysine and N ε-(carboxyethyl) lysine in cereal foods by LC–MS/MS. Eur. Food 
Res. Technol. 2014, 238, 367–374. 
110. Morales, F. J.; Somoza, V.; Fogliano, V. Physiological relevance of dietary melanoidins. Amino 
Acids 2012, 42, 1097–1109. 
111. Silván, J. M.; Morales, F. J.; Saura-Calixto, F. Conceptual study on maillardized dietary fiber in 
coffee. J. Agric. Food Chem. 2010, 58, 12244–9. 
112. Mesías, M.; Delgado-Andrade, C. Melanoidins as a potential functional food ingredient. Curr. 
Opin. Food Sci. 2017, 14, 37–42. 
113. Commission, E. First report on the harmonisation of risk assessment procedures; Brussels, 
2000. 
114. International Agency for Research on Cancer (IARC). Acrylamide. In IARC Monographs on the 
evaluation of the carcinogenic risk of chemicals to humans; Lyon, 1994; pp. 389–433. 
115. Shipp, A.; Lawrence, G.; Gentry, R.; McDonald, T.; Bartow, H.; Bounds, J.; Macdonald, N.; 
Clewell, H.; Allen, B.; Van Landingham, C. Acrylamide: review of toxicity data and dose-
response analyses for cancer and noncancer effects. Crit. Rev. Toxicol. 2006, 36, 481–608. 
116. Monien, B. H.; Frank, H.; Seidel, A.; Glatt, H. Conversion of the common food constituent 5-
hydroxymethylfurfural into a mutagenic and carcinogenic sulfuric acid ester in the mouse in 
vivo. Chem. Res. Toxicol. 2009, 22, 1123–1128. 
117. Cai, W.; He, J. C.; Zhu, L.; Chen, X.; Zheng, F.; Striker, G. E.; Vlassara, H. Oral glycotoxins 
getermine the effects of calorie restriction on oxidant stress, age-related diseases, and lifespan. 
Am. J. Pathol. 2008, 173, 327–336. 
118. Uribarri, J.; Cai, W.; Peppa, M.; Goodman, S.; Ferrucci, L.; Striker, G.; Vlassara, H. Circulating 
glycotoxins and dietary advanced glycation endproducts: two Links to inflammatory response, 
oxidative stress, and aging. J Gerontol A Biol Sci Med Sci 2007, 62, 427–433. 
119. Koschinsky, T.; He, C. J.; Mitsuhashi, T.; Bucala, R.; Liu, C.; Buenting, C.; Heitmann, K.; 
Vlassara, H. Orally absorbed reactive glycation products (glycotoxins): an environmental risk 
factor in diabetic nephropathy. Proc. Natl. Acad. Sci. U. S. A. 1997, 94, 6474–9. 
120. Sayej, W. N.; Knight III, P. R.; Guo, W. A.; Mullan, B.; Ohtake, P. J.; Davidson, B. A.; Khan, A.; 
Baker, R. D.; Baker, S. S. Advanced glycation end products induce obesity and hepatosteatosis 
in CD-1 wild-type mice. Biomed Res. Int. 2016, 2016, 1–12. 
121. Vlassara, H.; Uribarri, J. Advanced glycation end products (AGE) and diabetes: cause, effect, 
or both? Curr. Diab. Rep. 2014, 14, 453. 
122. Vlassara, H.; Cai, W.; Crandall, J.; Goldberg, T.; Oberstein, R.; Dardaine, V.; Peppa, M.; 
Rayfield, E. J. Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for 
diabetic angiopathy. Proc. Natl. Acad. Sci. U. S. A. 2002, 99, 15596–601. 
123. Vlassara, H.; Striker, G. E. AGE restriction in diabetes mellitus: a paradigm shift. Nat. Rev. 
Endocrinol. 2013, 7, 526–539. 
124. Hellwig, M.; Bunzel, D.; Huch, M.; Franz, C. M. A. P.; Kulling, S. E.; Henle, T. Stability of 
individual Maillard reaction products in the presence of the human colonic microbiota. J. Agric. 
Food Chem. 2015, 63, 6723–6730. 
125. Tuohy, K. M.; Hinton, D. J. S.; Davies, S. J.; Crabbe, M. J. C.; Gibson, G. R.; Ames, J. M. 
Metabolism of Maillard reaction products by the human gut microbiota – implications for health. 
Mol. Nutr. Food Res. 2006, 50, 847–857. 
126. Cani, P. D.; Osto, M.; Geurts, L.; Everard, A. Involvement of gut microbiota in the development 
of low-grade inflammation and type 2 diabetes associated with obesity. Gut Microbes 2012, 3, 
279–288. 
127. Benelam, B. Satiation, satiety and their effects on eating behaviour. Nutr. Bull. 2009, 34, 126–
173. 
Introduction 
 
 53 
 
128. Halford, J. C. G.; Harrold, J. A. Satiety-enhancing products for appetite control: science and 
regulation of functional foods for weight management. Proc. Nutr. Soc. 2012, 71, 350–362. 
129. Martirosyan, D. M.; Singh, J. A new definition of functional food by FFC: what makes a new 
definition unique? Funct. Foods Heal. Dis. 2015, 5, 209–223. 
130. Shao, A.; Campbell, W. W.; Chen, C.-Y. O.; Mittendorfer, B.; Rivas, D. A.; Griffiths, J. C. The 
emerging global phenomenon of sarcopenic obesity: Role of functional foods; a conference 
report. J. Funct. Foods 2017, 33, 244–250. 
131. Hetherington, M. M.; Cunningham, K.; Dye, L.; Gibson, E. L.; Gregersen, N. T.; Halford, J. C. 
G.; Lawton, C. L.; Lluch, A.; Mela, D. J.; Van Trijp, H. C. M. Potential benefits of satiety to the 
consumer: scientific considerations. Nutr. Res. Rev. 2013, 26, 22–38. 
132. Blundell, J. E.; Rogers, P. J.; Hill, A. J. Evaluating the satiating power of foods: implications for 
acceptance and consumption. In Food Acceptance and Nutrition; Colms, J.; Booth, D. A.; 
Pangborn, R. M.; Raunhardt. O., Eds.; Academic Press, 1987; pp. 205–219. 
133. van Bloemendaal, L.; IJzerman, R. G.; Ten Kulve, J. S.; Barkhof, F.; Konrad, R. J.; Drent, M. L.; 
Veltman, D. J.; Diamant, M. GLP-1 receptor activation modulates appetite- and reward-related 
brain areas in humans. Diabetes 2014, 63, 4186–96. 
134. Voigt, J.; Fink, H. Serotonin controlling feeding and satiety. Behav. Brain Res. 2015, 277, 14–
31. 
135. Donnelly, D. The structure and function of the glucagon-like peptide-1 receptor and its ligands. 
Br. J. Pharmacol. 2012, 166, 27–41. 
136. Kato, S. Role of serotonin 5-HT3 receptors in intestinal inflammation. Biol. Pharm. Bull. 2013, 
36, 1406–9. 
137. Wang, X.; Liu, H.; Chen, J.; Li, Y.; Qu, S. Multiple factors related to the secretion of glucagon-
like peptide-1. Int. J. Endocrinol. 2015, 2015, 651757. 
138. Ripken, D.; van der Wielen, N.; Wortelboer, H. M.; Meijerink, J.; Witkamp, R. F.; Hendriks, H. F. 
J. Nutrient-induced glucagon like peptide-1 release is modulated by serotonin. J. Nutr. 
Biochem. 2016, 32, 142–150. 
139. Paddon-Jones, D.; Westman, E.; Mattes, R. D.; Wolfe, R. R.; Astrup, A.; Westerterp-Plantenga, 
M. Protein, weight management, and satiety. Am. J. Clin. Nutr. 2008, 87, 1558S–1561S. 
140. de Graaf, C. Sensory responses, food intake and obesity; Woodhead Publishing Limited, 2005. 
141. Halton, T. L.; Hu, F. B. The effects of high protein diets on thermogenesis, satiety and weight 
loss: a critical review. J. Am. Coll. Nutr. 2004, 23, 373–85. 
142. Gevrey, J.-C.; Malapel, M.; Philippe, J.; Mithieux, G.; Chayvialle, J.-A.; Abello, J.; Cordier-
Bussat, M. Protein hydrolysates stimulate proglucagon gene transcription in intestinal 
endocrine cells via two elements related to cyclic AMP response element. Diabetologia 2004, 
47, 926–936. 
143. Geraedts, M. C. P.; Troost, F. J.; Tinnemans, R.; Söderholm, J. D.; Brummer, R. J.; Saris, W. 
H. M. Release of satiety hormones in response to specific dietary proteins is different between 
human and murine small intestinal mucosa. Ann. Nutr. Metab. 2010, 56, 308–313. 
144. Geraedts, M. C. P.; Troost, F. J.; Fischer, M. A. J. G.; Edens, L.; Saris, W. H. M. Direct 
induction of CCK and GLP-1 release from murine endocrine cells by intact dietary proteins. 
Mol. Nutr. Food Res. 2011, 55, 476–484. 
145. Salmenkallio-Marttila, M.; Due, A.; Gunnarsdottir, I.; Karhunen, L.; Saarela, M.; Lyly, M. Satiety, 
weight management and foods; Oslo, 2009. 
146. Slavin, J.; Green, H. Dietary fibre and satiety. Nutr. Bull. 2007, 32, 32–42. 
147. Howarth, N. C.; Saltzman, E.; Roberts, S. B. Dietary fiber and weight regulation. Nutr. Rev. 
2001, 59, 129–39. 
148. Cani, P. D.; Joly, E.; Horsmans, Y.; Delzenne, N. M. Oligofructose promotes satiety in healthy 
human: a pilot study. Eur. J. Clin. Nutr. 2006, 60, 567–572. 
Introduction 
 
54  
 
149. Cani, P. D.; Dewever, C.; Delzenne, N. M. Inulin-type fructans modulate gastrointestinal 
peptides involved in appetite regulation (glucagon-like peptide-1 and ghrelin) in rats. Br. J. Nutr. 
2004, 92, 521–526. 
150. Cani, P. D.; Neyrinck, A. M.; Maton, N.; Delzenne, N. M. Oligofructose promotes satiety in rats 
fed a high-fat diet: involvement of glucagon-like peptide-1. Obes. Res. 2005, 13, 1000–1007. 
151. Genta, S.; Cabrera, W.; Habib, N.; Pons, J.; Carillo, I. M.; Grau, A.; Sánchez, S. Yacon syrup: 
Beneficial effects on obesity and insulin resistance in humans. Clin. Nutr. 2009, 28, 182–187. 
152. Singer, J.; Grinev, M.; Silva, V.; Cohen, J.; Singer, P. Safety and efficacy of coffee enriched 
with inulin and dextrin on satiety and hunger in normal volunteers. Nutrition 2016, 32, 754–760. 
153. Mathern, J. R.; Raatz, S. K.; Thomas, W.; Slavin, J. L. Effect of fenugreek fiber on satiety, 
blood glucose and insulin response and energy intake in obese subjects. Phytother. Res. 2009, 
23, 1543–8. 
154. Bakuradze, T.; Parra, G. A. M.; Riedel, A.; Somoza, V.; Lang, R.; Dieminger, N.; Hofmann, T.; 
Winkler, S.; Hassmann, U.; Marko, D.; Schipp, D.; Raedle, J.; Bytof, G.; Lantz, I.; Stiebitz, H.; 
Richling, E. Four-week coffee consumption affects energy intake, satiety regulation, body fat, 
and protects DNA integrity. Food Res. Int. 2014, 63, 420–427. 
155. Fujii, Y.; Osaki, N.; Hase, T.; Shimotoyodome, A. Ingestion of coffee polyphenols increases 
postprandial release of the active glucagon-like peptide-1 (GLP-1(7–36)) amide in C57BL/6J 
mice. J. Nutr. Sci. 2015, 4, 1–9. 
156. Jokura, H.; Watanabe, I.; Umeda, M.; Hase, T.; Shimotoyodome, A. Coffee polyphenol 
consumption improves postprandial hyperglycemia associated with impaired vascular 
endothelial function in healthy male adults. Nutr. Res. 2015, 35, 873–881. 
157. Rafferty, E. P.; Wylie, A. R.; Elliott, C. T.; Chevallier, O. P.; Grieve, D. J.; Green, B. D. In vitro 
and in vivo effects of natural putative secretagogues of glucagon-like peptide-1 (GLP-1). Sci. 
Pharm. 2011, 79, 615–621. 
158. Olthof, M. R.; van Dijk, A. E.; Deacon, C. F.; Heine, R. J.; van Dam, R. M. Acute effects of 
decaffeinated coffee and the major coffee components chlorogenic acid and trigonelline on 
incretin hormones. Nutr. Metab. (Lond). 2011, 8, 10. 
159. Gavrieli, A.; Karfopoulou, E.; Kardatou, T.; Spyreli, E.; Kaloudi, E.; Yannakoulia, M. The effect 
of different doses of caffeinated coffee on energy intake and appetite feelings of healthy male 
and female volunteers. Proc. Nutr. Soc. 2011, 70, E346. 
160. Westerterp-Plantenga, M. S.; Lejeune, M. P. G. M.; Kovacs, E. M. R. Body weight loss and 
weight maintenance in relation to habitual caffeine intake and greent tea supplementation. 
Obes. Res. 2005, 13, 1195–1204. 
161. del Castillo, M. D.; Iriondo-DeHond, A.; Martinez-Saez, N.; Fernandez-Gomez, B.; Iriondo-
DeHond, M.; Zhou, J.-R. Applications of recovered compounds in food products. In Handbook 
of Coffee Processing By-Products: Sustainable Applications; Galanakis, C., Ed.; Elsevier: 
Oxford, 2017. 
162. Galanakis, C.; Martinez-Saez, N.; del Castillo, M. D.; Barba, F. J.; Mitropoulou, V. S. Patented 
and commercialized applications. In Food Waste Recovery: Processing Technologies and 
Industrial Techniques; Galanakis, C., Ed.; Academic Press-Elsevier, 2015; pp. 339–362. 
163. Murthy, P. S.; Madhava Naidu, M. Sustainable management of coffee industry by-products and 
value addition - A review. Resour. Conserv. Recycl. 2012, 66, 45–58. 
164. Mussatto, S. I.; Machado, E. M. S.; Martins, S.; Teixeira, J. A. Production, composition, and 
application of coffee and its industrial residues. Food Bioprocess Technol. 2011, 4, 661–672. 
165. Fernandez-Gomez, B. Sustainable use of coffee silverskin as a natural source of bioactive 
compounds for diabetes, Universidad Autónoma de Madrid, 2016. 
166. Borrelli, R. C.; Esposito, F.; Napolitano, A.; Ritieni, A.; Fogliano, V. Characterization of a new 
potential functional ingredient: coffee silverskin. J. Agric. Food Chem. 2004, 52, 1338–1343. 
Introduction 
 
 55 
 
167. Toschi, T. G.; Cardenia, V.; Bonaga, G.; Mandrioli, M.; Rodriguez-estrada, M. T. Coffee 
Silverskin: characterization, possible uses, and safety aspects. J. Agric. Food Chem. 2014, 62, 
10836–10844. 
168. Pourfarzad, A.; Mahdavian-Mehr, H.; Sedaghat, N. Coffee silverskin as a source of dietary fiber 
in bread-making: Optimization of chemical treatment using response surface methodology. 
LWT - Food Sci. Technol. 2013, 50, 599–606. 
169. Ballesteros, L. F.; Teixeira, J. A.; Mussatto, S. I. Chemical, functional, and structural properties 
of spent coffee grounds and coffee silverskin. Food Bioprocess Technol. 2014, 7, 3493–3503. 
170. Jiménez-Zamora, A.; Pastoriza, S.; Rufián-Henares, J. A. Revalorization of coffee by-products. 
Prebiotic, antimicrobial and antioxidant properties. LWT - Food Sci. Technol. 2015, 61, 12–18. 
171. Napolitano, A.; Fogliano, V.; Tafuri, A.; Ritieni, A. Natural occurrence of ochratoxin A and 
antioxidant activities of green and roasted coffees and corresponding byproducts. J. Agric. 
Food Chem. 2007, 55, 10499–10504. 
172. Mesías, M.; Navarro, M.; Martínez-Saez, N.; Ullate, M.; del Castillo, M. D.; Morales, F. J. 
Antiglycative and carbonyl trapping properties of the water soluble fraction of coffee silverskin. 
Food Res. Int. 2014, 62, 1120–1126. 
173. Moreira, A. S. P.; Nunes, F. M.; Domingues, M. R.; Coimbra, M. a. Coffee melanoidins: 
structures, mechanisms of formation and potential health impacts. Food Funct. 2012, 3, 903. 
174. Mussatto, S. I.; Carneiro, L. M.; Silva, J. P. A.; Roberto, I. C.; Teixeira, J. A. A study on 
chemical constituents and sugars extraction from spent coffee grounds. Carbohydr. Polym. 
2011, 83, 368–374. 
175. Ramalakshmi, K.; Rao, L. J. M.; Takano-Ishikawa, Y.; Goto, M. Bioactivities of low-grade green 
coffee and spent coffee in different in vitro model systems. Food Chem. 2009, 115, 79–85. 
176. Bravo, J.; Jua, I.; Monente, C.; Caemmerer, B.; Kroh, L. W. Evaluation of spent coffee obtained 
from the most common coffeemakers as a source of hydrophilic bioactive compounds. J. Agric. 
Food Chem. 2012, 60, 12565–12573. 
177. Cruz, R.; Cardoso, M. M.; Fernandes, L.; Oliveira, M.; Mendes, E.; Baptista, P.; Morais, S.; 
Casal, S. Espresso coffee residues: A valuable source of unextracted compounds. J. Agric. 
Food Chem. 2012, 60, 7777–7784. 
178. Esquivel, P.; Jiménez, V. M. Functional properties of coffee and coffee by-products. Food Res. 
Int. 2012, 46, 488–495. 
179. del Castillo, M. D.; Martinez-Saez, N.; Ullate, M. Formulación alimentaria que comprende 
marros de café y sus aplicaciones. WO2014128320 A1. 2014. 
180. Mussatto, S. I.; Ballesteros, L. F.; Martins, S.; Maltos, D. A. F.; Aguilar, C. N.; Teixeira, J. A. 
Maximization of fructooligosaccharides and β-fructofuranosidase production by Aspergillus 
japonicus under solid-state fermentation conditions. Food Bioprocess Technol. 2013, 6, 2128–
2134. 
181. Mussatto, S. I.; Aguiar, L. M.; Marinha, M. I.; Jorge, R. C.; Ferreira, E. C. Economic analysis 
and environmental impact assessment of three different fermentation processes for 
fructooligosaccharides production. Bioresour. Technol. 2015, 198, 673–81. 
182. Ribeiro, V. S.; Leitão, A. E.; Ramalho, J. C.; Lidon, F. C. Chemical characterization and 
antioxidant properties of a new coffee blend with cocoa, coffee silverskin and green coffee 
minimally processed. Food Res. Int. 2014, 61, 39–47. 
183. Fernandez-Gomez, B.; Nitride, C.; Ullate, M.; Mamone, G.; Ferranti, P.; del Castillo, M. D. 
Natural advanced glycation end products inhibitors from coffea roasting by-product. Fitoterapia 
2017, Under revision. 
184. Chen, K. I.; Lo, Y. C.; Liu, C. W.; Yu, R. C.; Chou, C. C.; Cheng, K. C. Enrichment of two 
isoflavone aglycones in black soymilk by using spent coffee grounds as an immobiliser for β-
glucosidase. Food Chem. 2013, 139, 79–85. 
Introduction 
 
56  
 
185. Sampaio, A.; Dragone, G.; Vilanova, M.; Oliveira, J. M.; Teixeira, J. A.; Mussatto, S. I. 
Production, chemical characterization, and sensory profile of a novel spirit elaborated from 
spent coffee ground. LWT - Food Sci. Technol. 2013, 54, 557–563. 
186. Vázquez-Sánchez, K.; Martinez-Saez, N.; del Castillo, M. D.; Campos-Vega, R. Antioxidant 
coffee dietary fiber for gastrointestinal health and diabetes. 20th Int. Conf. FFC - 8th Int. Symp. 
ASFFBC, 2015. 
187. Campos-Vega, R.; Gaytan Martinez, M.; Vázquez-Sánchez, K.; Morales Sanchez, E. Proceso 
de obtención de fibra dietaria antioxidante natural de subproductos mediante calentamiento 
ohmico y compuesto alto en fibra dietaria antioxidante natural de café usado. 
MX/a/2016008578. 2016. 
188. Vilela, W. F.; Leão, D. P.; Franca, A. S.; Oliveira, L. S. Effect of peroxide treatment on 
functional and technological properties of fiber-rich powders based on spent coffee grounds. 
Int. J. Food Eng. 2016, 2, 42–47. 
189. Ballesteros, L. F.; Teixeira, J. A.; Mussatto, S. I. Extraction of polysaccharides by 
autohydrolysis of spent coffee grounds and evaluation of their antioxidant activity. Carbohydr. 
Polym. 2017, 157, 258–266. 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                             
                            Hypothesis, 
objectives and work plan 
 
 
  59 
 
HYPOTHESIS, OBJECTIVES AND WORK PLAN 
 
Obesity and T2D have reached epidemic proportions in the past few years becoming serious health 
concerns. Both are related multifactorial complex diseases, and a large proportion of the cases are 
preventable. Nowadays, food choice, toxic food ingredients, nutritional deficiencies and lack of 
physical exercise cause more than 95% of all chronic diseases. In the last decades, the market of 
functional foods has surprisingly increased. Many plant extracts are emerging as functional 
candidates for the reduction of risk of non-communicable chronic diseases. Plant food by-products 
are sustainable sources of bioactive compounds with health promoting and therapeutic properties to 
satisfy consumer’s demands.  
Coffee is one of the most frequently consumed drinks in the world. Its total production in 2014-15 
was of 142 million 60 kg bags (International Coffee Organization, 2015). Several epidemiological 
studies document the protective effect of coffee components in the risk of chronic diseases such 
metabolic disorders associated to oxidative stress and inflammation including diabetes such dietary 
fibre and CGA among others bioactive compounds.  
CS is the only by-product produced during the roasting process in large amounts worldwide. SCG 
are the residual material obtained during the preparation of the coffee beverage or the instant coffee. 
On average, one ton of green coffee generates about 650 kg of SCG, and about 2 kg of wet SCG 
are obtained for each kg of soluble coffee produced. CS and SCG also contain appreciable amounts 
of bioactive nutrients and non-nutritive compounds. Coffee by-products are very abundant worldwide 
and they contain several health promoting compounds able to improve the metabolism of 
carbohydrates and lipids and to reduce the risk of chronic diseases. Coffee industry needs to recycle 
large amounts of wastes in order to reduce its environmental impact. In conclusion, the 
valorisation of coffee wastes using the bio-refinery approach represents a great opportunity 
for the sustainability and competitiveness of the coffee sector and the industry of functional 
beverages and foods for chronic diseases.  
The health effects of CS and SCG as ingredients of foods and beverages largely will depend on the 
bioaccesibility and bioavailability of their bioactive components in the organism. Digestion has a 
great impact on these events. Components released during this physiological process may affect 
satiety, bioactivity of food components and food safety. Few information is available on how the 
interaction between the digestion products of nutrients and non- nutrients affect health and it is of 
great interest.  
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The general objectives proposed for demonstrating the hypothesis of the present research were as 
follows:  
1. To validate the use of coffee wastes as sustainable food ingredients.  
2. To provide new knowledge on interest of the conversion of coffee by-products, CS and 
SCG, in functional ingredients to be employed in the elaboration of sustainable beverages 
and foods for chronic metabolic diseases presenting high sensorial quality. 
3. To study the impact of the digestion process of functional foods for chronic diseases 
containing coffee by-products on the release of satiety hormones and formation of 
compounds of interest in health and diseases (advanced glycation products).  
The specific objectives of the present thesis were as follows:   
 
1. To validate the utility of CS and SCG as food ingredients (Chapters 1 and 2) 
To achieve this goal, novel beverages based on CSE (Chapter 1) and bakery products based 
on CS or SCG (Chapter 2) were developed. The physical, nutritional and sensorial quality of 
the novel products was evaluated. Safety regarding processing neo-contaminants with health 
impact, and bioaccesibility in vitro of the bioactive components were examined on CS- and 
SCG-containing biscuits. Microbiological quality of SCG-containing biscuits was assessed. 
 
2. To determine the biological effects of CSE and SCG as food ingredients to reduce the 
risk of obesity and T2D (Chapters 1 and 2) 
To achieve this goal, it was evaluated the effects of novel beverages based on CSE on body fat 
reduction in vitro and in vivo employing as animal model Caenorhabditis. elegans (C.elegans) 
(Chapter 1). Moreover, in vitro effects of the bioaccessible food components released during 
the simulated human digestion of SCG-containing biscuits on α-glucosidase activity and satiety 
hormones were examined (Chapter 2). The satiating effect was evaluated in gut intestinal cells 
by the measurement of GLP-1 and serotonin release.  
 
3. To evaluate the digestion process on the release of compounds with health impact 
(Chapter 3) 
To achieve this goal, in vitro oral gastrointestinal digestion of simplified meal systems 
comprising an average meal and high-sugar meals was performed. The formation of MRPs 
associated to the pathogenesis of diabetes and its complications were examined.  
 
Figure 1 shows the work plan performed to achieve each objective proposed in the thesis.
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Figure 1. Scheme of the work plan performed at the present investigation [ACSE, Arabica coffee silverskin extract; AGEs, advanced glycation end products; BSA, bovine serum 
albumin; CGA, chlorogenic acid; CML; carboxymethyl lysine; CS, coffee silverskin; CSE, coffee silverskin extract; CZE, capillary zone electrophoresis; ELISA, Enzyme-Linked ImmunoSorbent Assay; FOS, 
fructooligosaccharides; GLP-1, glucagon-like peptide-1; HMF, hydroxymethyl furfural; HPLC, high-performance liquid chromatography; MGO, methylglyoxal; MRPs, Maillard reaction products; NBT, 
nitroblue tetrazolium; RCSE, Robusta coffee silverskin extract; SCG, spent coffee grounds] 
Evaluation of beverage quality 
Study of bioactivity in vivo 
Evaluation of food quality 
Study of bioaccesibility in vitro 
Validation as food ingredient 
Evaluation of food quality 
Study of bioaccesibility in vitro 
Study of bioactivity in vitro 
IMPACT OF DIGESTIVE PROCESS ON HEALTH-IMPACT 
COMPOUNDS 
Patent 
WO2014128320 
Beverages (ACSE and RCSE) 
Nutritional analysis (glucose, carbohydrates, proteins, fibre)  
Biofunctional analysis (phenolic content, antioxidant capacity, 
melanoidins; and CGA and caffeine by CZE) 
Sensorial analysis (20 untrained panellists, hedonic test and 
acceptance level test)  
Effect on body fat accumulation (C. elegans, n=120) 
Treatment with CSE-beverages, CGA, caffeine and 
decaffeinated green coffee supplement  
Fluorescence (480 nm excitation, 571 nm emission) 
10 biscuits (with sucrose or maltitol or stevia)  
Physical parameters (moisture, thickness, texture 
and colour) 
Food safety (neo-contaminants -acrylamide and 
HMF- by HPLC) 
In vitro digestion: Novel biscuit (CSE + solid residue + 
stevia) and control biscuit (stevia) 
Chemical and nutritional composition of digests 
NOVEL BEVERAGES NOVEL BAKERY PRODUCTS 
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Solid residue 
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Physicochemical characterization 
Safety (microbiological quality –aerobic, endospores, 
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Evaluation as dietary fibre (thermal and digestive 
resistance) 
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Sensorial analysis (26 untrained panellists, hedonic 
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Alpha-glucosidase inhibition  
Release of satiety hormones (serotonin and GLP-1 
in Caco-2 and HuTu-cells, respectively, by ELISA) 
In vitro digestion: Average meal (BSA, digestible starch and oil) and high-sugar meals (BSA, glucose 
or fructose or HFS) 
Intestinal incubation: Simple amino acid systems (lysine or arginine and fructose or glucose) 
Determination of MRPs: Amino acid content by amino acid analyzer, fructosamine by NBT assay, CML 
and MGO-derivative AGEs by ELISA, and fluorescent adducts by fluorescence 
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MAIN CONTRIBUTIONS 
 
This PhD thesis contributes to provide new knowledge on the validation of CS and SCG as food 
ingredients in the development of novel beverages and foods. Biological effects of these coffee 
wastes as food ingredients for the management of obesity and T2D have been examined in vitro, ex 
vivo and in vivo. The effect of the digestion process on the release of compounds with health impact 
has been evaluated. Therefore, this section has been divided in 3 chapters as follows: 1) Beverages 
based on CS; 2) Bakery foods based on CS and SCG; and 3) Impact of digestive process on the 
formation of potential harmful compounds.  
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CHAPTER 1 
 
Beverages based on coffee silverskin 
 
This chapter summarises in vitro and in vivo assays performed to gain insight into the use of CS as a 
novel beverage and its effects on the obesity disease. C. elegans was employed as the animal 
model to evaluate the reduction of fat deposits.  
  
 Study 1 published as: Martinez-Saez, N.; Ullate, M.; Martin-Cabrejas, M. a.; Martorell, P.; 
Genovés, S.; Ramon, D.; Del Castillo, M. D. A novel antioxidant beverage for body weight 
control based on coffee silverskin. Food Chem. 2014, 150, 227–234. DOI: 
10.1016/j.foodchem.2013.10.100 
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CHAPTER 2 
 
Bakery foods based on coffee silverskin and spent grounds 
 
The present chapter shows findings regarding the validation of CS and SCG as food ingredients of 
bakery products. Physical, nutritional, sensorial and safety qualities are presented. Evidence on the 
bioaccesibility in vitro of these bakery foods is shown. Effects of the bioaccessible food components 
released during the in vitro simulated human digestion of a novel coffee fibre-containing biscuit 
(CFB) on α-glucosidase activity and satiety hormones, serotonin and GLP-1, are shown. The 
satiating effect was evaluated ex vivo in gut intestinal cells (Caco-2 and HuTu-80). 
 
 Study 1 published as: Garcia-Serna, E.; Martinez-Saez, N.; Mesias, M.; Morales, F. J.; del 
Castillo, M. D. Use of coffee silverskin and stevia to improve the formulation of biscuits. 
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 Study 2 published as: Martinez-Saez, N.; Tamargo, A.; Domínguez, I.; Rebollo-hernanz, M.; 
Mesías, M.; Morales, F. J.; Martín-Cabrejas, M. A.; del Castillo, M. D. Use of spent coffee 
grounds as food ingredient in bakery products. Food Chem. 2017, 216, 114–122. DOI: 
10.1016/j.foodchem.2016.07.173.  
 
 Study 3 will be published as: Martinez-Saez, N.; Hochkogler, C. M.; Somoza, V. & del Castillo, 
M.D. In vitro assessment of the satiety effect of non-added sugar biscuit containing 
stevia, coffee fibre and fructooligosaccharides. This article has been submitted to Nutrients 
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Abstract: This study assessed the in vitro effects of the bioaccessible food components released 
during the simulated human digestion of a coffee fibre-containing biscuit (CFB) on α-glucosidase 
activity, antioxidant capacity and satiety hormones. This biscuit presented a significantly (p < 0.05) 
lower glycaemic sugar content (60.6 mg/g) and a higher antioxidant capacity (15.1 mg chlorogenic 
acid/g) than a sucrose-containing biscuit (SCB). The CFB significantly reduced (p < 0.05) α-
glucosidase activity (IC50 = 3.3 mg/ml) compared to the SCB (IC50 = 6.2 mg/ml). Serotonin and 
glucagon-like peptide-1 (GLP-1) release by differentiated Caco-2 and HuTu-80 cells, respectively, 
were stimulated by the CFB (354.7 ± 42.7% and 277.9 ± 14.1%) to the same order of magnitude as 
those of the SCB. In conclusion, the CFB was demonstrated to reduce simple sugar bioaccessibility 
and to improve satiety. 
Keywords: α-glucosidase; biscuits; coffee fibre; fructoologosaccharides; GLP-1; serotonin; stevia; 
non-nutritive sweeteners.   
 
1. INTRODUCTION 
Consumption of energy dense foods high in fat and sugar is associated with the prevalence of 
obesity, type 2 diabetes, cardiovascular diseases and several cancers [1]. There is solid evidence 
that the risk of becoming overweight or obese is lower when the daily intake of free sugars is less 
than 10% of the total energy [2]. Increasing the price of unhealthy foods through sugar taxes could 
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potentially discourage the overconsumption of sugar [1]. However, multiple strategies are needed to 
battle obesity and associated comorbidities, e.g. diabetes.  
Consumption of foods with a low glycaemic index (GI) can help regulate blood glucose levels, 
improve satiety, and control body weight [3]. Recently, high-fibre and sugar-free foods containing 
stevia as a non-nutritive sweetener have been developed by our group.[4] Stevia glycosides can 
help to optimize blood sugar and insulin levels in diabetics [5]. Foods high in fibre have been 
demonstrated to lower the GI as, for instance, galactomannan which slows gastric emptying and 
inhibits diabetes-related digestive enzymes [6,7].  
The α-glucosidase is a membrane-bound intestinal enzyme, essential for degrading 
oligosaccharides to monosaccharides [8]. Food constituents such as dietary fibres, stevia and coffee 
phenols have been shown to act as glucosidase inhibitors [5,7,9], and to reduce postprandial 
hyperglycaemia. However, results on these compounds present in complex food matrices are 
missing.  
Intake of satiety-inducing foods becomes a strategy to reduce sugar intake and related chronic 
diseases. Food ingestion activates the secretion of several gut-derived mediators [10], including the 
hormones localized in intestinal enterochromaffin cells, serotonin and glucagon-like peptide-1 (GLP-
1). GLP-1 plays a role in the regulation of food intake and presents glucometabolic effects and 
serotonin is implicated in the control of satiety [10,11].  
The goal of this study was to elucidate whether a replacement of sucrose by stevia, coffee fibre and 
fructooligosaccharides (FOS) in a sucrose-containing biscuit (SCB) improves its antioxidant capacity 
and outcome measures satiety in vitro. We report novel in vitro data on the potential use of a coffee 
fibre-containing biscuit (CFB) suitable for diabetics, people on a weight control diet and healthy 
people interested in maintaining a healthy body weight. This study also provides new evidence for 
using coffee fibre as a sustainable functional food ingredient. 
2. MATERIALS AND METHODS  
2.1. Chemicals 
Bradford reagent was provided by Bio-Rad Laboratories S.A. The following chemicals were ob-
tained from Sigma-Aldrich (St. Louis, MO, USA): α-amylase from human saliva (type IX-A), porcine 
pepsin from gastric mucosa (3.200-4.500 U/mg protein), pancreatin from porcine pancreas, porcine 
bile extract, bovine serum albumin (BSA), chlorogenic acid (CGA) (3-CGA), 2,2'-azino-bis (3-
ethylbenzothiazoline-6-sulphonic acid (ABTS)), 6-hydroxy-2,5,7,8-tetramethylchroman- 2-carboxylic 
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acid (Trolox), phenol 5% (w/v), potassium persul¬phate, Folin-Ciocalteu reagent, Nα-Acetyl-L-lysine, 
ortho-phthalaldehyde (OPA), α-glucosidase from intestinal acetone powders of  rat, 4-
methylumbelliferyl α-D-glucopyranoside (4-MUG), acarbose, 3-(4,5-dimethyl-2-thiazolyl) -2,5-
diphenyltetrazolium bromide (MTT) and trypan blue solution. We used the D-mannose/D-fructose/D-
glucose assay kit and galactomannan assay kit from Megazyme International Ireland Ldt. (Ireland), 
Multi Species GLP-1 Total ELISA kit (Cat-nº. EZGLP1T-36K) from EMD Millipore (Missouri, USA) 
and Serotonin High Sensitive ELISA kit (Cat-nº. EA630/96) from DLD Diagnostika GmbH (Hamburg, 
Germany). For cell culture, Dulbecco’s modified Eagle’s medium (DMEM), minimum essential 
medium Eagle (MEM), L-glutamine, penicil¬lin and streptomycin were purchased from Sigma-Aldrich 
(St. Louis, MO, USA). Fetal bovine serum (FBS) was from GIBCO Invitrogen (Karlsruhe, Germany). 
Water was purified using the Milli-Q and Elix system. All other chemicals and reagents were of 
analytical grade. 
2.2. Apparatus and materials 
BioTek powerWaveTM XS (BioTek Instruments, U.S.A), FP-6200 (JASCO, Easton, U.S.A) and 
Infinite® 200 PRO multimode (TECAN, Deutschland GmbH) microplates readers, convection oven 
(Romag S.A, Barcelona, Spain), UN 500 universal oven (Memmert, Germany) and Telstar Lyobeta-
15 lyophilizer (Telstar, Spain) were used for analyses. For the cell assays, a Neubauer cell counting 
chamber (0.100 mm depth, 0.0025 mm2) (Paul Marienfeld GmbH & Co. KG, Germany), an incubator 
(BINDER GmbH, Germany), a Thermo Scientific™ MSC-Advantage™ class II biological safety 
cabinet (Thermo Fisher Scientific, USA), an autoclave (3870EA, Tuttnauer, USA), a TR400-SW 
TRINO microscope (VWR, Austria), CELLSTAR® multiwell culture plates and standard cell culture 
flasks (Greiner Bio-One GmbH, Austria) were used. 
2.3. Food ingredients 
Spent coffee grounds (SCG) from Robusta instant coffee were used as a source of antioxidant 
coffee fibre [4]. SCG were supplied by Prosol S.A (Spain) and stored at -20°C until use. FOS powder 
(ORAFTI®P95) was from Beneo-Orafti and stevia sweetener powder, containing 3% steviol 
glycosides, was purchased at a local supermarket. All other basic ingredients were purchased at 
specialized and certified food markets.  
2.4. Food samples 
Biscuit formulations can be seen in Table 1. Biscuits were prepared following Martinez-Saez et al. 
[4]. Briefly, the dough was prepared by mixing salt, baking powder and sucrose or stevia. Mineral 
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water was added to the dry mixture and thoroughly blended. In a separate bowl, lecithin and oil were 
mixed and then added to the mixture. Finally, the flour, coffee fibre and FOS were gradually added 
and the dough was kneaded.  The dough was allowed to rest for 30 min, and shaped into discs.  The 
biscuits were baked at 185º C for 16 min in an air recirculation oven. Two sets of 3 biscuits were 
baked in duplicate (n = 6). The biscuits were placed in the centre of the tray in order to reduce 
process variability during baking. Biscuits were grounded to obtain a representative sample for 
further analyses.   
Table 1. Biscuit formulations: sucrose-containing biscuit (SCB) and coffee fibre-containing biscuit (CFB) made 
with stevia, coffee fibre and fructooligosaccharides (FOS). 
Biscuits were digested in triplicate under in vitro oral gastrointestinal human digestion conditions [4]. 
Briefly, all three stages, salivary (pH 6.9, 10 ml, 5 min, 3.9 U α-amylase/ml, aerobic), gastric (pH 2, 
13 ml, 90 min, 71.2 U pepsin/ml, aerobic), and abiotic duodenal step (pH 7, 16 ml, 150 min, 9.2 mg 
pancreatin and 55.2 mg bile extract/ml, aerobic) were performed in the same flask. Digests were 
then centrifuged and the soluble fractions containing bioaccessible compounds to be absorbed and 
metabolized were treated with cholestyramine resin (10% w/v) to remove the bile acids and mimic 
the human bile salt reabsorption. Soluble fractions were then frozen at -20°C, lyophilized and stored 
at room temperature until further analysis. 
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Coffee fibre, stevia and FOS were also digested in vitro following the above-described procedure to 
gain insight into their contribution to bioactive compounds.  
 2.5. Cell culture: Caco-2 and HuTu-80 
The human colon cancer cell line (Caco-2) was cultured in DMEM supplemented with FBS (10%), L-
glutamine (2%) and penicillin/ streptomycin (1%) at 37°C and 5% CO2. Cells were grown in 12-well 
plates until reaching confluence, approximately after 3 days. Cell differentiation was obtained by 
subsequent culture for a further 21 days including medium changes every two to three days. The 
enterocyte-like differentiated Caco-2 cells were then used for further studies on serotonin hormone 
release.  
The human duodenal cancer cell line (HuTu-80) was cultured in MEM supplemented with FBS 
(10%), L-glutamine (2%) and penicillin/ streptomycin (1%) at 37°C and 5% CO2. Cells were grown in 
24-well plates until reaching confluence, approximately after 1 day. HuTu-80 cells were not 
differentiated with enterocyte-like properties, and 24 hours after seeding, they were ready to be used 
for analyses on GLP-1 hormone release. 
After thawing, both cells lines were passaged 3-4 times to give cells time to recover their normal 
growth rate. 
2.6. Bioaccessibility of food components 
Digests of coffee fibre, stevia and biscuits (SCB and CFB) were characterized. 
2.6.1. Total carbohydrates 
Total carbohydrates were determined using the phenol–sulphuric method as described by Masuko et 
al. with slight modifications [12]. Samples (20 µl) were mixed with concentrated sulphuric acid (93–
98%) (61 µl) and phenol solution (5%, w/v) (18 µl) in a multi-well plate. After incubation at 90ºC for 5 
min in a water bath, the microplate was cooled to room temperature and absorbance was measured 
at 490 nm. The calibration curve was constructed using glucose (0.1–0.9 mg/ml) as standard. 
Reagent blank and sample blank were also prepared and analysed in each set of samples. All 
measurements were performed in triplicate and results were expressed as mg glucose equivalents 
(eq.)/g digest. 
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2.6.2. Galactomannan 
The procedure for determining galactomannan content was performed using an enzymatic kit 
following the manufacturer’s instructions. The method was adapted to a micromethod format. 
Analyses were carried out in triplicate and results were expressed as mg/g digest. 
2.6.3. Free sugars  
Glucose, fructose and mannose contents were determined using an enzymatic kit following the 
manufacturer’s instructions. The method was adapted to micromethod. The analysis was performed 
in triplicate. Results were expressed as mg glucose, mg fructose and mg mannose/g digest. 
2.6.4. Soluble proteins and peptides 
The Bio-Rad Protein Assay, based on the Bradford method in micro-method format, was used to 
determine proteins and peptides. Reagents were prepared according to manufacturer’s instructions. 
Briefly, a solution of Bradford reagent (1 : 4 reagent : milli-Q water) was prepared and filtered. Ten µl 
of sample and 200 µl of Bradford solution were placed in a multi-well plate. After 5 min of incubation 
at room temperature, absorbance was measured at 595 nm. Sample blank and reagent blank were 
also analysed. BSA was used as standard (0.05 – 1 mg/ml). All measurements were performed in 
triplicate. Results were expressed as mg BSA eq./g digest.  
2.6.5. Free amino groups 
The release of amino acids by proteolysis of proteins forming wheat flour and coffee fibre was 
measured by the OPA assay following Go et al. [13]. OPA reagent was freshly prepared by 
dissolving 10 mg OPA in 250 μl ethanol (95%, v/v), 9.8 ml PBS (10 mM, pH 7.4) and 20 μl β-
mercaptoethanol. The reaction was carried out in a 96-well microtest plate by mixing 10 µl sample, 
140µl PBS and 100 µl OPA reagent. Fluorescence was read at 360 ± 40 nm excitation and 460 ± 
40 nm emission wavelengths for 15 min at 37 ºC. The calibration curve was constructed using 
standard solutions of Nα-acetyl-L-lysine (0.025 – 1 mM). All measurements were performed in 
triplicate, and data were expressed as mg Nα-acetyl-L-lysine eq./g digest. 
2.6.6. Total phenolic content  
Total phenolic content (TPC) was determined by the Folin–Ciocalteu method as described by Contini 
et al. [14], adapted to a micromethod format. Ten µl of sample and 150 µl of Folin–Ciocalteu solution 
were incubated at room temperature for 3 min and 50 µl of sodium bicarbonate were added. 
Reaction was run for 120 min at 37ºC, and absorbance was read at 735 nm. Sample blank and 
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reagent blank were also analysed in each set of samples. The CGA calibration curve (0.1-1 mg/ml) 
was used for quantification. Measurements were performed in triplicate and results were expressed 
as mg CGA eq./g digest. 
2.6.7. Antioxidant capacity 
The overall antioxidant capacity of the digested biscuits and coffee fibre was analysed using the 
indirect ABTS•+ decolourisation assay as described by Oki et al. [15]. An ABTS•+ stock solution was 
prepared by adding 140 mmol/l potassium persulfate (44 µl) to a 7 mmol/l ABTS•+ aqueous solution 
(2.5 ml), and the mixture was then allowed to stand for 16 h at room temperature. The working 
solution of the radical ABTS•+ was prepared by diluting the stock solution 1:75 (v/v) in sodium 
phosphate buffer (5 mmol/l, pH 7.4) to obtain an absorbance value of 0.7 ± 0.02 at 734 nm. Samples 
(30 µl) were added to ABTS•+ solution (270 µl) in a microplate. Absorbance was measured at 734 
nm for 10 min at 30ºC. CGA (0.025-0.25 mmol/l) and trolox (0.025-0.25 mmol/l) were used for 
quantification. All measurements were performed in triplicate and results were expressed as mg 
CGA eq./g digest. 
2.7. Health-promoting properties of bioaccessible food components 
2.7.1. Alpha-glucosidase inhibition assay 
The α-glucosidase inhibitory activity of the digested biscuits, coffee fibre, stevia and FOS was 
analysed following the methodology described by Berthelot et al. and Geddes et al. [16,17] with 
slight modifications. Alpha-glucosidase enzyme was extracted previous to the assay. Briefly, 100 mg 
of rat intestine powder were dissolved in 3 ml NaCl (0.9%), sonicated in an ice bath for 6 min and 
then centrifuged at 10000 g for 30 min. The supernatant containing the enzyme was stored in the 
freezer. In a 96-well microplate, 100 μl of sample dissolved in PBS (100 mM, pH 6.9) were mixed 
with 100 μl α-glucosidase (diluted 1/10) and 100 μl 4-MUG (2 mM). Fluorescence was then 
monitored at an excitation wavelength of 360 nm and an emission wavelength of 460 nm for 30 min 
at 37 °C. Blank of sample and negative control (buffer, enzyme and 4-MUG) were included. 
Acarbose was used as a positive control (standard inhibitor). Curves of samples and acarbose were 
assayed to cover the whole range of inhibition of the enzyme (≈0.5-96%). The percentage (%) of α-
glucosidase inhibition was calculated using the equation: 
α-glucosidase inhibition (%) = 
Fnc-Fs
Fnc
 x 100 
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Where Fn.c. is the fluorescence of the negative control (without inhibitor) and Fs is the fluorescence 
of the sample. All measurements were performed in triplicate. Results were expressed as the 
concentration causing 50% inhibition (IC50 mg/ml). 
2.7.2. Assays of serotonin and GLP-1 secretion 
Soluble fractions recovered from the digested SCB, CFB and coffee fibre containing bioaccessible 
compounds for absorption and metabolism were used to stimulate the secretion of satiating 
hormones in cell cultures. The effect of stevia on the release of satiating hormones was also tested. 
 Cell viability: Cytotoxic effects of test samples were excluded by performing the colorimetric 
MTT assay [18]. Differentiated Caco-2 cells were incubated with samples (0.05, 0.5 and 5 
mg/ml) diluted in PBS containing ascorbic acid (0.1%) and after a 5-min exposure to cells, the 
samples were removed. HuTu-80 cells were first starved with medium free of serum, glucose 
and glutamine for 1 h prior to the incubation with the samples (0.01, 0.05 and 0.5 mg/ml) diluted 
in the starving-medium. After 90-min exposure, samples were finally removed.  
In both cellular lines, exposure was carried out at 37ºC and a negative (medium) and positive 
control (DMSO) were also included. The MTT solution (50 mg/ml, 1:6) was left to incubate (10-
15 min) and the resulting formazan diluted in DMSO was measured at 570 nm. Viability was 
determined relative to untreated negative control cells (100%). Three groups of different 
passaging and samples in duplicate were performed in each set of analysis (n = 3, tr = 6). The 
percentage of cell vitality was calculated as follows: vitality (%) = (dead cell number / total cell 
number) × 100. Results were expressed as total cell viability / control (T/C) [%]. 
 Stimulation and quantification of serotonin: Caco-2 cells were supplemented with the 
bioaccessible fractions (150 µl) at three different concentrations (0.5, 0.05, 0.01 mg/ml) in 
duplicate. Cells were washed with PBS prior to the addition of samples. The cells were then 
stimulated for 5 min in darkness in an orbital shaker. Supernatants were removed from the cells 
and frozen until further quantification of the serotonin hormone. Positive (cinnamaldehyde, 5 
mM) and negative (buffer) controls were also tested.  
The serotonin released by Caco-2 cells was quantified in darkness using a highly sensitive 
enzyme immunoassay kit (ELISA competitive) following the manufacturer’s instructions. Three 
groups of different passaging were performed in each set of analysis (n = 3, tr = 6). Results 
were expressed as T/C [%] compared to the control.  
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 Stimulation and quantification of GLP-1: HuTu-80 cells were first starved with medium free of 
serum, glucose and glutamine for 1 h prior to stimulation with the bioaccessible fractions (500 
µl) at 0.01, 0.05 and 0.5 mg/ml in duplicate. Positive (glutamine 40 mM) and negative (medium) 
controls were also tested. Exposure to the cells was for 1 h 30 min at 37 ºC. After the 
stimulation period, supernatants were collected and frozen until further quantification of the 
GLP-1 hormone.  
The GLP-1 hormone released from HuTu-80 cells was quantified using the sandwich ELISA kit 
following the manufacturer’s instructions. Three groups of different passaging were performed 
in each set of analysis (n = 3, tr = 6). Results were expressed T/C [%] compared to the control.  
2.8. Statistical Analysis 
Statistical analyses were performed using SigmaPlot 11.0 (Systat Software Inc., California, USA). 
Data were expressed as the mean value ± standard deviation for all analyses except for those 
comprising culture cells which were expressed as mean ± standard error of the mean (SEM). 
Differences between means were determined through analysis of variance (ANOVA), one-way 
ANOVA followed by Dunn's, Fisher LSD or Holm-Sidak post-hoc tests. Differences were considered 
to be significant at p < 0.05.  
3. RESULTS AND DISCUSSION 
3.1. Bioaccessibility of food components  
Table 2 shows data on the bioaccessible food components released during the digestion process. In 
the case of coffee fibre, the major component of the bioaccessible fraction of the digest were 
carbohydrates (11.3%), whereas only trace amounts of sugars such as glucose (0.01%), fructose 
(0.02%) and mannose (0.03%) were detected. In contrast, a higher content in polysaccharides like 
galactomannan (2%) was quantitated. TPC represented 1.56% of the bioaccessible food 
components, and proteins (0.88%) and free amino groups (2.2%) were also present. These results 
suggest that SCG used as coffee fibre mainly provides complex carbohydrates to the bioaccessible 
fraction, which is in accordance with the literature [4,19]. 
In the case of the SCB, the major components of the bioaccessible fraction of the digest were also 
carbohydrates (64.8%). Sugars represented 18% of total carbohydrates. Fructose (52.3%) and 
glucose (47%) were found in the highest amounts, followed by trace amounts of mannose (0.7%). 
Protein and amino acid contents were lower than 1% (0.41% and 0.80%, respectively) and TPC 
represented 0.85%. Wheat flour starch seems to be the main contributor to the carbohydrate content 
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of the biscuit (Table 1). According to the literature, wheat flour is composed of 65% digestible starch 
[20], which is hydrolysed by digestive enzymes -salivary and pancreatic α-amylases- to glucose 
molecules and oligosaccharides [21]. The sucrose added to the traditional formulation can also be 
converted into glucose and fructose, mainly by chemical reactions during the processing of cereal-
based products [22], and the acid conditions of the stomach [23], since the intestinal sucrase 
enzyme was not used in this particular digestion model. These available carbohydrates may turn the 
traditional biscuit into a high GI food which may consequently cause fast postprandial blood glucose 
glycaemic responses [24].  
High GI diets are associated with decreased satiety and increased glucose intolerance, a greater risk 
of overweight and obesity and impaired lipid metabolism [25]. Furthermore, glucose and fructose 
follow different metabolic pathways after their absorption, resulting in different effects on blood 
glucose concentrations. Obesity is related to an elevated intake of both sugars. Type 2 diabetes is 
associated with high glucose diets, while the overconsumption of fructose is associated with non-
alcoholic fatty liver diseases and augmented de-novo triglyceride synthesis [26]. 
The formulation of the CFB by replacing sucrose with stevia, coffee fibre and FOS clearly favoured 
the contents of ingredients with beneficial effects on GI (Table 2). The bioavailability of glycaemic 
sugars was significantly (p < 0.05) lower with reductions of 46.4 ± 8.8% and 35.6 ± 1.1% for glucose 
and fructose, respectively, compared to the SCB. The stevia sweetener did not significantly 
contribute to the sugar content of the CFB (Table 2), as it was hydrolysed in a small amount (4%). 
Stevia, in particular steviol glycosides, cannot be hydrolysed by the digestive enzymes in the small 
intestine, but is metabolized to steviol by the microbiota of the colon [27]. However, the stevia added 
to the CFB contained digestible carbohydrate –maltodextrin (97%)- as an additive. Stevia plays an 
important role in lowering the GI of foods. The moderate glucose levels found in CFB are a 
necessary primary energy source for proper cell function in the organism [28], and have a direct 
positive impact on the GI of the biscuit. On the other hand, galactomannan was present in the CFB 
unlike the SCB. The coffee fibre included in the CFB is a natural source of galactomannan (Table 2). 
Intake of galactomannan is associated with reduced weight gain, adiposity, liver fat and blood 
glucose levels [29], making coffee fibre an attractive ingredient for confectioneries. Moreover, the 
FOS incorporated in the CFB as soluble fibre has been shown to reduce post-prandial glycaemic 
responses [30]. Marangoni & Poli [25], also obtained a markedly lower glycaemic index in bread and 
biscuits by adding a proprietary fibre mixture to their formulations.  
Regarding the antioxidant properties of the biscuits, significant differences (p < 0.05) were found 
between the CFB and the SCB. In the bioaccessibility of antioxidants, estimated as the overall 
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antioxidant capacity of the food digests, the digestion of the CFB released a significantly greater 
amount of antioxidants (15.07 ± 1.45 mg CGA eq./g digest) than in the SCB (10.43 ±  0.90 mg CGA 
eq./g digest). Most of the antioxidants of the SCB may be ascribed to phenolic compounds (Table 2), 
in contrast, the CFB might also contain other non-phenolic antioxidants which may contribute to its 
overall antioxidant capacity. The bioaccessible fraction of the digested coffee fibre had a high 
antioxidant character (46.14 ± 3.61 mg CGA eq./g digest). Furthermore, stevia [31], FOS [32], and 
the gluten peptides released during the digestion process by chemical and enzymatic hydrolysis [33], 
may also exert an antioxidant character. The high antioxidant properties of the CFB may play an 
important role in reducing the risk of obesity and diabetes. Consequently, introducing food 
antioxidants through the diet may be of great interest. High-antioxidant diets have been related to 
reduced inflammation and increased circulating antioxidants in cross-sectional and randomized 
intervention studies [34].  
Table 2. Bioaccessible compounds released during in vitro oral-gastrointestinal digestion of a sucrose-
containing biscuit (SCB), a coffee fibre-containing biscuit (CFB), coffee fibre and stevia. 
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3.2. Health-promoting properties of foods 
3.2.1. Anti-diabetic properties 
IC50 values for the α-glucosidase inhibition were calculated from dose–response curves (Figure 1 
(a), (b) and (c)). The IC50 for acarbose was 4.4 μg/ml. Alpha-glucosidase inhibitors were detected in 
the digests of the samples. However, the content of α-glucosidase inhibitors released during 
digestion differed significantly (p < 0.05) between samples. The CFB presented the lowest IC50 
value of all the studied samples (Table 3). According to the literature, the CFB is a better inhibitor 
than other food products such as lemon (IC50 36.59 mg/ml), lime (10.96 mg/ml), grapefruit (62.10 
mg/ml) [35], green tea (11.1 mg/ml), sardine muscle hydrolizate (48.7 mg/ml) and yogurt (519.8 
mg/ml) [36].  
Stevia, FOS and coffee fibre are demonstrated to contribute to the inhibitory effect of the α-
glucosidase observed for the CFB, although stevia had a higher inhibitory capacity than the other 
two ingredients. The inhibitory effect of stevia against α-glucosidase has been previously described 
[9]. Phenolic compounds released during the digestion of coffee fibre may also act as α-glucosidase 
inhibitors, as for instance the main phenolic compound of coffee, CGA with potential benefits on type 
2 diabetes [37]. Other compounds released during the digestion of the CFB such as bioactive 
peptides could also exhibit anti-diabetic properties [38].  
These results suggest the potential use of the CFB as a diabetic-friendly biscuit with great interest 
for people with type 2 diabetes and/or overweight or obese, as it has the potential to delay intestinal 
glucose absorption and enhance postprandial hyperglycaemia levels. However, proof-of-principle 
human intervention studies are needed to verify this effect. 
Table 3. IC50 values against α-glucosidase activity and equivalents of acarbose of the bioaccessible fractions 
of digested sucrose-containing biscuit (SCB), coffee fibre-containing biscuit (CFB), coffee fibre, stevia and 
fructooligosaccharides (FOS). 
Chapter 2 – Study 3                                                                                                 Main contributions 
 
 121 
 
(a) 
(b) 
(c) 
Figure 1. Effect on α-glucosidase activity represented by dose-response curves of (a) acarbose (0.1 µg/ml – 
30 mg/ml), (b) soluble fractions recovered from the digested sucrose-containing biscuit (SCB) (0.5-100 mg/ml), 
coffee fibre-containing biscuit (CFB) (0.01-100 mg/ml) and stevia (0.05-200 mg/ml), and (c) soluble fractions 
recovered from the digested coffee fibre (0.5-1000 mg/ml) and FOS (0.5-2000 mg/ml). Values represent mean 
± standard deviation. Duplicate of sample preparation and triplicate of analysis (n = 6). 
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3.2.2. Release of satiety hormones   
Different doses of the tested samples were not cytotoxic (Figure S1, supplementary material). The 
effect of the samples on cellular secretion of serotonin is shown in Figure 2. Caco-2 cells treated with 
0.5 mg/ml of the CFB digest exhibited a 4-fold increase in serotonin secretion (355 ± 42.7%). No 
differences in serotonin release were found (p > 0.05) between the digests of the SCB and the CFB. 
However, the compounds released during the digestion of the antioxidant coffee fibre had a 
significant effect on the secretion of serotonin, increasing serotonin release 7-fold (763 ± 81.4%) 
compared to the basal level. To the best of our knowledge, this is the first time that the effect of the 
antioxidant coffee fibre on satiety hormones has been reported. Gostner et al. found that coffee 
compounds such as gallic acid and cafeic acid had the potential to increase tryptophan availability, 
needed for the biosynthesis of serotonin, via inhibition of indoleamine 2,3-dioxygenase which is 
involved in tryptophan metabolism [39]. Further studies are required to elucidate which of the 
compounds released during the digestion of the coffee fibre is responsible for its satiating effect.  
Figure 2. Serotonin release after stimulation of Caco-2 cells at 0.5, 0.05 and 0.01 mg/ml with soluble fractions 
recovered from the digested sucrose-containing biscuit (SCB), coffee fibre-containing biscuit (CFB) and 
antioxidant coffee fibre that contain bioaccessible compounds; as well as stevia. Results are displayed as T/C 
in percent compared to the control (cells with media = 100%). All measurements were expressed as mean ± 
SEM (n = 3, tr = 6). Significant differences between treatments were tested with one-way ANOVA followed by 
the Holm–Sidak posthoc test (p < 0.05) and marked with the letters a, b, c and d. 
In contrast, the natural hypocaloric sweetener, stevia, did not stimulate the serotonin secretion in 
differentiated Caco-2 cells at the tested concentrations. This result is in concordance with that 
described by Ripken et al. did not found serotonin release from porcine intestinal tissue segments 
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when incubated with Rebaudioside A, the sweetest glycoside of the stevia [40]. Moreover, Anton et 
al. reported in human intervention that the intake of preloads containing stevia had satiety levels 
similar to those of sucrose preloads, measured by the subjective visual analogue scale [41]. 
Therefore, more investigations are required to clarify the role of this hypocaloric sweetener and its 
metabolites in serotonin secretion.   
Other bioaccessible compounds may exhibit serotonin stimulation. For instance, gluten peptides 
from wheat flour have been shown to contribute to higher hypothalamic and cortical serotonin levels 
in animal models [42]. Phenolic compounds can also play an important role in appetite suppression 
by stimulating this important signalling molecule [43]. Furthermore, Maillard reaction products such 
as N(ε)-carboxymethyl lysine from heat-treated food like biscuits, have been found to contribute to 
satiety regulation through central/brain serotonin release in SH-SY5Y cells [44]. Therefore, biscuits 
made using sucrose as a sweetener might contain these advanced products of the Maillard reaction 
that could contribute to the stimulation of serotonin. However, replacing sucrose with stevia limits the 
progress of Maillard reaction in food toward advanced stages [45], and may not significantly 
contribute to a postprandial satiating effect of the food prepared according to the CFB. Despite the 
controversial effect of peripheral serotonin on satiety [46], there is evidence that peripheral serotonin 
unfolds similar effects on satiety than central serotonin [11,47]. Further studies are needed to identify 
the individual food components that contribute to the release of serotonin from the gut in the CFB 
and the SCB. 
Regarding cellular secretion of GLP-1, significant GLP-1 values were obtained (p < 0.05) for the 
stimulation of HuTu-80 cells with the bioaccessible compounds released during the digestion of food 
formulations (Figure 3). Compared to the non-treated control cells, GLP-1 release was significantly 
higher (p < 0.05), i.e. three times higher (278 ± 14.1%), after incubation of HuTu-80 cells with the 
soluble fraction of the digested novel CFB (0.05 mg/ml). No significant differences were found (p > 
0.05) between the SCB and the CFB. The same trend was observed for all concentrations of the 
biscuits. The compounds released during the digestion of antioxidant coffee fibre from SCG 
significantly stimulated the secretion of the GLP-1 hormone. Although researchers have previously 
reported GLP-1 stimulation caused by coffee beverages in cells, mice and humans,[48] this is the 
first report of the effect of coffee fibre from SCG.  
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On the other hand, stevia was not effective at the three tested concentrations, which is in agreement 
with the results of Fujita et al. presented for an in vivo animal model [49]. FOS present in the CFB 
(Table 1) has been associated with appetite suppression via stimulation of GLP-1 release [50]. Other 
bioaccessible compounds, such as proteins and peptides, may also stimulate GLP-1 release. For 
instance, intact and digested wheat proteins have been found to produce satiety and have an anti-
diabetic effect through GLP-1 stimulation [51]. Further studies are required to characterize the food 
compounds released during digestion and to determine those which contribute to the satiating effect 
of the biscuits. 
 
Figure 3. Glucagon-like peptide-1 (GLP-1) release after stimulation of HuTu-80 cells at 0.5, 0.05 and 0.01 
mg/ml soluble fractions recovered from the digested sucrose containing biscuit (SCB), coffee fibre containing 
biscuit (CFB) and antioxidant coffee fibre that contain bioaccessible compounds; as well as stevia. Results are 
displayed as T/C in percent compared to control (cells with media = 100%). All measurements were expressed 
as mean ± SEM (n = 3, tr = 6). Significant differences between treatments were tested with one-way ANOVA 
followed by the Holm–Sidak posthoc test (p < 0.05) and marked with the letters a, b, c and d. 
 
4. CONCLUSIONS 
To the best of our knowledge, this is the first report of anti-diabetic and satiating effects of 
bioaccessible compounds released during the digestion of a CFB and their ingredients, antioxidant 
coffee fibre, FOS and stevia. New evidence of the use of antioxidant coffee fibre as a sustainable 
functional food ingredient has been provided.  
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Supplementary material  
Figure S1. Cytotoxic effects of soluble fractions recovered from the digested sucrose-containing biscuit (SCB), 
coffee fibre-containing biscuit (CFB) and antioxidant coffee fibre that contain bioaccessible compounds; as well 
as, stevia, on (a) Caco-2 cells at concentrations of 5, 0.5 and 0.05 mg/ml, and on (b) HuTu-80 cells at 0.5, 0.05 
and 0.01 mg/ml, compared to control (cells with media, 100% viability). All measurements were expressed as 
mean ± SEM (n=3, tr=6). Significant differences vs. control were determined by One-Way ANOVA followed by 
Dunn's posthoc test (p < 0.05) and marked as '*‘.
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CHAPTER 3 
 
Impact of digestive process on the formation of potential 
harmful compounds 
 
 
This chapter presents evidence on the formation of compounds with health impact during the 
digestive process. In vitro abiotic gastrointestinal digestion of simplified meal systems was performed 
and the formation of MRPs associated to the pathogenesis of diabetes and its complications was 
examined.  
 
 Study 1: Martinez-Saez, N.; Fernandez-Gomez, B.; Weijing, C.; Uribarri, J. & del Castillo, M.D. 
In vitro formation of Maillard reaction products (MRPs) during simulated digestion of 
food models corresponding to average and sugar-containing meals. This article has been 
submitted to Food Research International on the 21st of My, 2017. 
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Abstract 
The aim of the present research was to study the formation of Maillard reaction products (MRPs) 
during digestive process of simplified meal systems. An average meal (protein, starch and oil) and 
sugar-containing meals (protein and glucose or fructose or high fructose corn syrup (HCFS)) were 
tested. Intestinal simple amino acid systems were also analyzed to gain insight into their contribution 
to the Maillard reaction (MR). Decrease of lysine (11.7-34%), arginine (24-35%) and other amino 
acids occurred after digestion of the meals. Fructosamine (42.6±4.7 and 332.9±10.4 µg/ml) and 
fluorescent adducts (22270±119.6 and 9283±188.3 RFU) were detected in digests of those meals 
containing HCFS and starch, respectively. Carboxymethyllysine (CML) (5.03±1.09 µg/ml) and MGO-
derivative AGEs (12.2±1.5 µg/ml) were found in the meals composed of fructose and only MGO-
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derivative AGEs (12.2±1.6 µg/ml) in presence of glucose. Physiological concentrations (43 mM) of 
sugars in simplified systems composed by single amino acids caused formation of MRPs under 
intestinal conditions. Arginine and fructose (314 mM) showed formation of fructosamine and different 
AGEs. Fructose (43 mM) gave rise to CML by interaction with lysine, which was observed within 1 
hour of incubation at intestinal conditions. This may be feasible under the conditions of fructose 
malabsorption. Results suggested the interest of the use of meal systems for a better understanding 
of complex chemical events taking place during digestion such as MR. This is the first study 
proposing the formation of non-fluorescent AGEs associated to the pathogenesis of diabetes during 
digestion of sugar containing and average meals. Their formation may be possible under those 
conditions where sugar absorption is delayed such as fructose malabsorption or the intake of a fatty 
meal. The occurrence of the MR during the digestion process may reduce the bioavailability of 
essential amino acids and increase the production of MRPs causing health disorders.  
 
1. INTRODUCTION 
The Maillard reaction (MR) is a series of non-enzymatic reactions between reducing sugars and 
proteins firstly described in foods during thermal processing and long-term storage. MR products 
(MRPs) provide sensory attributes of cooked foods, and are the main determinants of the 
consumer’s quality-oriented food choice. Early products of the MR (Amadori and Heyns compounds) 
tend to decline after overheating and give rise to advanced glycation end products (AGEs) (Mesías & 
Delgado-Andrade, 2017).  
The modern diet is a large source of MRPs (Goldberg et al., 2004; Uribarri et al., 2010; Vlassara & 
Uribarri, 2004) significantly contributing to those endogenously produced. Previous studies have 
showed that dietary AGEs are partially absorbed (Cai et al., 2008; Lin et al., 2003), approximately 
10–30% (Uribarri et al., 2007), and they are indistinguishable from endogenous AGEs (Cai et al., 
2002). Great interest has been raised due to their association with oxidative stress and inflammation, 
processes that eventually cause most chronic diseases, including diabetes, and cardiovascular 
disease (Sayej et al., 2016; Vlassara & Uribarri, 2014). Recently, a relationship has been reported 
between the intake of high fructose corn syrup (HFCS) sweetened soft drinks, fruit drinks and apple 
juice and the development of arthritis (DeChristopher, Uribarri, & Tucker, 2016), asthma 
(DeChristopher, Uribarri, & Tucker, 2015b) and chronic bronchitis (DeChristopher, Uribarri, & Tucker, 
2015a). The authors hypothesized that these associations might be mediated through the intestinal 
in situ formation of fructose-AGEs and their subsequent absorption. This event may be favored by 
the increased intake of beverages and food containing HFCS (Ventura, Davis, & Goran, 2011) in 
which the ratio of fructose to glucose is higher than 1:1 therefore creating conditions for potential 
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fructose malabsorption and intraluminal generation of fructose-AGEs (DeChristopher et al., 2016).  
In fact, malabsorption of simple carbohydrates affects 20% to 30% of the European population 
(Raithel et al., 2013). The dietary lipid content can affect the intestinal membrane function (Thomson, 
1982) thus attenuating intestinal sugar uptake and therefore potentially creating transient increase in 
intraluminal concentration of sugars  Moreover, the natural conditions of the digestive tract (pH, 
minerals, temperature) might be a favorable environment for the MR to take place (Nursten, 2005).  
Based on the above information, the need to study the effect of gastrointestinal digestion process on 
the MRP formation, a largely unexplored area, becomes very important.  
The aim of the present research was to obtain novel information regarding the nature of MRPs 
formed during in vitro oral gastrointestinal digestion (Hollebeeck, Borlon, Schneider, Larondelle, & 
Rogez, 2013). Simplified meal systems comprising an average meal composed of bovine serum 
albumin (BSA), digestible starch and oil; as well as, sugar-containing meals prepared with BSA and 
glucose or fructose or HFCS were tested. We further analyzed simple amino acid systems prepared 
using lysine or arginine and fructose or glucose under compatible intestinal conditions to evaluate 
their contribution. Analyses of amino acid content, fructosamine, carboxymethyllysine (CML), 
methylglyoxal (MGO)-derivative AGEs, and fluorescent adducts were performed. This is the first 
study reporting the formation of MRPs associated to the pathogenesis of diabetes and its 
complications during digestion of simplified meals. 
  
2. MATERIALS AND METHODS  
2.1. Reagents 
Alpha-amylase from human saliva (type IX-A), porcine pepsin from gastric mucosa (3.200–4.500 
U/mg protein), pancreatin from porcine pancreas, porcine bile extract, BSA, L-lysine, L-arginine, D-(-
)-fructose, D-(+)-glucose, soluble starch, cellulose microcrystalline, potassium and sodium chloride, 
sodium carbonate and bicarbonate, sodium phosphate monobasic and dibasic, 1-deoxy-1-
morpholinofructose (DMF), nitroblue tetrazolium (NBT), magnesium chloride, diethanolamine and 
Tween 20 were from Sigma-Aldrich (St. Louis, MO, USA). Ninhydrin was provided by Biochrom Ldt. 
(Cambridge, UK). CML standard ((S)-2-amino-6-(carboxymethyl-amino)-hexanoic acid, CAS-No. 
5746-04-3) was purchased from Iris Biotech GmbH (Marktredwitz, Germany). Competitive ELISA, 
based on monoclonal antibodies for CML (6C7) and MGO-derivative AGEs (3D11 mAb) (Cai et al., 
2002) were used to detect these relevant AGEs. The test sensitivity for CML and MGO-derivatives 
AGEs was 0.1 U/ml and 0.004 nmol/ml, respectively; the intra-assay variation was ±2.6% (CML) and 
±2.8% (MGO-derivatives AGEs) and the inter-assay variation was ±4.1% (CML) and ±5.2% (MGO-
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derivatives AGEs). The AGE content of each sample was based on the mean value of at least three 
measurements per sample and expressed as µg eq./ml. The secondary antibody (goat anti-mouse 
IgG (H+L)) was obtained from MP Biomedicals (Solon, OH, USA) and the alkaline phosphatase 
substrate (4-nitrophenyl phosphate disodium salt hexahydrate) from Sigma Aldrich (St. Louis, MO, 
USA). The blocking buffer (SuperBlock™ (PBS)) was purchased from Thermo Fisher Scientific Inc. 
(USA). Water was purified using Milli-Q and Elix system. All other chemicals and reagents were of 
analytical grade. 
2.2. Preparation of the simplified meal systems 
-An average meal was prepared with BSA (0.18 mM), soluble starch (56 mg/ml) and sunflower oil 
(8.3 mg/ml).  
-Simple sugar-containing meals were prepared as follows: 1) BSA (0.18 mM) and glucose (43 mM); 
2) BSA (0.18 mM) and fructose (43 mM); and 3) BSA (0.18 mM) and HFCS (43 mM, 60% fructose 
and 40% glucose).  
These samples were based on the main macronutrients of a meal (carbohydrates, protein and oil). 
Non-reactive cellulose powder was incorporated to adjust all of them to the same final weight. The 
concentrations were selected according to the volumes of ingested and secreted fluids, as well as 
the relative proportions of the dietary macronutrients. For a standard meal, we assumed an intake of 
120 g of total carbohydrates, 25 g of protein and 25 g of lipids. In 24 h, a human drinks roughly 2 l, 
and secretes 1 l of saliva, 2 l of gastric juice, 1 l of bile, 2 l of pancreatic juice, and 1 l of intestinal 
juice. Considering an average of three meals per day, the physiological concentration of each 
nutrient was calculated in the gastrointestinal tract (Hollebeeck et al., 2013; Tortora & Grabowski, 
1996).   
These simplified meals were then digested in duplicate under in vitro oral gastrointestinal human 
digestion conditions (Hollebeeck et al., 2013) with slight modifications, in order to evaluate the 
formation of MRPs during the digestive process. Briefly, all three stages, salivary (pH 6.9, 10 ml, 5 
min, 3.9 U α-amylase/ml, aerobic), gastric (pH 2, 13 ml, 90 min, 71.2 U pepsin/ml, aerobic), and 
abiotic duodenal step (pH 7, 16 ml, 150 min, 9.2 mg pancreatin, aerobic) were performed in the 
same flask at 37 ºC. BSA (0.18 mM) was included as the control. A complete digestion of the starch 
during the digestive process of the average meal could yield up to 314 mM glucose equivalents. The 
resulting digests were then centrifuged and the soluble fractions were frozen at -20°C, lyophilized 
(Telstar Lyobeta-15 lyophilizer (Telstar, Spain)) and stored at room temperature until further 
analysis. 
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2.3. Preparation of simple amino acid systems 
In order to gain insight into the contribution of the single amino acids (lysine and arginine) on the 
MRP formation during the digestion process of the above described meals, simple systems 
constituted by basic amino acids (40 mM) and sugars (glucose or fructose) at two different sugar 
concentrations were prepared as follows: 1) lysine (40 mM); 2) lysine (40 mM) and glucose (43 mM); 
3) lysine (40 mM) and glucose (314 mM); 4) lysine (40 mM) and fructose (43 mM); 5) lysine (40 mM) 
and fructose (314 mM); 6) arginine (40 mM); 7) arginine (40 mM) and glucose (43 mM); 8) arginine 
(40 mM) and glucose (314 mM); 9) arginine (40 mM) and fructose (43 mM); 10) arginine (40 mM) 
and fructose (314 mM). These systems were then incubated mimicking lumen intestinal conditions in 
vitro (pH 7, 37 ºC, 2h 30 min). 
Simple amino acid systems prepared with lower sugar concentration (43 mM): corresponds to 
physiological concentrations likely to be present in the lumen of the intestine when ingesting simple 
sugar-containing meals or ingesting HFCS beverages.  
Simple amino acid systems prepared with higher sugar concentration (314 mM): corresponds 
to a theoretical maximal concentration present as the result of complete digestion of the average 
meal containing starch. This sugar concentration does not prevail in the lumen under physiological 
conditions. However, such amount of sugar could be release during the digestion of average meal. 
As a consequence, it is interesting to study these theoretical sugar digestion conditions to identify 
the maximal amount of MRPs that can be formed from the precursors without taking into account the 
rate of sugar absorption. The information to be obtained from such model is very relevant from a 
food chemistry point of view. The model provides information regarding the reactivity of the different 
amino acids composing the food proteins and the maximal large number of MRPs that can be 
generated in the gut during the digestion process. There is a lack of information on this completely 
new field, which is of great interest because of the impact of MRPs and essential amino acids in 
human health.  
A delay on the absorption of the sugar due to either fructose malabsorption or change in intestinal 
membrane functionality because of the presence of fat has been assumed either for simplified meal 
and amino acids systems. Fat present in simplified meal also may be a substrate of the MR causing 
the formation of non-fluorescence adducts such as CML. Theoretically, intestinal physiological (≤ 50 
mM) and non-physiological conditions (50-100 mM) regarding the glucose or fructose concentrations 
(Ferraris, Yasharpour, Lloyd, Mirzayan, & Diamond, 1990) can be achieved in both cases avoiding 
clinically evident diarrhea.  
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In addition, a kinetic study was performed on the system constituted by lysine (40 mM) and fructose 
(43 mM) in order find out how much time of reaction is necessary for the formation of MRP. This 
system was incubated under lumen intestinal conditions in vitro (pH 7, 37 ºC) for 1h, 2h, and 3h. 
Samples in duplicate were then lyophilized (Telstar Lyobeta-15 lyophilizer (Telstar, Spain)) and 
stored at room temperature until further analysis. 
2.4. Amino acid content analysis  
Amino acid analysis was performed directly on digests from the simplified meals, prepared as 
indicated in section 2.2. The analysis was carried out using an amino acid analyzer (Biochrom 30, 
Biochrom Ldt. Cambridge, UK). It is based on an acid hydrolysis of the sample followed by cationic 
exchange chromatography (high pressure PEEK column packed with Ultropac 8 cation exchange 
resin sodium form) with post column derivatization using ninhydrin. Samples (1 ml) were first 
hydrolyzed with 3 ml of HCl (10.6 N). The hydrolysates were then filtered through grade filter paper, 
and filtrate (0.5 ml) was applied to a SepPak® C18 cartridge (Waters Cromatografía, S.A., 
Barcelona, Spain) previously activated with methanol (5 ml) and water (10 ml). Finally, samples were 
eluted with 3 ml of HCl (3 N), and 70 µl of this volume were injected in the chromatograph. Analysis 
was performed in duplicate and results were expressed as mmol/g BSA. 
2.5. Early glycation products 
The formation of fructosamine was measured on both simplified meals and amino acid systems.  
2.5.1. Fructosamine assay  
NBT assay was carried out to determine fructosamine following the micromethod of Vlassopoulos, 
Lean, & Combet (2013) in both the simplified food models and the amino acid systems. Briefly, 
samples (25 µl) were mixed with 100 µl nitroblue tetrazolium (0.25 mM) previously dissolved in 
sodium carbonate buffer (100 mM, pH 10.8). Microplates were incubated for 20 min at 37 ºC and 
measured spectrophotometrically (BioTek powerWaveTM XS microplate spectrometer (BioTek 
Instruments, U.S.A)) against control at 530 nm. The fructosamine analogue (DMF) was used as 
standard (0.5-5 mM). All measurements were performed in triplicate and expressed as µg DMF 
eq./ml. 
2.6. Advanced glycation end products (AGEs) 
The analysis of CML and MGO-derivative AGEs, and fluorescent adducts was performed in both the 
average and sugar-containing meals, and in the amino acid systems. 
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2.6.1. Carboxymethyl lysine (CML) and MGO-derivative AGEs 
Competitive ELISA, based on monoclonal antibodies for CML (6C7) and MGO-derivative AGEs 
(3D11 mAb) (Cai et al., 2002) was used to detect these relevant AGEs. The test sensitivity for CML 
and MGO-derivatives AGEs was 0.1 U/mL and 0.004 nmol/ml, respectively; the intra-assay variation 
was ±2.6% (CML) and ±2.8% (MGO-derivatives AGEs) and the inter-assay variation was ±4.1% 
(CML) and ±5.2% (MGO-derivatives AGEs). The AGE content of each sample was based on the 
mean value of at least three measurements per sample and expressed as µg eq./ml.  
CML content was also quantitated by using an amino acid analyzer (Biochrom 30, Biochrom Ldt. 
Cambridge, UK). It comprises an ion exchange HPLC column (high pressure PEEK column packed 
with Ultropac 8 cation exchange resin sodium form) with post column derivatization using ninhydrin 
Quantitation was carried out according to the external standard method using a commercial standard 
of pure CML. Results were expressed as µM. 
2.6.2. Fluorescent adducts 
Fluorescent adducts were measured by fluorescence spectrophotometry (microplate  fluorescence 
reader, FP-6200 (JASCO, Easton, U.S.A)) using 360 ± 40 nm and 460 ± 40 nm as excitation and 
emission wavelengths, respectively. Samples (150 µl) were added to black microplates in triplicate 
and results were expressed as relative fluorescence units (RFU). 
3. RESULTS  
3.1. Progression of the MR during digestion of food simplified meals 
3.1.1. Amino acid content as first indicator  
Figure 1 illustrates the consumption of the basic amino acids, lysine and arginine, during the 
digestive process of an average meal and sugar-containing meals. As can be observed, a significant 
decrease (p < 0.05) of both amino acids occurs for all the tested meals. The arginine amino acid 
presented a decrease 2 fold greater than lysine (24% vs 11.70%). The meal containing HFCS and 
the average meal with starch and oil demonstrated significantly (p < 0.05) higher loss of these amino 
acids (34.05% lysine and 35.4% arginine; and 23.44% lysine and 32.7% arginine, respectively) than 
the glucose and fructose-containing meals (12.20% lysine and 23.92% arginine; and 11.70% lysine 
and 24.51% arginine, respectively). In the case of arginine content, the average meal and the sugar-
containing meals with HFCS presented amino acid reduction during digestion of the same order of 
magnitude (p > 0.05). Furthermore, significant (p < 0.05) consumption was observed for other amino 
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acids different from lysine and arginine released from the BSA during the digestive process (table 1). 
Glycine (42.88-100% blocked), serine (27.78-100% blocked), tyrosine (42.49-54.05% blocked), 
isoleucine (34.22-45.07% blocked) and phenylalanine (19.93-54.08% blocked) exhibited the greatest 
reactivity for all the meals tested. Indeed, the average meal showed complete blockage of several 
amino acids (aspartic, threonine, serine, glutamic, glycine, alanine, cysteine and valine) released 
from the BSA during the digestion process. Both, the meal composed of BSA and HFCS and the 
average meal significantly exhibited the largest total amino acid loss (p < 0.05) among all the meals. 
Figure 1. Amino acid content  (lysine (lys) and arginine (arg)) of an average meal [BSA (0.2 mM) + starch 
(≈314 mM glucose) + oil] and high-sugar meals [BSA (0.2 mM) + glucose (43 mM); BSA (0.2 mM) + fructose 
(43 mM); BSA (0.2 mM) + high fructose corn syrup (HFCS) (43 mM sugars, 60% fructose : 40% glucose] 
submitted to in vitro simulated oral-gastrointestinal digestion. Data are presented as mean (n = 6) ± standard 
deviation. Different letters indicate significant differences (p < 0.05) between samples.  
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Table 1. Content of other amino acids (AAs) and their percentage of blockage in an average meal [BSA (0.2 
mM) + starch (≈314 mM glucose) + oil] and sugar-containing meals [BSA (0.2 mM) + glucose (43 mM); BSA 
(0.2 mM) + fructose (43 mM); BSA (0.2 mM) + high fructose corn syrup (HFCS) (43 mM sugars, 60% fructose : 
40% glucose] submitted to in vitro simulated oral-gastrointestinal digestion. 
N.D. Not Detected. Data are presented as mean ± standard deviation; duplicate of sample preparation and duplicate of analysis (n = 6). 
Different letters indicate significant differences (p < 0.05) between the samples of the same row. 
 
3.1.2. Early MRPs and AGEs  
The formation of MRPs during the in vitro simulated oral-gastrointestinal digestion of the average 
meal and sugar-containing meals is shown in table 2. Regarding the MRPs produced in the early 
stages of the reaction, fructosamine was detected. This compound was significantly (p < 0.05) found, 
in descending order, in the average meal, HFCS- and glucose-containing meals. Fructosamine was 
not detected in the meal prepared with BSA and fructose. On the other hand, the analyses of the 
advanced MRPs showed the presence of CML and MGO-derivatives AGEs determined by ELISA, 
and fluorescent adducts by fluorescent measurement, differed among the samples (table 2). The 
meal constituted by BSA and fructose was the only one that presented significant (p < 0.05) 
formation of CML. Of interest, the meal with BSA and HFCS did not showed formation of CML 
despite the presence of fructose. However, MGO-derivatives AGEs were significantly (p < 0.05) 
detected in both glucose- and fructose-containing meals but no significant (p > 0.05) differences 
were found between these samples. Again, the meal with BSA and HFCS did not show MGO-
derivatives AGEs despite the presence of both fructose and glucose. Furthermore, fluorescents 
MRPs during the digestive process were detected only in the meal composed of BSA, starch and oil 
Main contributions                                                                                                 Chapter 3 – Study 1 
 
146  
 
(average meal), and that prepared with BSA and HFCS. The average meal exhibited the highest 
amount of fluorescents adducts.  
Table 2. Formation of Maillard reaction products (MRPs) during in vitro simulated oral-gastrointestinal 
digestion of an average meal [BSA (0.2 mM) + starch (≈314 mM glucose) + oil] and high-sugar meals [BSA 
(0.2 mM) + glucose (43 mM); BSA (0.2 mM) + fructose (43 mM); BSA (0.2 mM) + high fructose corn syrup 
(HFCS) (43 mM sugars, 60% fructose : 40% glucose]. 
N.D. Not Detected. Data are presented as mean ± standard deviation; duplicate of sample preparation and triplicate of analysis (n = 6). 
Different letters indicate significant differences (p < 0.05) between the samples of the same column. 
3.2. Progression of the MR in simple amino acid systems 
3.2.1. Early MRPs and non-fluorescent AGEs 
In order to better understand the formation of MRPs during the human digestion, simple systems 
constituted by lysine or arginine and glucose or fructose were studied. Table 3 presents the 
contribution of these amino acids and sugars to the intestinal MRPs’ formation. Fructosamine was 
detected only in those systems containing high sugar concentrations (314 mM). The presence of 
fructose significantly (p < 0.05) caused greater formation of fructosamine (3 and 6 times more, for 
lysine and arginine systems, respectively) than glucose suggesting that our assay can also detect 
Heyns products. Lysine system presented higher amount of fructosamine than arginine (p < 0.05) 
when incubated with glucose (314 mM). Fructosamine was of the same order of magnitude (p > 
0.05) for both amino acids in presence of fructose (314 mM). Fructosamine was not detected in any 
of the systems with physiologiccal concentration of either glucose or fructose (43 mM). 
In the analysis of advanced MRPs measured by ELISA (table 3), the presence of fructose led to a 
significantly (p < 0.05) greater amount of these advanced compounds than glucose. Lysine 
incubated with 43 mM of fructose showed 14.69±2.19 µg CML eq./ml while 20.21±3.55 µg CML 
eq./ml (p < 0.05) was detected in presence of 314 mM, and both values were significantly higher (p < 
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0.05) than the control (lysine, 11.42±1.84 µg eq./ml). This result was confirmed by the identification 
of CML by using an amino acid analyzer as described in section 2.6.2. An amount of 1.86 µM for 
CML was detected in the intestinal lysine and fructose (314 mM) system, and also several 
unidentified peaks of compounds formed were revealed (chromatograms provided as supplementary 
material, figure 1S). In addition, it was already observed significant (p < 0.05) formation of CML 
(13.16±1.75 µg/ml) within 1 hour of incubation of lysine and fructose (43 mM) at intestinal conditions 
(pH 7, 37ºC) compared to the control (lysine, 9.77±1.20 µg/ml). In contrast, MGO-derivatives AGEs 
were detected only in the arginine systems containing high fructose concentrations (314 mM). 
Table 3. Contribution of the basic amino acids, arginine (Arg, 40 mM) and lysine (Lys, 40 mM) to the formation 
of Maillard reaction products (MRPs) mimicking lumen intestinal conditions in vitro (2h 30 min, pH 7, 37 ºC ) 
when incubated with glucose or fructose at 43 or 314 mM under the conditions described in section 2.3.  
N.D. Not Detected. Data are presented as mean ± standard deviation; duplicate of sample preparation and triplicate of analysis (n = 
6). Different letters indicate significant differences (p < 0.05) between the samples of the same column.   
3.2.2. Fluorescent AGEs 
The formation of fluorescent adducts in the amino acid systems incubated under intestinal conditions 
is shown in Figure 2.  All systems composed of lysine and glucose or fructose presented significant 
(p < 0.05) formation of fluorescent adducts (≈ 20% increase) but differences were not detected (p > 
0.05) among them. In the case of the amino acid systems constituted by arginine, a very significantly 
lower fluorescence (p < 0.05) was found for the arginine control compared to lysine control. The 
formation of fluorescent adducts experimented a 3-fold increase for those arginine systems prepared 
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with glucose and a 5-fold increase for those prepared with fructose. A dose-response relationship 
was not detected for any of the systems 
Figure 2. Formation of fluorescent adducts during incubation of basic amino acids (lysine (lys) and arginine 
(arg), 40 mM) with glucose (gluc) or fructose (fruct) at 43 and 314 mM under lumen intestinal conditions (2h 30 
min, pH 7). Data are presented as mean (n = 6) ± standard deviation. Different letters indicate significant 
differences (p < 0.05) between samples.  
4. DISCUSSION 
The data generated confirm the occurrence of the MR during the digestive process of an average 
meal (BSA, starch and oil) and sugar-containing meals (BSA and glucose or fructose or HFCS); as 
well as, during incubation of systems with only a reactive amino acid and fructose within the time 
period expected for a normal digestion and assuming delay of the sugar absorption due to its 
malabsorption or fat presence. As expected, the formation of the MRPs differed depending on the 
nature of the meal. 
The loss of free amino acids is the first indicator of the occurrence of the MR during the digestion 
process of the meals (table 1 and figure 1). During gastrointestinal digestion of dietary proteins 
(BSA), amino acids and peptides can be released during the gastric and intestinal steps by chemical 
and enzymatic hydrolysis. The amino groups, from the released amino acids and peptides, are 
susceptible to react with reactive carbonyl groups present in the intestinal lumen. Therefore, the 
reaction comprises not only the formation of MRPs from the amino groups of the arginine and lysine 
side chains, but also the alpha amino groups of all the released amino acids (figure 3). Basic amino 
acids (arginine, lysine) and others with different polarity (glycine, serine, tyrosine, isoleucine and 
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phenyl alanine) were highly blocked. These results are in line with data previously reported for amino 
acid reactivity in the MR at different studied conditions (Golon, Kropf, Vockenroth, & Kuhnert, 2014; 
Kwak & Lim, 2004; Mennella, Visciano, Napolitano, del Castillo, & Fogliano, 2006; P. Yu, Xu, & Yu, 
2016). 
Figure 3. Formation of Maillard reaction products (MRPs) in the intestinal lumen through the reaction between 
different amino acids released from the BSA protein during the digestive process and (A) fructose at 
physiological concentrations (43 mM) under malabsorption state and (B) glucose at a maximum theoretical 
concentration released from the complete digestion of starch of an average meal (314 mM) containing fat 
which modulates the intestinal epithelial membrane.  
Of interest, it has been described that in malabsorption state, the fructose not absorbed in the 
intestine may react with tryptophan from food through the MR and block its absorption, which causes 
a potential reduction in the synthesis of serotonin and thereby symptoms of depression (Huether, 
Kochen, Simat, & Steinhart, 1999; Ledochowski, Widner, Bair, Probst, & Fuchs, 2000). It is 
described that fructose possess higher proportion of open-chain form compared to glucose and 
therefore greater active form to react in the MR (Laroque et al., 2008). This may be the reason why 
HFCS, which presents both sugars combined in a 60:40 ratio (fructose : glucose), achieved higher 
loss of amino acids than glucose and fructose individually This result might support recent 
epidemiological investigations describing a relationship between intake of HFCS-containing 
beverages and development of asthma, bronchitis and arthritis as a consequence of glycation 
reactions within the lumen of the intestine (DeChristopher et al., 2015a, 2015b, 2016).  
Main contributions                                                                                                 Chapter 3 – Study 1 
 
150  
 
Furthermore, the remarkable loss of amino acids in the average meal may be due to its content in 
starch and oil. The high glucose amount potentially released from the starch (≈314 mM) during the 
digestion suggests greater formation of MRPs. Likewise, many researchers reported a positive role 
of dietary lipids promoting the MR by the formation of lipid-derived reactive carbonyls from the lipid 
oxidation (Hidalgo, León, & Zamora, 2016; L. Yu et al., 2016; Zamora & Hidalgo, 2011). In vivo 
digestion, however, is rapidly followed by absorption leaving little time for the MR unless there is a 
significant simultaneous sugar malabsorption. The latter is likely during ingestion of large loads of 
HFCS-rich beverages or foods containing fat.   
The simplified pathways for the formation of early and advanced MRPs during the digestive process 
of the studied meals and amino acid systems are schematically presented in the figure 4. Briefly, MR 
includes an initial formation of Schiff’s base, followed by intermolecular rearrangement and 
conversion into Amadori/Heyns products. They undergo further processing to form a heterogeneous 
group of amino acid-bound moieties, such as non-fluorescent adducts (e.g., CML) and cross-linking 
fluorescent products (e.g., pentosidine), called AGEs. Pathways of AGE formation involve glucose 
autoxidation through the generation of α-oxoaldehydes, such as MGO, which is a major precursor of 
AGEs. Of note, during the digestive process different length peptides with different glycation 
reactivities are also released along with the release of free amino groups. 
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Figure 4. Simplified pathways for the formation of early and advanced Maillard reaction products (MRPs) 
during the digestive process of an average meal (BSA, starch and oil), high-sugar meals (BSA and glucose or 
fructose or high fructose corn syrup (HFCS) and simple amino acids systems (lysine or arginine and glucose or 
fructose), as described in section 2.2 and 2.3 
Fructosamine, an early MRP, was found in most meal systems, except in those containing only BSA 
and fructose. Formation of fluorescent adducts occurred mostly in the meal systems with the highest 
formation of fructosamine, which suggests pathways going mostly into the formation of cross-linking 
fluorescent products such as pentosidine rather than CML. The non-fluorescent AGEs (CML and 
MGO-derivative AGEs) were found exclusively in the meal prepared with BSA and fructose (43 mM) 
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(table 2) which is supported by the previously commented results. The current results confirm the 
formation of non-fluorescent products during the human digestive process. To date, there are not 
studies in this area. New evidence is presented in this study. As regards the fluorescent adducts with 
characteristic fluorescence of AGEs, 7-fold and 2-fold increases were detected for the meals 
containing starch and HFCS, respectively, during the digestive process (table 2). These results are 
supported by the analysis of amino acid systems incubated at conditions similar to those in the 
intestinal lumen (figure 2). In line with these findings, a very recent study showed formation of 
fluorescent adducts, when incubating free amino acids (arginine, lysine and glycine, 50mM) with 
fructose or glucose (50 mM) under conditions compatible with those of the digestive system (Bains & 
Gugliucci, 2017). Unlike what these authors described, we observed high fluorescence of the lysine 
solution itself (control). This may be due to the capacity of lysine in high concentrations to form self-
assembling aggregates (Homchaudhuri & Swaminathan, 2001). Moreover, we could not 
demonstrate a dose dependent formation of fluorescent AGEs between fructose or glucose and 
amino acids. The analysis of fluorescent AGEs by measurement of fluorescence intensity is 
somehow limited and nonspecific. Pentosidine, crossline and pyrropyridine may be some of the 
fluorescent cross-linked AGEs formed during digestive process (Nursten, 2005). Pentosidine can be 
formed by the reaction of lysine and arginine, forming a fluorescent crosslink with any of several 
carbohydrate precursors including glucose (Hatfield, 2005). The identification of several other 
unidentified peaks in the lysine and fructose (314 mM) system (supplementary material, figure 1S) 
suggests the formation of compounds that require further studies. 
Our finding on formation of MRPs, both early and advanced, during conditions mimicking the 
digestive process, including concentration of reactants and time of reaction, supports the concept of 
intraluminal generation of AGEs as another source of exogenous AGEs (DeChristopher et al., 2016). 
Currently, most workers in the field have suggested that exogenous AGEs come already preformed 
in certain AGE-rich food we ingest (Uribarri et al., 2010). The fate of exogenous and intestinally 
generated AGEs is an area that requires intensive further study. We know that a small percent of the 
ingested AGEs are absorbed into the circulation becoming incorporated into the body pool of AGEs 
and therefore contributing to an overall state of chronic oxidative stress and inflammation (Vlassara 
& Uribarri, 2014) and probably the same happens with the compounds generated intraluminally. The 
largest amount of unabsorbed AGEs will cotinue its transit into the colon where it can interact with 
the microbiota, react with AGE receptors (RAGE) within the colonic wall initiating a localized 
inflammation that may eventually propagate systemically or simply be excreted in the stool.  
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Several studies have reported human colonic microbiota degrading selected glycated amino acids. 
Higher degradability of early MRPs than advanced products have been shown due to the their lower 
chemical stability (Hellwig et al., 2015). Some of these MRPs can play a role in colon toxicology, 
through increased colonic protein fermentation, and may also act as systemic toxicants and inducers 
of inflammation (Tuohy et al., 2006). Low-grade intestinal inflammation for example plays a key role 
in the pathophysiology of irritable bowel syndrome (Sinagra et al., 2016). Moreover, these MRPs can 
modulate gut microbiota composition (Seiquer, Rubio, Peinado, Delgado-Andrade, & Navarro, 2014; 
Tuohy et al., 2006) and they may act as a growth substrate for detrimental bacteria such as some 
Clostridium and Bacteroides species (Mills et al., 2008). A relationship between unabsorbed AGEs 
and the greater prevalence of allergies/inflammation has recently been postulated (Smith, 
Masilamani, Li, & Sampson, 2015). Moreover, a common colonic bacteria, E. Coli, produces, 
accumulates and releases AGEs into the medium (Cohen-Or, Katz, Ron, Shanley, & Wheeler, 
2011). Therefore they may adversely alter their colonic microbial composition, potentially enhancing 
their risk for the development of metabolic diseases such as obesity and type 2 diabetes (Cani, Osto, 
Geurts, & Everard, 2012). As mentioned above, fructose reaction with tryptophan can prevents its 
absorption decreasing levels of serotonin and perhaps inducing depression (Huether et al., 1999; 
Ledochowski et al., 2000). The marked loss of amino acids released from proteins though the MR 
during digestion demonstrated in our data an interesting but usually forgotten issue, which is the loss 
of the nutritional value of foods resulting from the MR. 
5. CONCLUSIONS 
Novel information regarding the nature of MRPs formed during the digestive process of simplified 
average meal and sugar-containing meals was obtained. Content of different amino acids decreased 
after digestion. Early MRPs and fluorescent adducts were detected in digests of those meals 
containing HFCS and starch. CML and MGO-derivatives AGEs were found in the meals composed 
of fructose. Moreover, fluorescent adducts were detected in the control intestinal systems (amino 
acids alone). According with the results on simplified amino acids systems nature of both 
components, amino acids and sugars, has an impact on the formation of specific MRPs. Results on 
the identity of the MR found in simplified amino acids systems and meal agreed. This is the first 
study proposing the formation of a non-fluorescent AGE associated to the pathogenesis of diabetes 
and other intestinal inflammatory diseases during digestion of simplified meals containing fructose. 
On the other hand, our results support that the bioavailability of other amino acids beside arginine 
and lysine may be greatly reduced by MR during the digestion process which may affect human 
health 
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Supplementary material  
Figure 1S. Identification of carboxymethyl lysine (CML) by amino acid analysis as described in Materials and 
Methods, in (A.1) a solution of standard CML (5 µg/ml = 26.7µM) and in (A.2) an intestinal system prepared 
with lysine (40 mM) and fructose (314 mM). CML appeared with a retention time of 31.5 min and unidentified 
peaks were also present in A.2. Intestinal control of lysine (40 mM) was also included (A.3) which did not show 
no significant peak other than that of the native amino acid. 
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GENERAL DISCUSSION 
The development of novel foods with health-promoting properties involves several essential steps 
(figure 1). After identifying a potential new bioactive ingredient (step 1) it is necessary to 
demonstrate its efficacy and to determine the intake level in order to achieve the desired effect (step 
2). This efficacious levels should be demonstrated to be safe (step 3). Next, a suitable food vehicle 
must be developed for the bioactive compounds (foods or beverages) (step 4) and scientific 
research about their efficacy should be provided (step 5).  
 
Figure 1. Steps in the development of health-promoting foods. Adapted from Institute of Food Technologists 
(IFT) (2005) [1].  
Sweet drinks, packaged snacks, and biscuits have been shown to contribute significant amounts of 
energy to the population [2]. As a consequence, interest on consumption of functional foods for 
reducing the risk of obesity and T2D has significantly increased. In order to satisfy consumers’ 
demands, the present research focuses the attention on the design of sustainable healthier 
beverages and bakery products. Beverages and bakery products contain coffee by-products, CS and 
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SCG, as natural sources of health-promoting compounds. Bakery foods were formulated combining 
coffee components and other food ingredients exerting health-enhanced properties such as non-
nutritive sweeteners (stevia) and soluble dietary fibres (FOS).  
Several studies have investigated the positive effects of modifying major nutrients of the diet on 
glycaemia, weight, and other metabolic outcomes. However, the use of bioactive compounds from 
natural sources as a successful approach in reducing the risk of these metabolic chronic diseases is 
still a challenge [3].  
1. Novel beverages  
At present, beverages are by far the most active functional food category because of convenience 
and possibility to meet consumer demands as well as their excellent delivering means for nutrients 
and bioactive compounds [4]. The different types of commercially available beverages could be 
grouped in: (1) dairy-based beverages including probiotics and minerals / ω-3 enriched drinks, (2) 
vegetable and fruit beverages, and (3) sports and energy drinks. Moreover, the development of 
novel beverages is focused on the research in the following approaches: (1) exploitation of 
microorganism functionality, (2) optimization of the production and formulation, (3) use of prebiotics 
and symbiotics, (4) utilization and processing of natural ingredients and (5) use of by-products of 
fruit and food industries as functional ingredients. This latter approach is the core of the present 
thesis.  
Recovery of bioactive phenols from virgin olive oil wastes and their addition to milk beverages [5], 
the use of plum skin extract as functional ingredient in fruit juice-based beverages and flavoured iced 
teas [6] or the production of whey-based fruit beverages [7] are some of the proposed applications to 
revalorize food wastes. Coffee wastes have been hardly used in the design of functional beverages 
so far. Qishr is an ancient infusion made from pulp of the fermented coffee berries that today is 
consumed as a beverage of spiced coffee husks, ginger and cinnamon instead of coffee in Yemen 
[8]. “Cascara tea” is a fruity taste beverage prepared with the skin of the coffee cherry produced in 
Central America (http://www.npr.org/sections/thesalt/2015/12/01/456796760/cascara-tea-a-tasty-
infusion-made-from-coffee-waste). Moreover, two commercial beverages, based on coffee husks, 
are attracting the interest of the western consumers. Bai Brands uses coffee husk extract as an 
ingredient in their beverages, which contain antioxidants and caffeine (http://www.drinkbai.com/), 
and KonaRed preserves the majority of the nutrients from the coffee plant and the dominant 
polyphenols (CGA, quinic acid and ferulic acid) in the beverages prepared with coffee husks 
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(https://www.konared.com/). However, these drinks with coffee by-products have not been 
associated yet to any particular health benefit beyond those described for their individual bioactive 
compounds present in the coffee wastes.  
The use of CS for the preparation of novel beverages has been proposed for the first time in this 
study (chapter 1; figure 2). The CSE used in this study was obtained by a simple water extraction 
stage (100 °C for at least 10 min) described in patent WO2013004873 A1. Our previous studies 
indicated that this green extraction process of CSE produces completely recyclable solid waste 
enriched in bioactive compounds [9]. Moreover, the present thesis provides knowledge on the 
potential effect of the CSE prepared as an antioxidant beverage on body fat accumulation in vivo 
and the bioactive compounds that may be responsible of this effect. 
Figure 2. Effect of coffee silverskin extracts (CSEs) on fat accumulation. 
The development of novel beverages requires sensorial analyses in order to evaluate the quality 
attributes of the product and to meet consumers’ demands. Coffee beverages are considered to 
have unique sensory properties. The aroma is the main attribute of the sensory experience for coffee 
consumers. The brewed coffee sensory attributes are divided in appearance, odour/flavour, taste, 
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mouthfeel and aftertaste, with multitude of descriptors such as roasty, fruity, rancid, sweet, better 
and astringent [10]. Our results conclude that the acceptance level of the beverages made with CSE 
was satisfactory since 95% of the panel were favourable towards the beverages.  
The novel beverages based on CSE present reduced sugar content since they were prepared 
without addition of nutritive sweeteners and glucose amount was not detected. These novel drinks 
respond to the global obesity concerns and fit perfectly with the requests from the European Union to 
reformulate drinks and set a target of 10% added sugar reduction. To achieve this goal, food and 
drink industry are encouraging consumers choices towards low and no calorie drinks. In this sense, 
the Union of European Soft Drinks Association (UNESDA) has announced a plan to reduce added 
sugars in all soft drinks by a further 10%, tripling the pace of sugar reduction 
(http://www.foodnavigator.com/Market-Trends/European-soda-makers-vow-to-reduce-added-sugar-
by-further-10). Furthermore, the sugar taxes have being considered by the European governments. 
Recently, Spain announced plans for a tax on sugar-sweetened beverages 
(http://www.foodnavigator.com/Policy/Spain-and-Estonia-to-tax-sugary-drinks), which has been into 
effect by the moment only in Catalonia. The UK government has approved the sugar tax on soft 
drinks that will come into force April 2018. These sugar taxes could be extended to other foods and 
drinks products, following research on its effectiveness on reducing obesity after 2 years 
(http://www.foodmanufacture.co.uk/Regulation/Sugar-tax-on-soft-drinks-may-be-extended-in-UK).   
Moreover, regarding the recommendations for a good hydration, the SENC strongly suggests 
drinking mineral and tap water and sugar-free beverages such coffee and tea as part of a daily 
intake (figure 3) [11]. It is in line with the daily recommendations proposed in the Healthy Eating 
Plate of Harvard School of Public Health (figure 5, page 22). 
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Figure 3. Healthy Hydration Pyramid designed by the Spanish Society of Community Nutrition (SENC, 2016) 
[11]. 
Regarding the in vivo biological effects of these novel beverages on the body fat reduction, C. 
elegans was employed as the animal model. This worm has been considered an excellent candidate 
for whole organism-based high-throughput screening in drug assessment as a preclinical model [12], 
and more recently has become an attractive in vivo animal model for initial studies of nutrition 
interventions prior to conﬁrmation in higher animal species [13]. C. elegans conserves 65% of the 
genes associated with human genes and its intestine presents close similarities to the human 
gastrointestinal tract [14,15]. Due to the translucent body of these worms the analysis of intestinal fat 
deposition by lipid-staining dyes is very convenient [16]. Whereas mammals have dedicated 
adipocytes, C. elegans store fat in droplets in their intestinal and hypodermal cells, which can be 
directly visualized in intact animals [17]. Regarding the lipid metabolism, over 300 genes in 
C.elegans have shown to cause a reduction in body fat when inactivated [16]. Its metabolic 
pathways have been examined most extensively in the context of insulin signalling since down-
regulation of insulin signalling confers an extended adult lifespan and increased fat accumulation. 
Activation of signalling by the DAF-2 insulin receptor inhibits the FOXO-transcription factor DAF-16, 
thereby promoting an increased fast metabolism. In contrast, a down regulation of DAF-2 allows 
activation of DAF-16, which promotes fat accumulation [17]. In addition, a number of enzymes 
General discussion 
 
166  
 
involved in lipid metabolism are highly expressed in the intestine [18]. The T21H3.1, Y49E10.16, 
T10B5.7 and F28H7.3 genes have been found to encode lipase enzymes. C. elegans releases eight 
member of the α/β hydrolase lipase family, which are secreted into the intestinal lumen and function 
as digestive enzymes [19]. They are very similar to the mammalian gastric and pancreatic lipases 
from the α/β hydrolase lipase family [20]. 
Our results show that the main bioactive compounds of the CSE, CGA and caffeine, significantly 
reduce lipid deposits in C. elegans. They were found in physiologically active doses in the beverages 
prepared with CSE, however unexpectedly a synergic and/or additive effect was not detected. 
Melanoidins, which are also present in the CSE beverages, are constituted by carbohydrates, 
including dietary fibre (soluble Maillardized fibre), proteins and polyphenols such as CGA [21]. All of 
them conform the matrix of the beverage and thereby may be affecting the bioaccesibility and 
bioavailability of CGA and caffeine, respectively, by adhering them to their complex structure [22,23]. 
Moreover, unlike those beverages prepared with ACSE, those containing RCSE achieved higher 
effects on lipid metabolism and similar to those found in a commercial dietary supplement, made 
from Robusta decaffeinated green coffee extract. Robusta specie has been shown to possess higher 
content of bioactive compounds and CGA appears as the main one to affect lipid metabolism.  
Recently, our group has demonstrated that CSE and CGA are able to significantly inhibit the activity 
of pancreatic lipase in vitro [24], which is in charge of the hydrolysis of most of the dietary lipids we 
intake, and thereby plays a key role in the efficient digestion of triglycerides [25]. Therefore, its 
inhibition may be one of the possible mechanisms of action exerted by the CSE beverages to reduce 
fat accumulation in C.elegans. Other authors have reported that mulberry leaf polyphenols 
containing CGA as main polyphenol compound reduced fatty acid storage in C. elegans. 
Subsequent genetic screens and gene expression analyses demonstrated that polyphenol function 
mainly depended on the germline signalling pathway, thus influencing the activities of down-stream 
transcription factors, such as DAF-12, DAF-16, PHA-4, and NHR-80; as well as the expression 
levels of their target genes [26]. Moreover, dietary fibre of the beverages from CSE might also have 
impact on body fat accumulation. Several studies assayed the effect of supplementation with dietary 
fibre from barley and oat (0.5, 1 and 3%) in C.elegans wild type N2. Both types of dietary fibre 
showed to reduce body fat, which appeared to be primarily mediated via SIR-2.1, DAF-16, and DAF-
16/DAF-2 and DAF-2 gen, respectively [13,27]. All together may be supporting the lyporegulatory 
character of CSE. 
In addition, these novel beverages based on CSE have antioxidant properties, which may be 
attributed not only to polyphenols, such as CGA, but to other compounds like melanoidins. These 
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bioactive compounds present multiple biological activities that may enhance the value of these 
beverages [28]. Nevertheless, further research should be conducted to elucidate the contribution of 
the different bioactive compounds present in the beverage and their mechanisms of action.  
Therefore, it has been achieved a sustainable use of coffee wastes, in particular CSE, in the 
development of novel beverages for body weight control that also meet European requests on the 
sugar content reduction and the current consumer’s demands.  
2. Novel bakery foods 
Biscuits represent the largest category of snack item among bakery products [29]. It has become 
one of the popular snack foods for both young and elderly people due to their affordable price, 
convenience, shelf-stable, and nutritive value [30]. Biscuits offer a valuable supplementation vehicle 
for nutritional improvement and bioactive compounds [31]. Components of coffee by-products, such 
as fibre and non-nutritive compounds, are excellent ingredients to be incorporated in bakery 
products, in order to enhance their sensorial and nutritional quality, and to simultaneously achieve a 
sustainable effect in the coffee sector.  
Coffee flour (www.coffeeflour.com) is a new ingredient developed from the coffee pulp, presenting 
high content in fibre and ash, and low fat level [32]. It has been proposed for its utilization in different 
food formulations such as breads, cookies and muffins with better nutritional properties. The high 
amount of dietary fibre in coffee husk appears as an advantage in making “energy bars”, by grinding 
the whole coffee husk and thereby, including all antioxidants and fibre into the product. Then, the 
coffee husk could be launched as an allergic-friendly ingredient since it is naturally gluten free [33]. 
Just one study on the use of chemically pre-treated CS, as an ingredient of bread formulations, has 
been reported [34]. However, no previous works on the use of natural whole SCG and CS, as food 
ingredient for improving technological and nutritional quality of bakery products, have been 
conducted.  
2.1. Bakery products based on coffee silverskin 
The present thesis shows the feasibility and effectiveness of applying 1) CS,  2) CSE, or 3) CSE 
combined with the solid residue recovered from the extraction process, to non-added sugar biscuits 
where sugar content has been replaced with stevia (chapter 2, article 1; figure 4).   
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Figure 4. Use of coffee silverskin (CS), CS extract (CSE) and its solid residue in non-added sugar biscuits.  
This is the first time it is achieved a full recovery of CS through the whole conversion into two 
products, natural colouring and source of fibre. On one hand, the content of dietary fibre (6.6% 
soluble and 60.5% insoluble in CS) [35], plays a key role on the technological quality, as a texturizing 
agent, and on the nutritional properties, as enhancer of the nutritional value of the biscuits. On the 
other hand, the colouring has an essential impact on the sensorial properties of the biscuits, which 
will provide the typical golden colour expected of this type of baked products. This double effect of 
the use of whole CS on sensory and nutritional quality is essential for achieving high acceptance by 
the consumers. 
MR is one of the prevalent reactions during coffee roasting as well as during biscuit baking process; 
however, other non-enzymatic food-browning reactions might contribute to the dark colour of the 
melanoidins formed in the MR (17% in ACSE [36]). The non-enzymatic oxidation of phenols was 
reported to yield brown coloured structures [37]. The ACSE used in this study as food ingredient 
possess 1.1% of CGAs [36]. Part of these CGAs might be incorporated via the phenolic acid moiety 
through non-ester bonds to coffee melanoidin structures, therefore providing the colour of the baked 
biscuits caused by the oxidation of CGA [38]. Moreover, CS has been shown to possess 1.6-12% of 
sugar content [39], which may be contributing to brown-coloured compounds formed because of 
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reaction of caramelization. However, MR yields much more intense colours than caramelization [40] 
since this latter involves long lengths of time [41], and amino groups and phenolic compounds 
compete with monomeric sugar-sugar caramelization reactions. Our results showed that sugar-free 
biscuits have the non–enzymatic browning reactions limited [42]. However, those biscuits containing 
stevia as non-nutritive sweetener and CSE, did not present significant differences in colour 
compared with biscuits prepared with sucrose. The results support the validity of using CSE as a 
natural colouring.  
Furthermore, along with the desired flavour and colour-related substances, neo-contaminants, such 
as acrylamide and HMF, are formed during the MR. Both compounds possess genotoxic and 
carcinogenic properties [43]. CSE and its main phenolic compound –CGA-, have been shown to 
exert antiglycative properties, thereby limiting the MR [31,32]. The use of CS as an ingredient of the 
biscuits, partially improves to a great extent this neo-contaminant formation. In addition, the non-
nutritive sweetener –stevia-, plays a key role on the safety quality of the products. Our results show 
a reduced formation of these neo-contaminants when sugar is replaced with stevia. The combination 
of both, coffee by-product and non-nutritive sugar replacers, provide a safer product.  
Likewise, the digestive process plays a decisive role on the release of compounds of interest in 
health and disease [44]. The nature and amount of food components, such as carbohydrates, fat, 
protein, and dietary fibre; as well as, the processing and preparation of the food might influence the 
release of neo-contaminants from the food matrix [45]. Our results show that after in vitro simulated 
oral-gastrointestinal digestion of the biscuits formulations [46], acrylamide was not bioaccessible to 
be absorbed. Other authors have also reported a gradual decrease in acrylamide levels through the 
gastric, duodenal and colon phases during in vitro digestion of biscuits [47]. This is due to the 
Michael addition of amino acids to acrylamide during the digestive process. Acrylamide possess the 
potential to react with the nucleophilic groups (–SH, –NH2) of amino acid side chains. In fact, 
cysteine becomes highly reactive toward acrylamide, especially under the simulated duodenal 
conditions. Therefore, the levels of acrylamide ingested with foods may not directly indicate its 
absorption rate through gastric, duodenal and colonic routes. Gastrointestinal conditions and the 
ingested food composition affect the levels of bioavailable acrylamide, and it should be taken into 
consideration. 
Furthermore, these biscuit formulations present low content of bioaccessible glucose, which is in 
concordance with the European recommendations regarding the formulation of food products with 
reduced sugar amount. Consequently, these innovative foods may be potentially suitable for 
diabetics or people who want to lose weight. Further studies should be required to evaluate the 
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biological effects of these biscuit formulations on the management of these metabolic chronic 
diseases.  
2.2. Bakery products based on spent coffee grounds 
For the first time, it has been proposed the use of SCG from the industrial instant coffee process as 
food ingredient in the development of a healthy product line of pastry, confectionery and/or bakery 
products such as bread, buns, biscuits, breakfast cereals and snacks, among others (patent 
WO2014128320 A1; figure 5; Annex 1) [48]. The patented application proposes the utilization of 
SCG as sustainable natural antioxidant insoluble dietary fibre. Since SCG come from the food 
industry, their use as coffee fibre is of food grade as well, and its conversion in a co-product may be 
feasible, regarding food safety and traceability. It can be used in the range between 4-8%, which 
corresponds to the nutrition claims “source of fibre” and “high fibre content”, respectively (European 
Regulation (EC) No 1924/2006). The antioxidant properties of the insoluble coffee fibre can be 
associated with phenolic compounds bound to proteins, polysaccharides and melanoidins [49,50]. 
There is evidence for the existence of a complex dietary fibre-protein-MRP-polyphenols, named 
“maillardized insoluble dietary fibre” in bakery products [51].  
This coffee antioxidant fibre combines beneficial effects of both, dietary fibres and antioxidants. 
Insoluble fibre may play an important role for weight loss during consumption of a high-fat diet by 
adhering fat to its complex structure [52,53], and it has been inversely associated with the risk of 
T2D [54]. The mechanisms of action behind insoluble fibre have been suggested to be more 
peripheral. An accelerated secretion of GIP hormone, which stimulates postprandial insulin release, 
is observed directly after the ingestion of insoluble fibre in healthy women. The insoluble fibre can 
also result in a reduced appetite and food intake [55], thereby decreasing the caloric intake and BMI. 
The short chain FFAs produced via fermentation of the insoluble fibre, have shown to reduce 
postprandial glucose responses [56] through the inhibition of glucose metabolism via GLUT 4 
transporters [57] and to prevent inflammation [58]. On the other hand, the intake of antioxidant 
dietary fibre has been recommended for health improvement of the gastrointestinal tract. The 
pathogenesis of various gastrointestinal diseases such as irritable bowel syndrome and inflammatory 
bowel disease is partially due to oxidative stress. Antioxidant compounds may be beneficial at 
reducing the risk of these gastrointestinal diseases [59]. In fact, this is consistent with the current 
concept that antioxidants act by inhibiting oxidative stress pathways in a tissue- and environment-
specific manner and not by simply acting as scavengers [60]. 
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This gluten-free coffee fibre can be used into diverse combinations with other basic and/or novel 
ingredients such as non-nutritive sweeteners and gluten-free flours. Therefore, it may allow their use 
for people with special nutritional needs, such as diabetic and overweight or obese people. In this 
sense, further investigations have been performed and described in the present PhD thesis. New 
knowledge is provided with regard to the validation of this coffee fibre from SCG as a new food 
ingredient and its sustainable feasibility to be incorporated in non-added sugar biscuits with potential 
health-promoting properties for metabolic chronic diseases (chapter 2, article 2; figure 5; Annex 
5). 
Figure 5. Validation of antioxidant insoluble dietary fibre from SCG as food ingredient and formulation of 
bakery products.  
Our results show that SCG possess a very high amount of insoluble dietary fibre (42%), which is 
superior to other natural sources of insoluble fibre -black beans (16%), lentils (8%), almonds (12%), 
whole grains (7%) and some fruits (2-2.6%)-. The coffee fibre is stable to thermal process such as a 
baking and to the abiotic gastrointestinal digestion in vitro. On the other hand, it contains low 
amounts of free CGA and caffeine, and none levels of free sugar. This coffee fibre is also a small 
source of neo-contaminants -acrylamide (37 µg/kg) and HMF (61 mg/kg)-. The acrylamide values 
are 92–96% lower than the indicative values proposed by European Commission (2013) for roast 
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(200-250 µg/kg) and instant coffee (350-595 µg/kg) [61]. Likewise, HMF levels are also very far from 
those amounts found in coffee (100–1900 mg/kg) and instant coffee (400–4100 mg/kg) [62]. The 
coffee fibre is exhausted of these compounds as a consequence of the extraction process during the 
preparation of soluble coffee beverage. In addition, the coffee fibre derived from the instant coffee 
production presented high microbiological safety in this particular case. Therefore, SCG become a 
cost-friendly source of healthy insoluble dietary fibre that does not require further purification to be 
used as food ingredient of bakery products to enhance their nutritional and biological quality. 
Sugar was replaced with non-nutritive sweeteners such as stevia, and FOS were added as soluble 
dietary fibre and enhancer of the taste of the coffee fibre-containing biscuit (CFB). The sensory and 
acceptance tests of the novel biscuits show that the coffee fibre and stevia are highly accepted 
ingredients, and above all when combined with FOS in the formulation. FOS present slightly 
sweetness and might act masking negative off-flavours from the stevia [63] and coffee fibre [64]. 
Therefore, these novel biscuits seem to meet consumers’ preferences. Furthermore, CFB exhibited 
lower levels of both, dietary early MRPs and AGEs, than the sucrose-containing biscuit (SCB). This 
indicates that the presence of sucrose during baking increases the amount of compounds that can 
be limited by the replacement with non-nutritive sweeteners. In addition, coffee fibre contains CGA 
and other phenolic compounds (2 mg/g), contributing one CFB (≈10 g) in 0.4 mg CGAs. CGA 
possesses antiglycative properties (IC50 = 0.4 mg/ml) [36], thus, this coffee fibre might also prevent 
the formation of MRPs and AGES associated with oxidative stress and inflammation, and eventually 
causing higher risk of most chronic diseases, such as T2D and obesity [65,66]. Incorporation of FOS 
to the biscuits also contributes to the balance of soluble: insoluble dietary fibre and promotes the 
growth of specific beneficial gut bacteria [67]. Recently, relationship between non-digestible 
carbohydrates, including FOS, and reduction of post-prandial glycaemic responses was established 
by EFSA (2014) [68].   
Additionally, in vitro effects of the bioaccessible food components released during the simulated 
human digestion of the novel CFB, on α-glucosidase activity and satiety hormones were examined. 
To the best of our knowledge, this is the first report on the potential antidiabetic and satiating effects 
of foods comprising coffee fibre and non-nutritive sweeteners (chapter 2, article 3; figure 6). 
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Figure 6. Biological effects of novel coffee fibre-containing biscuit (CFB) on glucose tolerance and satiety. 
The content in glycaemic sugars such as glucose and fructose in the biscuit digests was significantly 
reduced. The CFB can be classified as “no added sugars” declaring that may “contains naturally 
occurring sugars” (European Regulation (EC) No 1924/2006). Likewise, the content of insoluble and 
soluble dietary fibre of the novel biscuits provided by the coffee fibre from SCG and FOS 
respectively, lead to categorize these novel biscuits under the nutrition claim “high fibre” (≥ 6 g of 
fibre per 100 g or ≥ 3 g of fibre per 100 kcal). Recent studies have concluded that foods high in fibre 
and whole grains enhance satiety when consumed as snacks [69]. 
The present study shows antioxidant character of the CFB digest. The transportation of dietary 
antioxidants through the gastrointestinal tract has been described as an essential function of dietary 
fibre. Polyphenols linked to dietary fibre may be released in the colon by the action of the microbiota, 
producing bioactive metabolites and an antioxidant environment, thereby reducing the risk of 
gastrointestinal diseases associated with oxidative stress and inflammation [70] (figure 6 (i)). CGA, 
which is present in the coffee fibre, has shown potential to inhibit signalling molecules involved in 
inflammation processes, thereby acting as an anti-inflammatory antioxidant compound [58]. 
Stevia and FOS present in the novel biscuit were effective inhibitors of α-glucosidase activity in vitro 
(figure 6 (ii)). Moreover, previous studies have reported an association of antioxidants, in particular 
polyphenols, with α-glucosidase inhibition [71]. The release of phenolic compounds incorporated in 
the coffee fibre structure during the digestion process may enhance tolerance to carbohydrates by 
inhibiting intestinal α-glucosidase. Diterpens such as cafestol and kahweol, which have been 
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described to be present in SCG [72], might be contributing to this inhibitory effect on α-glucosidase 
exerted by the novel biscuits [73]. Alpha-glucosidase inhibitors prevent the degradation of complex 
carbohydrates into glucose, and carbohydrates remain longer in the intestine, reducing their impact 
on blood sugar and therefore postprandial hyperglycaemia. The control of glucose absorption plays 
a key role in the management of T2D.  
The coffee fibre exhibited a potent stimulation of the gut serotonin and GLP-1 hormones ex vivo 
(figure 6 (iii)). These intestinal hormones can regulate the feeling of fullness via neural paracrine 
routes with subsequent afferent signalling to brainstem nuclei [74,75]. GLP-1 also regulates the 
feeling of fullness via the endocrine pathway through the hepatic portal and cava vein [74]. The 
intestinal secretion of serotonin responds to chemical and mechanical stimuli after food intake [76]. 
Thus, the antioxidant coffee fibre is expected to exhibit a greater stimulation of satiety hormones in 
vivo than that described in this study, due to the physical effect of the indigestible material obtained 
from the digestive process. In addition, the soluble fibre (FOS) incorporated to the novel biscuits may 
be also positively affect the release of these satiety hormones. It has been described, in a double 
blind randomized clinical trial, an increase of the satiety feeling when FOS enriched cookies (10 per 
day) were consumed by obese patients for a month [77]. On the other hand, galactomannan, a 
soluble fibre that is released from the SCG during the digestive process, may enhance satiety by 
forming a viscous gel in the stomach, and thereby slowing gastric emptying and enhancing fullness 
[57]. It has been suggested recently the potential of eating high-fibre snacks between meals to 
promote satiety and suppress overconsumption at the subsequent meal [69].   
The secretion of GLP-1 hormone also participates in glycaemic tolerance via glucose-induced 
secretion of insulin from pancreatic β-cells and via glucagon release inhibition from pancreatic α-
cells [78] (figure 6). Therefore, a double antidiabetic and satiating potential effect might be achieved 
thanks to the secretion of GPL-1.  
Other ingredients and compounds released during the digestion of the novel biscuit such as gluten 
peptides might also be involved in the described biological effects. Further research is required in 
order to find out which other compounds released during the digestion of the novel biscuits, 
comprising coffee fibre and non-nutritive sweeteners, are responsible of the potential effects on 
satiety and glucose tolerance. Clinical studies should be also conducted to evaluate their effect in 
vivo.
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Figure 6. Pathways of action of the novel coffee fibre-containing biscuit (CFB): (i) antioxidant capacity, (ii) inhibition of intestinal α-glucosidase and (iii) secretion of 
satiety hormones. Ingredients shown to have in vitro biological effects in the present study are represented in black, and those with potential physiological effects 
described in the literature are represented in green. 
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3. Impact of the digestive process on the release of 
compounds associated with chronic diseases 
MR has been traditionally described to occur in foods during cooking. This non-enzymatic reaction 
provides compounds responsible of the colour and flavour but also neo-contaminants such as 
acrylamide and HFM, and other compounds with health impact. The MR occurring in foods 
generates numerous of heterogeneous compounds, such as Amadori or Heyns products 
corresponding to the early stages, and AGEs from the advanced steps. All of them are the so-called 
dietary MRPs. It has been observed that hyperglycaemia state in diabetic people contributes to an 
accelerated non-enzymatic glycation in the body and thereby, to the endogenously formation of 
AGEs [66]. Dietary MRPs are partially absorbed by the intestine contributing to those endogenous 
formed [79,80] thus, increasing the pool of AGEs found in the human body. These compounds 
derived from the glycation reactions have been associated with oxidative stress and inflammation, 
processes that eventually cause most chronic diseases, including diabetes [81].  
Due to the increased intake of fructose as HFCS and its relationship with different chronic diseases 
such as asthma, bronchitis and arthritis, it has been hypothesized that these associations might be 
mediated through the intestinal in situ formation of AGEs and their subsequent absorption [82]. 
Therefore, the gastrointestinal tract would become another spot of MRPs’ formation if this hypothesis 
was confirmed. In this sense, the present research aimed to study the formation of these compounds 
during in vitro oral gastrointestinal digestion [46] of simplified meal systems comprising an average 
meal and sugar-containing meals (chapter 3; figure 7). This is the first report that confirms this 
event under the studied conditions. 
The gastric phase of the digestive process (pH 2, 37º C, 1 h 30 min) is essential to break the dietary 
proteins and release free amino acids or peptides to the medium. These reactive amino groups react 
with the carbonyl groups of the sugars present in the intestine, whose conditions (pH 7, 37º C, 2 h 30 
min) seem to favour the reaction between them. The reactivity of sugars and amino acids have been 
largely studied over the past years, however, this study is the first described under human digestive 
conditions. Moreover, the reaction comprises not only the formation of MRPs from the amino groups 
of the arginine and lysine side chains, but also the alpha amino groups of all the released amino 
acids. Fructosamine and fluorescent adducts were detected in digests of those meals containing 
HCFS and starch, respectively. CML and MGO-derivative AGEs were found in the meals composed 
of fructose and only MGO-derivative AGEs in presence of glucose. Physiological concentrations (43 
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mM) of sugars in simplified systems composed by single amino acids caused formation of MRPs 
under intestinal conditions. Fructose (43 mM) gave rise to CML by interaction with lysine, which was 
observed within 1 hour of incubation at intestinal conditions. This result is remarkable since 
emphasizes the MR is taking place very fast, which has not been recognized widely in the past.  
Figure 7. Maillard reaction products (MRPs) generated during gastrointestinal digestion of an average and 
sugar-containing meals. 
There is evidence that more excess of free fructose is being consumed than has been assumed. 
Results from a study indicate that popular soda beverages are sweetened with a HFCS variant that 
is 60% fructose and 40% glucose, rather than the 55/45 formula that is generally recognized as safe 
[83,84]. These findings raise the possibility that daily excess free fructose intakes exceed dosages 
that have been correlated with fructose malabsorption [85,86]. Notably, equal amounts of fructose 
and glucose monomers are not associated with adult fructose malabsorption [87]. However, HFCS is 
not solely responsible of the glycation reaction occurring in the intestine. Our results show that 
accumulation in the intestinal lumen of a theoretical maximal concentration of glucose (314 mM) as 
the result of complete digestion of the average meal containing starch promotes the formation of 
MRPs as well. A delay on the absorption of the sugar due to either fructose malabsorption or change 
in intestinal membrane functionality because of the presence of fat [88,89] seems to favour these 
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reactions. Therefore, the intake of sugar-containing meals, in presence of dietary fat or 
malabsorption state will probably develop the formation of these AGEs-derivatives in situ.  
Considering the above information, the reformulation of foods plays a key role to lessen the 
formation of MRPs during the human digestive process. Fully and readily digestible carbohydrates 
such as glucose and starch promotes a rapid increase in blood glucose or glycaemic response. 
Foods containing high amount of these available carbohydrates are considered as high GI and GL 
foods. It is the case of highly processed starchy foods, which will probably impact on the available 
glucose concentration in the small intestine due to their fast digestibility, thereby favouring the 
formation of MRPs in situ. The intake of low GI and GL foods appears as an effective alternative to 
reduce this event, since non-digestible carbohydrates are resistant to hydrolysis in the small intestine 
and therefore, they are not bioaccessible. EFSA has issued a favourably opinion for resistant starch 
and FOS being considered to have effect on reduction of postprandial glucose response [68]. 
Resistant starch can be used to replace flour on a 1 for 1 basis without significantly affecting dough 
handling or rheology because of its fine particle size. Its physical properties provide crispiness and 
improved texture in the end-product. Resistant starch has been successfully used in a range of 
baked products with reduced sugar content [90]. Coffee flour (http://www.coffeeflour.com/) obtained 
from the coffee fruit possess high content of dietary fibre (50%) and low glycaemic sugars that make 
it excellent to replace normal flour in bakery products as well. It may reduce the release of 
compounds associated with chronic diseases during the digestive process. Likewise, the use of non-
nutritive sweeteners as replacers of sucrose, as well as the sustainable use of coffee by-products 
such as CS as food ingredient of bakery products might limit the glycation of the amino acids and 
peptides released during the digestive process [91]. Further studies should be performed to confirm 
these preliminary findings by employing in vivo assays.  
4. Future perspectives 
Before the legal authorization of the health claims of functional foods or food components, the Panel 
on Dietetic Products, Nutrition and Allergies (NDA) of the EFSA demands evidence from all the 
studies performed, including in vitro, animal and human studies [92]. Human intervention studies are 
only feasible once the product is already developed and it is necessary to establish the dose–
exposure relationship (pharmacokinetic studies) and at last the exposure–response relationship 
(pharmacodynamic studies) (figure 8).  
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Figure 8. Steps for the authorization of health claims in functional foods: from the in vitro assays, 
recommended in early stages of the development of a functional food, to human intervention studies, which 
are aimed to establish the dose–exposure relationship and the exposure–response relationship. 
In this context, the present PhD thesis provides novel scientific information supporting the usefulness 
and validation of the coffee by-products, CS and SCG, as food ingredients of novel beverages and 
bakery foods. Moreover, the biological effects in vitro, ex vivo or employing animal models, of these 
novel foods and ingredients to reduce the risk of obesity and T2D are presented. Likewise, it is 
demonstrated the importance of the digestive process in the release of bioactive components and/or 
the formation of compounds associated with metabolic chronic diseases in vitro.  
“Promotes satiety” or “helps to manage body weight” could be some of the statements of health 
claims related to the novel beverages and foods presented in this thesis. More research would be 
necessary to complete the whole process for an authorized health claim. Studies in animals to 
confirm the satiating and antidiabetic effect are required, as well as postprandial human studies to 
assess the effects of the dose. Long-term, randomized, controlled, dietary intervention trials with 
appropriate compliance biomarkers are also necessary in order to assess the full and unequivocal 
role that the bioactive compounds play in preventing chronic human disease.  
Furthermore, future research on the gastrointestinal benefit effects of the patented antioxidant coffee 
fibre might be of interest. Studies in vivo and clinical trials on the potential protection against 
inflammatory chronic diseases such as irritable bowel syndrome, as well as its mechanisms of action 
of the coffee fibre may be a remarkable future research line. 
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CONCLUSIONS 
From the work performed in the present PhD thesis can be deduced the following conclusions: 
1. The use of CS for the preparation of novel beverages has been proposed for the first time. It 
has been obtained an antioxidant beverage with acceptable sensorial properties and reduced 
sugar content, which meet current consumer’s demands and global requests on the sugar 
content reduction.  
2. The novel antioxidant beverage based on CSE reduces body fat accumulation in vivo. 
Physiological active concentrations of caffeine and CGA in the beverage contribute to this 
effect. RCSE beverage exhibits similar effects to those of a commercial dietary supplement 
made of Robusta decaffeinated green coffee extract. 
3. For the first time, full recovery of CS by means of the green conversion into two different 
products, natural colouring and source of dietary fibre, has been proposed. 
4. The use of CSE together with its solid residue, as food ingredient, improves technological, 
nutritional and sensorial properties of non-added sugar biscuits. The biscuits based on 
sustainable coffee ingredients show greatly reduced HMF and non-bioaccessible acrylamide 
levels. 
5. SCG from the industrial instant coffee process were proposed as sustainable source of 
antioxidant insoluble dietary fibre for human consumption. The coffee fibre is stable to baking 
and to the abiotic gastrointestinal digestion in vitro. It presents none levels of free sugar and 
low amounts of free CGA, caffeine, acrylamide and HMF. As a consequence, it can be 
considered as a low cost safe food ingredient.  
6. CFBs containing non-nutritive sweeteners and FOS, present similar sensorial acceptance to 
that observed for commercial biscuits with high consumer adhesion in the market, and possess 
reduced levels of health-impact compounds such as food processing contaminants and AGEs.  
7. CFB digests present higher antioxidant character and significantly reduced glycaemic sugars 
compared to SCBs, which may be beneficial for human health 
8. The bioaccessible food components, released during the simulated human digestion of the 
novel CFB, inhibit in vitro α-glucosidase activity and promote the release of satiating hormones, 
serotonin and GLP-1, in Caco-2 and HuTu-80 cells, respectively.  
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9. The formation of early MRPs and AGEs associated to the pathogenesis of diabetes, during in 
vitro abiotic gastrointestinal digestion process of model systems mimicking sugar-containing 
and average meals, respectively, has been described for the first time.  
In summary, the present PhD thesis confirms the feasibility of using the coffee by-products, CS and 
SCG, in the development of novel beverages and foods with enhanced technological, nutritional and 
sensorial quality as well as with biological effects to reduce the risk of obesity and T2D.  It has been 
achieved the production of novel sustainable health promoting ingredients and foods. In addition, 
new knowledge on the impact of the digestive process on the release of health-impact compounds 
has been generated. 
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CONCLUSIONES 
Del trabajo realizado en la presente tesis doctoral se deducen las siguientes conclusiones: 
1. Por primera vez se propone el uso de cascarilla de café para la elaboración de nuevas 
bebidas. Se ha obtenido una bebida antioxidante con propiedades sensoriales aceptables, y 
contenido reducido en azúcar que responden a la actual demanda del consumidor y a la 
solicitud a nivel mundial de reducir el contenido de azúcar. 
2. La nueva bebida antioxidante a base de extracto de cascarilla de café reduce la acumulación 
de grasa corporal in vivo. Concentraciones fisiológicas activas de cafeína y ácido clorogénico 
en la bebida contribuyen a este efecto. La bebida de extracto de cascarilla Robusta presenta 
efectos similares a los de un suplemento dietético comercial preparado con extracto de café 
verde Robusta descafeinado.  
3. Se ha propuesto por primera vez la recuperación completa de la cascarilla de café mediante su 
conversión sostenible en dos productos diferentes, un colorante natural y fuente de fibra 
dietética.  
4. El uso de extracto de cascarilla junto con su residuo sólido, como ingrediente alimentario, 
mejora las propiedades nutricionales y sensoriales de las galletas sin azúcares añadidos. Las 
galletas basadas en ingredientes de café sostenibles, presentan una reducción significativa de 
hidroximetilfurfural y acrilamida no bioaccesible. 
5. Se proponen los posos de café procedentes del proceso de café instantáneo como fuente 
sostenible de fibra dietética antioxidante insoluble. La fibra de café es estable al horneado y a 
la digestión abiótica gastrointestinal in vitro. Ésta presenta niveles no significativos de azúcar y 
pequeñas cantidades de ácido clorogénico y cafeína libres, acrilamida y hidroximetilfurfural. En 
consecuencia, se considera la fibra de café como un ingrediente alimentario seguro de bajo 
coste. 
6. Las galletas elaboradas con fibra de café, las cuales contienen edulcorantes no nutritivos y 
FOS, presentan una aceptación sensorial similar a la observada para galletas comerciales con 
alta adhesión del consumidor en el mercado, y poseen niveles reducidos de compuestos de 
impacto para la salud tales como contaminantes del procesado de los alimentos y productos 
avanzados de la reacción de Maillard. 
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7. Los digeridos de las galletas de fibra de café presentan mayor carácter antioxidante y azúcar 
glicémicos significativamente reducidos comparado con las galletas de sacarosa, lo que podría 
ser beneficioso para la salud.  
8. Los compuestos bioaccesibles liberados durante la digestión humana simulada de la nueva 
galleta de fibra de café, inhiben la actividad α-glucosidasa in vitro y promueven la secreción de 
hormonas de saciedad, serotonina y péptido similar al glucagón tipo 1 (GLP-1), en células 
Caco-2 y HuTu-80, respectivamente.  
9. Se ha descrito por primera vez la formación de productos de la reacción de Maillard, de las 
etapas iniciales y avanzadas asociados con la patogénesis de la diabetes, durante la digestión 
abiótica gastrointestinal in vitro, de sistemas modelo que simulan comidas con azúcar y una 
comida promedio, respectivamente.  
En resumen, la presente tesis doctoral confirma la viabilidad de utilizar los subproductos del café, 
cascarilla y posos de café, en el desarrollo de nuevas bebidas y alimentos con mayor calidad 
tecnológica, nutricional y sensorial, y con efectos biológicos para reducir el riesgo de obesidad y 
diabetes tipo 2. Se ha logrado la producción de nuevos ingredientes y alimentos que promueven la 
salud sostenible. Además, se han generado nuevos conocimientos sobre el impacto del proceso 
digestivo sobre la liberación de compuestos con impacto en la salud. 
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Abstract 
 
Almond shell is a major waste from the almond 
processing industry. Its feasibility as natural 
source of health-promoting components was 
examined. The by-product was fractionated 
under basic conditions following an easy scale-
up process. The chemical composition of the 
recovered fraction and its antioxidant and 
antidiabetic properties were evaluated. Novel 
information regarding the chemical composition 
of the polysaccharides was also obtained. 
Almond shell is formed by lignin-carbohydrate 
complexes possessing antioxidant properties 
and capacity to inhibit α-glucosidase. 
According to our knowledge, this is the first 
time α-glucosidase inhibitory activity of a lignin-
carbohydrate complex is reported. Biscuits 
containing non-caloric sweetener soluble 
(2.5%) and insoluble (5.6%) dietary fiber, 
natural antioxidants (1.34 mg gallic acid 
equivalents/g) andα-glucosidase inhibitors (1g 
biscuit ≈ 1mg acarbose)achieved a high 
sensorial score (7.2 out of 9) when almond 
shell was incorporated to them. The application 
of a fraction from almond shell containing 
lignin-polysaccharides complexes as food 
ingredient in biscuit formulations for people 
with particular nutritional requirements is 
feasible and new.  
 
Keywords 
Almond shell, antidiabetic effect, antioxidant 
properties, dietary fiber, novel ingredient, novel 
food 
 
1. Introduction 
 
Increased oxidative stress and inflammation 
processes play a major role in causing chronic 
diseases such as diabetes [1]. Diabetes 
mellitus is characterized by high blood glucose 
levels, resulting from insulin deficiency or 
functional disturbance of the receptors, with 
alterations in the metabolization of 
carbohydrates, proteins and lipids [2].  
Inhibition of α-glucosidase significantly 
decreases postprandial hyperglycemia after 
the intake of a diet rich in glycemic 
carbohydrates, which is a key strategy in the 
control of diabetes [3].Acarbose, a potent α -
glucosidase inhibitor, represents a new 
concept in the treatment of metabolic 
disorders, particularly type 2 diabetes and, in 
some countries, prediabetes. It reduces the 
absorption of dietary carbohydrates by 
reversible competitive inhibition of α-
glucosidase activity, reducing post-prandial 
blood glucose increment and insulin response. 
Acarbose is considered an efficient oral 
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antidiabetic drug even though it produces side 
effects such as diarrhea and flatulence 
[4].Therefore, it would be meaningful to search 
for new glucosidase inhibitors from natural 
products without such side effects. 
Agro-industrial by-products are considered 
promising opportunities, offering new 
biologically active and functional components 
for application in food and pharmaceutical 
industries [5].Almond shell is a major waste of 
the almond processing industry. This by-
product has been used in the production of 
bioethanol [6]. However, to the best of our 
knowledge its application in foods as a healthy 
ingredient has not been previously reported. 
Almond shell is a thick woody endocarp, mainly 
composed of cellulose, hemicelluloses and 
lignin [7].Some polysaccharides in the cell 
walls of lignified plants can link to lignin to form 
lignin-carbohydrate complexes (LCCs). These 
complexes are known by their excellent anti-
HIV, antiviral and pro- or anti-inflammatory 
activities [8]. As far as we know, there are no 
reports dealing with the α-glucosidase 
inhibitory activity of LCCs. Moreover, data on 
the chemical composition of extracts enriched 
in polysaccharides from almond shell suggest 
they could potentially be used as functional 
food ingredients with antioxidant properties 
[7].The development of new functional 
ingredients has the advantage that food 
manufacturers can add extra value to products 
the consumer is already familiar with. Biscuits 
could represent a potential candidate for the 
addition of functional ingredients, but their 
nutritional profile has to be improved in view of 
formulating functional products, reduced in 
sugars and caloric content. Therefore, this 
study aims to evaluate the effect of almond 
shell fractions enriched in polysaccharides and 
lignin on antioxidant and α-glucosidase 
activities; as well as their usefulness as natural 
food ingredients to reduce the risk or treat type 
2 diabetes. Healthier biscuits have been 
prepared using the novel food ingredient and 
stevia as a natural non-caloric sweetener. 
2. Materials and methods 
 
2.1. Reagents 
 
Fiber kit and D-glucose, mannose and fructose 
kit were supplied by Megazyme International 
Ireland Ltd. Sulfuric acid (93–98%) and ethanol 
(96%) were purchased from Panreac S.A. 
(Spain). Phenol (5%, w/v), 2,2-azino-bis (3-
ethylbenzothiazoline-6-sulphonic acid (ABTS)), 
potassium persulphate, Folin–Ciocalteu 
reagent and 6-hydroxy-2,5,7,8-
tetramethylchromane-2-carboxylicacid 
(trolox),α-glucosidase from rat intestine and 4-
methylumbelliferyl α-D-glucopyranoside (4-
MUG) were purchased from Sigma Chemical 
Co. (St. Louis, MO, USA). Water was purified 
using Milli-Q system. All other chemicals and 
reagents were of analytical grade. 
 
2.2. Apparatus 
 
A microplate spectrophotometer 
BioTekpowerWaveTM XS (BioTek Instruments, 
United States),a texture analyzer (LLOYD 
instruments, England), an activity water system 
(Aw Sprint TH-500, Novasina, Switzerland) and 
Agilent GC 6850A instrument equipped with 
HP-5MS capillary column were used for the 
analyses. 
 
2.3. Food ingredients 
 
The basic ingredients used to elaborate the 
biscuits(i.e. wheat flour, sucrose, sunflower oil, 
baking powder, salt, stevia powder containing 
3% steviol glycosides) were purchased at 
specialized and certified food local markets. 
Food grade soy lecithin was provided by 
Manuel Riesgo SA (Spain).  
Almond shell was collected in the city ofSfax 
(Tunisia), ground and sieved to small particles 
between 0.2 mm and 0.5 mm. Data on 
physicochemical characterization of almond 
shell  is provided in Online Resource 1.  
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2.4. Sample preparation  
 
2.4.1. Almond shell as novel food ingredient 
  
Extraction was performed following the 
procedure described by Ebringerová et al. [7] 
with minor modifications to obtain fractions with 
antioxidant capacity and a high polysaccharide 
content. Ground almond shell was treated with 
5% NaOH (1:10 w/v) at 60°C for 1h, vacuum 
filtered in a büshi funnel using cellulose filter 
paper, added with three volumes of 
isopropanol and incubated overnight at 
4°C.Finally, the fraction was isolated by 
decreasing the pH to 7by adding concentrated 
acetic acid and centrifuging at 4500 rpm for 15 
min at 20 °C. The isolate fraction was 
exhaustively dialyzed against distilled water 
under magnetic stirring for three days at 
4°Cand then freeze-dried. The powder was 
stored in sealed plastic bags at 4 °C until use. 
The obtained alkali-extracted almond shell 
fraction (AEASF) was dissolved in water (1:10 
w/v) and centrifuged at 4000 rpm for 10 min at 
20°C. The supernatant (water soluble fraction, 
WSF)and precipitate (water insoluble fraction, 
WIF), were recovered. WIF was washed with 
water (1:10 w/v) and centrifuged. Water soluble 
fractions were then mixed. WSF and WIF were 
frozen at -20°C, freeze-dried and stored until 
analysis. WSF in a concentration of 1mg/ml 
was further fractionated by ultrafiltration using 
filter devices with a molecular weight cut-off of 
3 kDa (Millipore), following the instructions of 
the manufacturer. Fractions containing water 
soluble compounds with higher (HMW) and 
lower (LMW) molecular weight than 3 kDa 
were frozen at – 20°C and freeze-dried. 
Powdered samples (AEASF, WIF, WSF, HMW 
and LMW)were stored under dry conditions 
until analysis. Samples preparations were 
performed in triplicate. Yields are expressed as 
percentage (%). 
 
 
 
2.4.2. Food preparation 
 
Biscuits with AEASF as food ingredient (B, C, 
E and F) and those without AEASF (controls, A 
and D) were formulated as indicated in Table 
1.The dough was prepared by mixing salt, 
baking powder and sugar or stevia. Mineral 
water at room temperature was added to the 
dry mixture and thoroughly blended to obtain a 
homogeneous mixture. Lecithin and oil were 
mixed in a separate bowl and then added to 
the mixture. Finally, flour was added gradually 
to the mixture, and the dough was kneaded to 
obtain homogeneous, elastic and slightly sticky 
dough. The dough was allowed to rest for 30 
min and shaped into discs with a 4 cm 
diameter and 0.8 cm thickness. The surface of 
each biscuit was punctured several times using 
a fork to prevent puffing. In the formulations 
with AEASF, it was combined with the flour and 
added as described above. The biscuits were 
baked at 190°C for 20 min in the oven. Two 
sets of 4 biscuits were baked in duplicate 
(n=8). The biscuits were placed in the center of 
the tray forming a square, in order to reduce 
variability during baking. The biscuits were 
cooled to room temperature prior to analysis 
(18–20 °C). 
 
2.5. Physico-chemical and nutritional 
characterization of the novel ingredient 
(AEASF) and food formulations 
 
2.5.1. Free mannose, fructose and glucose  
 
Mannose, fructose and glucose contents were 
determined in WSF, HMW and LMW fractions 
using an enzymatic kit following the 
manufacturer’s instructions (D-Mannose-D-
Fructose-D-Glucose Assay procedure, 
Megazyme International Ireland, Ireland). The 
method was adapted to a micromethod format. 
Results were expressed as %. The analysis 
was performed in triplicate. 
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2.5.2. Total carbohydrates 
 
Carbohydrate content was determined in WSF 
and its corresponding HMW and LMW fractions 
using the phenol–sulfuric acid method 
described by Musako et al. [9]. The color 
reaction was initiated by mixing 100 µl of 
samples with 300 µl of concentrated sulfuric 
acid (93–98%) and followed with the addition of 
90 µl of phenol (5%, w/v) in a glass flask. The 
reaction mixture was kept at 90°C for 5 min. 
After cooling the samples to room temperature, 
the absorbance was measured at 490 nm. A 
calibration curve was constructed using 
glucose (0.1–0.4 mg/ml). Reagent and sample 
blanks were also prepared and analyzed in 
each set of samples. All measurements were 
performed in triplicate and results were 
expressed as %. 
 
2.5.3. Dietary fiber 
 
Dietary fibre (DF) content (insoluble (IDF), 
soluble (SDF) and total (TDF)) was determined 
in AEASF and its soluble (WSF) and insoluble 
(WIF) fractions using the Total Dietary Fiber 
Assay Kit (Megazyme International Ireland, 
Ireland) as indicated in the manufacturer’s 
instructions, and based on an enzymatic–
gravimetric method. Results were expressed 
as %.The analysis was performed in triplicate. 
 
2.5.4. Monosaccharide composition of 
polysaccharides extracted from almond 
shell 
 
The elemental monosaccharide composition of 
the polysaccharide extracted from WSF, LMW 
and HMW fractions was analyzed by gas 
chromatography-flame ionization detector (GC-
FID) as described by Ben Jeddou et al.[10]. 
 
2.5.5. Lignin content 
 
The content in lignin was measured on WIF, 
WSF, HMW and LMW fractions from the 
AEASF. On the basis of the standard T222 om-
11, 1g (m0) of oven-dry-matter was placed in a 
1 L flask with 15.0 mL of 72% sulphuric acid 
and kept at 20°C for 1 h in a thermostatic 
water-bath. After this, 575 mL of distilled water 
were added and the mixture was brought to 
boiling for 4 h under reflux. The insoluble 
fraction was recovered in a tarred fritted glass 
filter (m1) of porosity No. 3 and washed with 
hot water until neutral pH. The set filter-lignin 
was oven-dried at 105°C for 24 h, cooled in a 
desiccator and finally weighed (m2), 
determining the acid insoluble lignin content (% 
in dry basis) as: 
Acidinsolublelignin(%)=(m_2-m_1)/m_0 × 100 
The filtrate obtained from the crucible was kept 
for soluble lignin estimation, which was 
measured spectrophotometrically at 280 nm. 
Acid-soluble lignin was determined according 
to TAPPI UM 250 standards. It can be 
estimated through the following expression:  
Acid soluble lignin (%) = {(Absorbance at 280 
nm × Dilution factor/20) × 100}/(1000 × m0) 
 
2.5.6.Total phenolic content 
 
Folin–Ciocalteu adapted to a micromethod 
format [11] was selected to determine the total 
phenolic content (TPC) in theWSF,  HMW and 
LMW fractions. The reaction was initiated by 
mixing 10 µl of sample with 150 µl of freshly 
prepared Folin–Ciocalteu solution. The mixture 
was equilibrated for 3 min at room temperature 
and then 50 µl of sodium bicarbonate solution 
were added. The reaction was followed for 120 
min at 37 °C by measuring absorbance at 735 
nm. Sample blank and reagent blank were also 
analyzed in each set of samples. A gallic acid 
calibration curve was used for quantification 
(0.1-1mg/ml). Results were expressed as mg 
gallic acid equivalents (GAE)/g sample. All 
measurements were performed in triplicate. 
 
2.6. Biological activities of the novel 
ingredient (AEASF) and food formulations 
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2.6.1. Total antioxidant capacity 
 
Antioxidant capacity of the soluble fractions 
from the AEASF (WSF, LMW and HMW) and 
the biscuits formulations (A, B, C, D, E and 
F)was determined by ABTS radical scavenging 
activity measured as described by Oki et al. 
[12]. Previously, biscuits were dissolved in 
water (100 mg/ml) and centrifuged. Then, 
supernatants were diluted with PBS (5mM, 
pH7.4). 
Two and a half mL of 7 mM ABTS•+ aqueous 
solution were mixed with 44µl of 140 mM 
potassium persulfate. The mixture was then 
allowed to stand in the dark for 16 h at room 
temperature. The working solution of the 
radical ABTS•+ was prepared by diluting the 
stock solution 1:75 (v/v) in 5 mmol/L sodium 
phosphate buffer pH 7.4 to yield an 
absorbance value of 0.7 ± 0.02 at 734 nm. The 
working solution of ABTS•+(270µl) was added 
to 30 µl of sample solution in a microplate. 
Absorbance was then measured at 734 nm for 
10 min at 30°C with measurements every 2 
min. After 5 min, the reaction was complete. 
Trolox (0.15–2 µmol/L) was used as standard 
and results were expressed as the %of 
inhibition, IC50 and µmol trolox equivalents 
(eq.)/g sample. All measurements were 
performed in triplicate. 
 
The original QUENCHER assay (direct ABTS) 
was also performed on the insoluble fraction of 
the AEASF (WIF) by measuring the quenching 
activity of the ABTS•+reagent as detailed 
byAçar et al. [13] for insoluble fractions. WIF 
was first diluted 10 folds in cellulose and then 
10 mg of this mixture were weighed. The 
reaction was started by adding 10 mL of 
ABTS•+. The mixture was vortexed for 1 min 
and placed on a rotator in the dark. After 
mixing for 30 min at 37°C, the sample was 
centrifuged at 5000 rpm for 2 min. The 
absorbance of clear supernatant was 
measured at 734 nm. The decrease in color 
was correlated to the antioxidant concentration. 
Trolox (0.2–2 mmol/L) was used to calculate 
overall antioxidant capacity. Results were 
expressed as mmol trolox eq./g WIF. All 
measurements were performed in triplicate. 
  
2.6.2.Alpha-glucosidase inhibitory activity 
assay 
 
This assay was performed on the soluble 
fractions of the AEASF (WSF, LMW and HMW) 
and the biscuits formulations (A-F). Alpha-
glucosidase enzyme was previously extracted 
to the assay. Briefly, 100 mg of rat intestine 
powder were dissolved in 3 ml of NaCl (0.9%), 
sonicated in an ice bath for 6 min and then 
centrifuged at 10000 g for 30 min. The 
supernatant containing the enzyme was stored 
in the freezer.  In a 96-well microplate, 100μl of 
sample dissolved in PBS 100 mM (pH 6.9) 
were mixed with 100μl of α-glucosidase 
(diluted 1/10) and 100μl of 4-MUG (2mM). 
Fluorescence was then monitored at an 
excitation wavelength of 360 nm and an 
emission wavelength of 460 nm for 30 min at 
37°C. Blank of sample and negative control 
(buffer, enzyme and 4-MUG) were included. 
Acarbose was used as a positive control. The 
percentage of α-glucosidase inhibition was 
calculated using the equation: 
"α-glucosidase inhibition (%)= "  ("F" _"nc"  "-" 
"F" _"s" )/"F" _"n.c"   " x 100"  
Where Fn.c. and Fs are the fluorescence of the 
negative control and sample, respectively. All 
measurements were performed in triplicate. 
 
2.7. Quality attributes of the biscuits 
 
2.7.1. Water activity and Ph 
 
The water activity (Aw) of biscuits (A-F) was 
measured by a water activity meter. The 
ground biscuit was placed in the specimen 
holder of the device to record its water activity. 
The analysis was performed in duplicate and 
the mean value was reported. 
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For the pH, 1 g of ground biscuit was mixed 
with 50 mL of deionized water and vortexed for 
5 min. The mixture was held at room 
temperature for 1 h to separate solid and liquid 
phases. After carefully removing the 
supernatant layer, pH was measured using a 
pH meter. The analysis was carried out in 
duplicate. 
 
2.7.2. Color and texture analyses  
 
Color parameters were expressed according to 
CIE L*a*b* scale [14]. Measurements were 
made using the Hunter Lab system with a 
colorimeter (Minolta CR-300, Japan). Four 
independent measurements of a* (redness), b* 
(yellowness) and L* (lightness) parameters 
were carried out on the top and bottom areas 
of the biscuits (A-F).  
The hardness of the biscuits (A-F) was 
measured using a texture analyzer. Results 
were expressed as newton (N). The analysis 
was carried out in duplicate. 
 
2.8. Sensorial analysis of the biscuits 
 
Sensory evaluations of the biscuits (A-F) were 
carried out. Ten pre-trained panelists 
participated in the sensory tests. Biscuits with 
6-digit number codes were randomly presented 
to panelists. A 9-point hedonic scale (1 = 
dislike extremely, 5 = neither like nor dislike, 9 
= liked extremely) was used to evaluate the 
biscuits for color, flavor, crispness, hardness, 
mouth feel and overall acceptability. Panelists 
were asked to swallow samples and to rinse 
their mouths with water between samples. Five 
and higher scores of overall acceptability were 
considered as acceptable in this study.  
 
2.9. Statistical analysis 
 
Data were expressed as mean ± standard 
deviation (SD). The data were then analyzed 
using Duncan’s method for significance tests 
using the software SPSS Version 13.0 (IBM® 
SPSS® Statistics, USA). 
 
3. Results and discussion 
 
3.1. Ingredient characterization  
 
3.1.1.Chemical composition of AEASF 
 
The extraction yield of the AEASF was 
9.6±1.5%. This yield was lower than that 
obtained by Ebringerová et al. [7] and it may be 
related to the botanical origin of almond tree. 
An economical extraction and purification of 
process has been used. However, the 
extraction yield was achieved. The combined 
use of low intensity heat (60ºC) with other 
unconventional technologies such as 
ultrasound and microwave-assisted extraction, 
high pressure combined with thermal 
processing, supercritical Carbon Dioxide (SC-
CO2), pulsed electric fields assisted 
processing to improve extraction yield of 
AEASF or subcritical water extraction may be 
investigated in the future. These approaches 
have been proposed as promising technologies 
that can be useful for extraction of 
glucosinolates and isothiocyanates from 
natural sources. They are difficult to isolate 
because their high reactivy. In addition, their 
hydrolysates are believed to be toxic and anti-
nutritional for animals. Non-conventional 
techniques seem to ensure high extraction 
yields and low degradation of  them [15]. 
 
Table 2(a) shows DF values corresponding to 
AEASF, WSF and WIF. AEASF under the 
conditions hereby described showed a quantity 
of TDF of 43.2% (w/w). The SDF content 
(25%) was greater than the IDF content 
(18.28%), with an IDF/SDF ratio of 1:1.4.DF 
was also found in the two fractions isolated 
from AEASF. WSF contained≈ 40% TDF and 
SDF was three times higher than IDF. WIF, 
accounting for 22.1±1.4%of the AEASF, was 
mainly composed of IDF (81±0.2). Almond 
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shell can be considered a natural abundant 
source of both SDF and IDF. SDFs have been 
linked to reduced cholesterol in the blood and 
decreased intestinal absorption of glucose, 
whereas IDFs are associated with water 
absorption and intestinal regulation [16]. These 
physiological effects of SDFs and IDFs depend 
on their structural and physical properties, 
which can result in behavior such as hydration, 
swelling and enzymatic attack [16]. 
Total carbohydrate content, free glycemic 
sugars and TPC of WSF and the 
corresponding HMW and LMW fractions were 
also evaluated. WSF was rich in carbohydrates 
(44.5±5%). HMW (44.5% of the WSF) 
presented 19.5±3.2% carbohydrates and LMW 
fraction (55.5% of the WSF) 25±2.6% 
carbohydrates. No free simple sugars 
(fructose, glucose and mannose) were found in 
the isolated fractions (WSF, HMW and LMW), 
indicating that ingredients with a low glycemic 
index were obtained. TPC of the WSF, HMW 
and LMW fractions were 47.6±1.8, 31.7±0.4 
and 21.8±0.6mg GAE/g, respectively. These 
values were in the range reported by Sfahlan 
et al. [17], who obtained TPC values in almond 
shell ranging from 18.4 to 62.7 mg GAE/g. 
Moreover, these values obtained in this study 
were higher than those quantified in hazelnuts 
kernel which varied from 491.2 mg GAE/ kg to 
1700.4 mg GAE/ kg depending on the cultivar 
and environmental conditions [18].  
The monosaccharide composition of the WSF, 
HMW and LMW fractions was that illustrated in 
Table 2(b). The monosaccharide composition 
showed that the WSF is mainly composed of 
glucose (14.7%) and xylose (13.9%) (p>0.05), 
followed by arabinose and galactose (p>0.05) 
and finally, by galacturonic acid and 
rhamnoses (p>0.05). These results are in 
agreement with others studies which reported 
that the water soluble fraction of almond shell 
treated with 5% NaOH during 60 min is 
composed of xylan and pectin polymers. It was 
also reported that the water insoluble fraction is 
composed of xylan with low pectin 
contamination [7]. 
The monosaccharide composition of the HMW 
fraction showed that xylose (9.1%) was the 
significantly highest sugar (p<0.05), followed 
by galactose (4.7%) and arabinose (3.5%). 
Glucose, rhamnose and galacturonic acid were 
significantly lower (p<0.05).  On the basis of 
the results, it can be concluded that xylose was 
present in the backbone and some residues of 
galactose, arabinose, glucose, rhamnose and 
galacturonic acid might be linked in the position 
of branched structure in the HMW fraction. As 
shown in Table 2(b), the LMW fraction is 
mainly composed of glucose (13.5%), followed 
by significantly smaller amounts (p<0.05) of 
xylose and arabinose. Galacturonic acid, 
galactose and rhamnose (p>0.05) were 
present in the lowest quantities. All these 
results demonstrate the heterogeneity of these 
polysaccharides.    
Regarding the lignin composition, results 
showed values of 2.5±0.1%, 8.7±0.8%, 
11.4±0.5% and 0.4±0.04% for the WIF, WSF, 
HMW and LMW fractions, respectively. Lignin 
is considered as non-carbohydrate DF  and a 
complex chemical compound usually derived 
from wood and some algae as well as an 
integral part of the secondary cell walls of 
plants [19].All these results implied that the 
obtained ingredient is a lignin-carbohydrates 
complex in which the relative high contents of 
carbohydrate constituents make hydrophobic 
lignin highly water-soluble [20].  
 
3.1.2. Biological activity of the novel 
ingredient 
 
3.1.2.1. Total antioxidant capacity 
 
Figure 1(a) shows the antioxidant capacity of 
almond shell fractions (WSF, HMW and LMW 
fractions). All samples presented antioxidant 
character. The IC50 values for WSF, HMW and 
LMW fractions were 0.21, 0.22 and 0.86 
mg/ml, respectively, corresponding to 786.8, 
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768 and 192.9 µmoltroloxeq./g, respectively. 
All the results described above indicated that 
the active substances (WSF, HMW and LMW 
fractions) comprised lignin as well as 
carbohydrate, had antioxidant capacity. 
Previous reports showed that lignins are 
hindered phenolic polymers which have strong 
antioxidant properties [21]. Carbohydrates 
were also proved to exhibit free radical 
scavenging activities [10]. Therefore, the 
potential antioxidant capacity of these fractions 
may be due to the supply of hydrogen by the 
carbohydrate or lignin constituents, which 
combine with radicals and forms a stable 
radical to terminate the radical chain reaction. 
Basing on our results, the antioxidant power of 
WSF should be attributed to its HMW fraction, 
which contained high lignin content. Lignin 
seems to be major contributor to the overall 
antioxidant character found for WSF. The total 
antioxidant capacity of WSF was higher than 
that previously reported for hazelnut kernels 
(1682.5µmoltrolox eq./kg) [18]. 
WIF showed an overall antioxidant capacity of 
1530 mmol trolox eq./g. Results indicate that 
almond shell is a good source of insoluble 
antioxidant DF. The antioxidant character of 
this polymer may be closely associated to the 
high amount of xylanin its structure  [7]. The 
WIF antioxidant property may also be ascribed 
to lignin [20] which is present in 2.5%.On the 
other hand, phenolic compounds may be 
bound to the structure of polysaccharides and 
lignin enhancing the antioxidant properties of 
the complex [22]. 
The transportation of dietary antioxidants 
through the gastrointestinal tract has been 
described as an essential function of  DF [23]. 
Polyphenols linked to DF may be released in 
the colon by the action of bacterial microbiota, 
producing bioactive metabolites and an 
antioxidant environment, thereby reducing the 
risk of gastrointestinal diseases associated 
with oxidative stress and inflammation. The 
presence of DF and polyphenols has also been 
reported to decrease the glycemic index [24]. 
 
3.1.2.2. Inhibition of intestinal α-
glucosidase activity in vitro 
 
The effect of the novel ingredient (AEASF) on 
α-glucosidase activity is shown in Figure 2(a). 
The three samples (WSF, HMW and LMW 
fractions) inhibited the activity of this enzyme. 
IC50values were of 1.5, 1.2 and 7.9 mg/ml, 
corresponding to 23.2, 30.3 and 4.5 mg 
acarbose eq./g for the WSF, HMW and LMW 
fractions, respectively. Results indicated that 
the HMW fraction is composed of more 
efficient inhibitors of the enzyme than the LMW 
fraction. This activity may be ascribed to both 
lignin-carbohydrate complex and phenols. 
Polyphenols possess the ability to bind to the 
active protein pocket of the α-glucosidase 
enzyme [25]. Several studies suggest that 
plant polyphenols act as inhibitors of 
carbohydrate hydrolyzing enzymes [26]. 
Carbohydrates were also proved to possess α-
glucosidase inhibitory activity [27].Therefore, 
the strong potential α-glucosidase inhibitory 
activity may be due to both effect of 
carbohydrates and lignin containing 
polyphenols. As far as we know, there is no 
report to date, describing the α-glucosidase 
inhibitory activity of a lignin-carbohydrate 
polymer.  
The capacity of the HMW fraction to inhibit the 
activity of α-glucosidase (90%) was higher than 
that reported for wheat, buckwheat, corn and 
oats (18–31%) [28],  and was comparable to 
that found for sorghum (95%). Results also 
indicated that almond shell is source of α-
glucosidase inhibitors. Therefore, it can be 
incorporated into food as a potential 
antidiabetic agent. To the best of our 
knowledge, this is the first time that this 
property is associated with fractions recovered 
from this agronomical by-product. 
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3.2. Characterization of biscuits  
 
3.2.1. DF composition and bioactivity 
properties 
 
The DF content of the different biscuits (A-F) is 
shown in table 3. The highest values were 
found for C and F biscuit formulations (15.4% 
and 17.7% TDF) containing stevia and 
sucrose, respectively, and both, AEASF as 
ingredient source of DF (43%). As expected, 
the lowest amounts of fiber were reported by A 
(sucrose) and D (stevia) control biscuits (4.0% 
and 4.1%). According to the nutritional claims 
approved by the European Commission 
Regulation (EU) No 1924/2006 [29] relative to 
fiber content, new biscuit formulations 
containing AEASF  fiber (B, C, E and F)could 
be classified within “high fiber content” 
nutritional claim (≥ 6 g of fiber per 100 g).The 
incorporation of the novel ingredient (AEASF) 
to the biscuit formulation significantly (p<0.05) 
increased the amount of TDF above 6% and 
the proportion of IDF. The SDF/IDF ratios were 
of 1:1.7 and 1:1.5, for sucrose (A) and stevia 
(B) control biscuits, 1:2.2 for B and E biscuits, 
and 1:4.6 and 1:4.1 for C and F, respectively. 
The soluble/insoluble fiber ratio has been 
established at 1:3 [30], which in concordance 
with our findings. Recommendations with 
regard to DF consumption differ depending on 
the regulatory body. For instance, the World 
Health Organization (WHO) suggests a daily 
consumption of 27–40 g of TDF. However, the 
American Dietetic Association (ADA) 
recommends an intake between 20 and 30 g of 
fiber/day, of which 3–10 g should be SDF (15–
30% soluble fiber).The consumption of a 
portion (≈ 45 g) of “high fiber content” biscuits 
supplemented with AEASF (B, C, E and F 
biscutis) can provide 2.8 g, 6.9 g, 3.6 g and 7.9 
g of TDF and 0.86 g, 1.2 g, 1.1 g and 1.53 g of 
SDF, respectively. Therefore, a moderate 
consumption (5 units/ day) of the novel “high 
fiber content” biscuit formulations (F) made 
with stevia and AEASF fiber provides 23% of 
the daily average amount of TDF 
recommended by the WHO and 24% of the 
SDF recommended by the ADA.  
Addition of AEASF significantly increased 
(p<0.05) the TPC of the biscuits (table 3), 
achieving the highest values the C and F 
biscuits. No significant differences in TPC were 
found between control biscuits (A and D) 
(p>0.05) and among the biscuits supplemented 
with the same percentage of fiber (B and E 
(p>0.05); C and F (p>0.05)). Thus, 
supplementation of novel biscuits with AEASF 
fiber not only improves the balance of DF of 
the food formulations but also their phenolic 
content.  
Antioxidants and α-glucosidase inhibitors may 
be degraded during the baking process. No 
data on the thermal stability of biocompounds 
present in AEASF have been previously 
reported. Biscuit formulations containing this 
novel ingredient (B, C, E and F) showed 
significantly higher (p<0.05) antioxidant 
capacity than control biscuits (A and D) (Figure 
1 (b) and (c)). The antioxidant capacity values 
of the biscuits containing equal amounts of 
AEASF (B and E; C and F) were of the same 
order of magnitude (p>0.05). Biscuits with the 
highest DF content (C and F) presented the 
greatest antioxidant capacity. These results fit 
with the TPC above described and support the 
stability of antioxidant compounds to the 
thermal treatment. 
As can be observed in figure 2 (b) and (c), the 
α-glucosidase inhibitors in the novel biscuits 
resisted the baking process. The “high fiber 
content” biscuits (C, 15.4% and F, 17.6%) 
corresponding to the highest concentration of 
AEASF showed the highest inhibitory potential 
against the activity of α-glucosidase. According 
to our calculations, the intake of 1 g of biscuit 
may correspond to 1 mg of acarbose and 
moderate consumption of these novel biscuits 
(5 units/day) may exert an antidiabetic effect 
similar to that of 50 mg acarbose. Novel 
biscuits made using ingredients recovered from 
almond shell (AEASF) present a great potential 
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as functional and/or medical food since they 
may be useful in reducing the risk and treating 
chronic metabolic disorders related to the 
metabolism of carbohydrates and oxidative 
stress such as type 2diabetes.  
 
3.2.2. Quality parameters 
 
The measurement of Aw is crucial considering 
the development of a food product. It can be 
used for the determination of shelf-life and it is 
an analysis of quality control [31]. As shown in 
Table 3, sucrose replacement by stevia 
increased Aw. These results agree with others 
previously reported [32, 33]. However, the 
increase of almond shell DF in the formulation 
of biscuits slightly decreased their Aw, which is 
in concordance with those results described by 
Garcia-Serna et al. [33] who observed less 
moisture content when coffee silverskin was 
incorporated as DF in biscuits. This Aw 
decrease may be attributed to the greater 
ability to strongly bind water of the soluble and 
insoluble fibers present in almond shell 
compared to wheat flour and therefore lower 
water availability in the biscuits. Addition of 
AEASF may enhance the quality of dietary 
biscuits made with stevia. Similar results 
reported by Prokopov et al. [34], showed that 
adding 10% and 20% cabbage leaf power rich 
of dietary fiber to sponge cake, increased 
water binding and thereby water retention 
power. Aw below 0.5 limits the growth of all 
microorganisms and chemical degradative 
reactions in food are widely decreased [35]. 
Then, all the tested biscuits containing sucrose 
or stevia and with or without almond shell DF, 
can be considered microbiological safe. 
Previous studies recognize the use of dietary 
fiber as an aid in delaying the aging of bakery 
products [34].  
The demand for health-oriented products that 
containing high fiber, natural antioxidants, and 
low calorie content; such as, those proposed in 
the present article is increasing because of 
their beneficial health effects [34]. The 
replacement of sugar by stevia scarcely 
decreased pH values of the biscuit 
formulations (Table 3) unlike those recent 
results found by others authors [32], who 
associate steviosides with increase of pH in 
biscuits. In contrast, supplementation with 
AEASF fiber significantly (p<0.05) increased 
the pH (≥7).Our results are in accordance with 
those pH values observed for biscuits, which 
have been described to range from 7.0 to 7.3 
[36]. These values are suitable for stability or 
keeping qualities due to the fats being more 
readily attacked and broken down in an acid 
medium than in alkaline medium [37].  
Sugar replacement significantly increased 
(p<0.05) L* and increased a*, color parameters 
(Table 3). The addition of AEASF to the biscuit 
formulation significantly affected their color 
profile (online resource 2). L* and 
b*parameters significantly (p<0.05) decreased 
in a dose-dependent manner, while a* 
increased with the addition of DF (Table 3). 
These results are in line with those previously 
reported by Garcia-Serna et al. [33].These 
findings support the potential of almond shell 
components as natural coloring.  
Texture analysis of biscuits is shown in Table 
3. Sucrose biscuits were harder than those 
made with stevia [32, 33, 38]. Addition of 
AEASF significantly increased (p<0.05) the 
hardness of biscuits in a dose-dependent 
manner. These mechanical changes are 
related to an increase in fibers and 
carbohydrates and to reduced gluten 
development capacity. Popov-Raljic et al. [39] 
previously reported that the nature of DF used 
in biscuits affects their rheological properties, 
water activity, viscosity and sensorial 
characteristics such as color. 
According to our results, almond shell 
incorporated as DF in combination with stevia 
produces dietary biscuits with acceptable 
quality properties. 
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3.2.3. Sensorial analysis 
 
All biscuits prepared hereby were evaluated for 
their color, flavor, crispness, hardness, 
mouthfeel and overall acceptability using 9-
point hedonic scale (Table 4). According to the 
data, both the sweetener and the DF content 
have influence on the sensorial analysis of the 
biscuits. Regarding the use of stevia as 
sweetener, can be observed crispness was 
significantly (p<0.05) scored lower (D, 5.7) 
than the biscuit containing sucrose (A, 6.5) and 
overall acceptability decreased (F, 6.1) when 
compared to the respective biscuit made with 
sucrose (C, 7.1). The other attributes were not 
affected by the replacement of sucrose by 
stevia. As previously reported, 
fructoligosacharides (FOS) presents slightly 
sweetness and could enhance taste of the 
biscuits by masking negative off-flavors from 
stevia and therefore, to improve the overall 
acceptance [40]. As far as AEASF fiber 
addition is concerned, biscuits were less 
appreciated for the color, hardness and mouth 
feel attributes when high amount of AEASF 
was added (C and F biscuits) but more 
appreciated for the crispness. Similar results 
demonstrated by Prokopov et al. [34], showed 
that the addition of 10% and 20% cabbage leaf 
powder changed the sensory cakes 
characteristics, which became less appreciated 
for the sensation for sweetness and the color. 
 Moreover, there were no significant 
differences in the flavor for all biscuits, contrary 
to what was reported by Prokopov et al. [34], 
who showed that the sponge cake made with 
cabbage leaf powder has a strongly expressed 
odor specific towards the sample odor. 
Moreover, those “high fiber content” biscuits 
supplemented with AEASF in their formulations 
(B, 6% DF and E, 8% DF) achieved the highest 
scores for all sensorial parameters.  
In the overall acceptance, all evaluated biscuits 
resulted in formulations with acceptable 
sensory characteristics. The modifications of 
the control biscuit composition did not 
significantly impair overall acceptability of the 
final products. However, the highest scores 
were attributed to biscuits (B and E) prepared 
with sucrose and stevia and supplemented with 
AEASF with 6% and 8% of DF, respectively (B, 
7.6 and E, 7.2). The lowest values were for the 
control biscuits (A, 7 and D, 6.4). Therefore, we 
could consider AEASF highly-accepted 
ingredient to include in innovative biscuits 
since diary baked products were obtained 
according with consumers’ preferences. 
 
4. Conclusion 
 
Fractions recovered from almond shell 
following the procedures hereby described 
have a great added value due to their potential 
to prevent and/or treat diabetes as a diet-
related chronic disease. Biscuits made with the 
almond shell contain SDF and IDF, natural 
antioxidants and inhibitors of α-glucosidase 
enzyme and, in addition, they present 
acceptable sensorial properties according to 
consumers’ preferences.  
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FIGURE CAPTIONS 
Figure 1.Concentration-response curves of 
total antioxidant capacity as the percentage 
(%) inhibition of the radical ABTS•+ of the (a) 
fractions recovered from almond shell (WSF, 
water soluble fraction; HMW, water soluble 
compounds with molecular weight higher than 
3 kDa; LMW, water soluble compounds with 
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molecular weight lower than 3 kDa), (b) 
biscuits containing sucrose (A, control) and 
AEASF fiber (Band C, “high fiber content”), and 
(c) biscuits containing stevia as sweetener (D, 
control) and AEASF fiber (Eand F, “high fiber 
content”). Data are presented as mean ± SD. 
 
Figure 2.Inhibitory effect on alpha-glucosidase 
activity of the (a) fractions recovered from 
almond shell (WSF, water soluble fraction; 
HMW, water soluble compounds with 
molecular weight higher than 3 kDa; LMW, 
water soluble compounds with molecular 
weight lower than 3 kDa), (b) biscuits 
containing sucrose (A, control) and AEASF 
fiber (B and C, “high fiber content”), and (c) 
biscuits containing stevia as sweetener (D, 
control) and AEASF fiber (E and F, “high fiber 
content”).Data are presented as mean ± SD.
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Table 1. Food formulations: A, control biscuit using sucrose as sweetener; B and C, sucrose biscuits 
containing alkali-extracted almond shell (AEASF, 3.9% and 15.3%, respectively) as source of dietary fiber;  D, 
control biscuit using stevia as sweetener; E and F, stevia biscuits containing AEASF (3% and 14.7%, 
respectively).  
 
 
Table 2. (a) Content of total (TDF), insoluble (IDF) and soluble (SDF) dietary fiber of the alkali-extracted 
almond shell (AEASF) and its soluble (WSF) and insoluble (WIF) fractions, and (b) monosaccharide 
composition of the water soluble fraction (WSF) and its corresponding high (HMW) and low (LMW) molecular 
weight fractions. Results were expressed as %. 
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Table 3. Total (TDF), soluble (SDF) and insoluble (IDF) dietary fiber, total phenolic content (TPC) 
and quality attributes (pH, Aw, hardness and color) of the proposed biscuits: A, control sucrose 
biscuit; B and C, sucrose biscuits containing alkali-extracted almond shell (AEASF, 3.9% and 15.3%, 
respectively) as source of dietary fiber; D, control stevia biscuit; and E and F, stevia biscuits 
containing AEASF (3% and 14.7%, respectively). 
 
Table 4. Sensory evaluation scores (1 to 9 scale) of biscuits: A, control sucrose biscuit; B and C 
sucrose biscuits B and C, sucrose biscuits containing alkali-extracted almond shell (AEASF) dietary 
fiber (“high fiber content”, 6.3% and 15.4%, respectively);  D, control stevia biscuit, and E and F, 
stevia biscuits containing AEASF dietary fiber (“high fiber content”, 8.12% and 17.7%, respectively). 
 
 
 
 
 
Annex 4 
 
 243 
 
Supplementary material 
 
Table 1. Physico-chemical composition of almond shell. Results are expressed as % of total dry material and 
mg/100g 
 
Figure  1. Visual appearance of the novel biscuits: A, control biscuit using sucrose as sweetener; B and C, 
sucrose biscuits containing alkali-extracted almond shell (AEASF) dietary fiber (“high fiber content”, 6.3% and 
15.4%, respectively); D, control biscuit using stevia as sweetener; and E and F, stevia biscuits containing 
AEASF dietary fiber (“high fiber content”, 8.12% and 17.7%, respectively).
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4. “Determinación de la bioaccesibilidad de productos de la reacción de Maillard y antioxidantes 
en café usado (Coffea arabica L.)”. K, Vázquez Sánchez, M. D. del Castillo, N., Martinez-Saez, 
R., Campos Vega. Congreso Internacional de Investigación e Innovación. 21-22nd April, 2016, 
Guanajuato, Mexico. Poster. 
5. “Effect of new biscuit formulations in the release of satiety hormones”. N. Martinez-Saez, C.M. 
Hochkogler, V. Somoza, M.D. del Castillo. 7th International Simposium of Food Development 
and Innovation: "Challenges, progress and innovation in food processing", 7-9th October, 2015, 
LATU, Montevideo, Uruguay. Poster. 
6. "Reduction of after-taste in innovative biscuit formulations made with stevia". N. Martinez-
Saez, M.D. del Castillo. 7th World Convention on Stevia: Stevia Tasteful 2015 - Science, 
Formulation & Extraction: The Subtle Balance. 11-12th June, 2015, Berlin, Germany. Oral 
presentation.  
7. “Feasability of spent coffee grounds as dietary fibre”. N. Martinez-Saez, M. Ullate, M.A., 
Martín-Cabrejas, M.D. del Castillo. II Simposio Científico Internacional para la Innovación en la 
Industria Marina y Alimentaria, 15-16th September, 2014, Vigo, Spain. Poster. 
8. “Aplicación de los marros del café como fuente de fibra antioxidante”. N. Martinez-Saez, M. 
Ullate, M.A., Martín-Cabrejas, M.D. del Castillo. CIALFORUM, Madrid, España. 5th June, 
Madrid, Spain. Oral presentation. 
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9. “A novel antioxidant beverage for body weight control based on coffee silverskin”. N. Martinez-
Saez, M. Ullate, M.A., Martín-Cabrejas, P. Martorell, S.R. Genovés, M.D. del Castillo. Second 
International Congress on Cocoa and Tea. 9-11th October, 2013, Naples, Italy. Oral 
presentation. 
10. “Innovative alternative use of coffee by-products”. M. Ullate, B. Fernández-Gomez, N. 
Martinez-Saez, M.D. del Castillo. Second International Congress on Cocoa and Tea. October 
9-11th, 2013, Naples, Italy. Poster. 
11. “Mitigation of food processing contaminants by alternative sugar substitutes”. M.D. del Castillo, 
N. Martinez-Saez, E. García-Serna, F.J. Morales.  EUROFOODCHEM XVII. 7-10th May, 2013, 
Istanbul, Turkey. Poster. 
 
Participation in teacher training programs 
 
Practical classes at the UAM of the following subjects : 
2017 - “Sensorial Analysis” (Bachelor’s Degree in “Food Sciences”, 3rd course)  
2015 - “Instrumental and Sensorial Analysis of Foods” (Bachelor’s Degree in “Human Nutrition 
and Dietetics”, 2nd course). 
2014 - “Food Products” (Bachelor’s Degree in “Food Sciences”, 2nd course) and “Instrumental 
and Sensorial Analysis of Foods” (36h) (Bachelor’s Degree in “Human Nutrition and Dietetics”, 
2nd course).  
 
Training courses  
 
1) II Technical Training School: "How to use the consensus model, calibrate the digestive 
enzymes”. INFOGEST Cost Action. 19-23rd January, 2015, Faculty of Pharmacy, University of 
Granada, Spain.  
2) I Jornadas de Ciencia y Gastronomía: De la Ciencia a la Innovación. FACYRE. 22-23rd 
September, 2014.  CIAL, Madrid, Spain.  
3) Training course for working with experimental animals: Category B.  BINAEX. 21st April -9th 
June, 2014. Accredited by the “Área de Protección Animal de la DG de Medio Ambiente de la 
Comunidad de Madrid por Resolución 10/114426,9/14 de fecha 13/05/2014”.  
4) II Training School: “Food Digestion and Human Health”. INFOGEST Cost Action. 24-28th 
March, 2014, at the Food Science Institute, Budapest, Hungary. 
 
